Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AC008162.2		ENSG00000278646	"Novel protein similar to cancer/testis antigen family 47, member A12 (CT47A12)"		X	120877496-120878924	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	7	"testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"U-266/70: 3.8"									HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoli		"HPA042483: AB_2678017"																		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.5;parathyroid gland: 92.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 116.4;Distal tubular cells: 52.8;Early spermatids: 141.6;Late spermatids: 168.0;Paneth cells: 87.0;Proximal enterocytes: 127.0;Undifferentiated cells: 52.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 14.8;T-reg: 13.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 93.9;RPMI-8226: 41.2;TIME: 57.7;U-138 MG: 42.4;U-266/84: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.5	0.2	1.9	14.2	2.1	1.1	3.3	0.6	2.2	0.4	35.2	80.7	82.4	0.3	13.7	1.5	0.6	1.6	0.3	2.0	0.0	9.8	1.4	11.1	9.4	0.1	0.1	0.2	0.8	92.9	0.0	2.4	0.1	0.4	58.5	0.6	0.8	24.4	1.0	18.9	98.5	2.6	0.1	1.3	38.2	22.6	0.4	2.6	0.5	0.1	12.7	10.2	0.3	1.1	4.1	0.0	0.0	0.0	0.5	0.9	0.1	1.5	0.8	1.0	0.7	3.6	1.9	0.1	1.7	0.7	2.4	1.9	0.0	11.2	1.4	0.1	0.0	0.3	0.8	0.1	0.3	0.1	0.2	0.0	20.4	10.4	23.6	17.5	93.9	0.7	23.0	0.0	3.1	0.1	0.2	0.6	0.3	0.1	5.8	0.0	0.3	41.2	1.7	0.2	0.1	0.2	1.5	0.0	0.8	2.8	0.0	0.8	57.7	42.4	2.0	0.7	2.6	1.2	47.1	0.0	7.9	1.3	0.2	2.7	0.0	0.0	0.0	0.3	2.6	0.2	3.7	0.3	0.1	0.2	14.8	1.3	0.3	0.1	0.2	0.2	13.5	1.7	1.9	2.1	0.6	2.2	2.0	0.0	0.1	0.1	0.1	0.1	0.4	1.1	0.2	0.0	1.1	0.7	4.0	5.1	0.3	3.9	0.6	0.0	0.1	1.9	0.1	0.0	2.6	5.5	0.0	0.2	0.1	116.4	52.8	0.7	141.6	0.2	0.0	0.3	5.4	2.7	13.1	2.4	0.2	1.1	32.1	0.1	5.7	0.0	0.0	0.2	11.4	0.0	0.4	40.7	2.0	0.8	1.5	168.0	1.8	3.1	1.8	0.0	27.9	0.0	1.0	1.0	0.1	7.9	87.0	0.7	7.8	0.6	127.0	0.7	0.8	0.0	0.0	0.2	1.2	1.6	0.7	0.4	5.7	0.1	6.2	0.0	52.3	0.5
AL772284.1		ENSG00000277535	"Novel cancer/testis antigen family protein"		X	119073226-119076373	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in single"	26	"testis: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Approved	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD30A	NY-BR-1	ENSG00000148513	"Ankyrin repeat domain 30A"	Q9BXX3	10	37125725-37384111	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"breast: 38.1"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 295.9;Breast myoepithelial cells: 84.8"	"Cancer enriched"	"Detected in single"	37	"breast cancer: 11.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"A549: 2.7;U-266/70: 10.4"									HPA071849			Uncertain	Nucleoli		NA	NA				"Cluster 5: Breast - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	Nucleoli		"HPA071849: "	"unprognostic (2.79e-1)"											"unprognostic (2.81e-1)"	"unprognostic (1.01e-7)"	"unprognostic (1.41e-1)"		"unprognostic (5.93e-1)"		1.0	0.0	0.0	0.0	0.0	0.0	38.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	295.9	84.8	0.3	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	16.3	0.0	0.4	1.0	0.0	0.0	1.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	8.5	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	45.8	1.7	0.0	0.0	0.3	0.3	0.1	0.0	0.0
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14854038	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"testis: 8.2"	"Group enriched"	"Detected in some"	8	"Early spermatids: 13.1;Excitatory neurons: 32.6;Inhibitory neurons: 39.3;Late spermatids: 13.9;Spermatocytes: 23.7"	"Cancer enriched"	"Detected in single"	5	"breast cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 63.1"									"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA060455: AB_2684282, HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.1	0.1	0.2	0.0	0.4	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	8.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.7	0.0	1.1	4.4	0.3	63.1	0.0	6.7	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.4	0.4	0.4	0.1	0.1	0.2	0.1	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.4	0.0	0.0	0.0	2.8	1.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.9	0.0	13.1	0.7	0.1	0.2	1.8	0.0	32.6	0.0	0.4	0.1	0.0	1.8	0.0	0.1	0.0	0.1	0.1	0.0	39.3	1.6	0.0	0.3	0.0	13.9	0.9	0.2	0.0	1.0	0.0	0.0	0.0	2.5	1.1	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	23.7	1.7	0.0	0.3	0.5	0.1	0.0	1.1	0.3
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253253-183298504	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 76.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 151.2;Distal enterocytes: 150.4;Squamous epithelial cells: 169.9;Syncytiotrophoblasts: 157.9;Urothelial cells: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"neutrophil: 5.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 82.4;HBEC3-KT: 70.3;hTCEpi: 83.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 14.7"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	11.9	2.4	3.3	13.7	3.5	76.5	5.5	2.3	3.2	6.0	0.9	22.6	38.2	5.1	9.1	37.5	9.6	21.3	3.5	3.7	4.0	3.8	3.3	15.0	1.1	5.6	3.8	4.6	7.5	3.5	5.7	13.9	4.6	7.9	19.6	1.2	10.1	3.3	7.4	10.3	42.0	6.7	4.3	1.6	11.3	7.3	3.5	7.6	5.2	4.5	5.3	24.2	13.8	5.5	46.2	4.4	23.8	14.7	19.5	57.0	21.5	0.7	1.1	4.6	3.8	9.0	23.6	0.0	2.7	0.1	82.4	20.6	24.7	70.3	3.9	0.1	15.3	2.4	1.9	0.0	24.8	23.4	10.9	27.0	83.5	3.7	62.1	6.2	43.4	0.1	26.6	0.1	38.1	0.0	0.1	7.6	10.1	26.9	38.5	7.3	12.0	0.1	14.4	12.7	1.0	22.6	12.7	0.1	5.3	10.6	0.0	28.0	64.6	1.1	9.0	1.4	11.0	0.0	0.0	0.0	8.8	54.1	23.8	0.0	1.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.2	0.3	3.3	3.5	2.3	3.2	3.7	4.0	5.6	3.8	4.6	4.3	3.5	5.5	151.2	6.4	17.5	2.3	1.2	65.1	70.2	35.8	101.3	10.0	18.4	10.4	2.2	21.5	40.5	5.5	22.9	31.0	1.9	150.4	1.9	18.0	13.4	58.0	13.1	26.3	38.2	6.3	1.8	11.8	10.7	9.2	70.3	55.3	14.0	2.4	2.2	0.6	29.6	3.3	1.5	88.2	34.6	15.6	123.2	26.5	1.5	76.8	12.4	80.6	9.4	3.1	0.0	4.5	0.8	35.7	126.4	0.4	1.4	43.1	74.9	4.8	118.5	13.1	0.0	23.6	5.4	7.9	0.8	169.9	84.8	157.9	4.3	0.2	36.2	144.4
BAHCC1	"BAHD2, KIAA1447"	ENSG00000266074	"BAH domain and coiled-coil containing 1"	Q9P281	17	81395457-81466332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 47.3;Cone photoreceptor cells: 22.9;Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 25.5;MOLT-4: 31.7;NB-4: 108.4;REH: 33.0"	"Low region specificity"	"Detected in all"							"HPA023386, HPA076910"	Approved		Approved	Nucleoli		NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoli		"HPA023386: AB_1859537, HPA076910: AB_2732325"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.78e-2)"	5.9	5.4	4.0	1.8	5.2	4.9	5.0	7.9	6.4	5.8	0.0	4.9	3.3	6.6	1.0	2.9	6.7	3.1	4.0	3.2	2.6	5.6	3.2	4.4	0.7	4.3	3.6	7.7	5.2	2.1	5.2	0.9	3.3	5.6	0.9	2.1	3.7	1.9	3.8	3.8	4.3	1.5	1.1	3.7	5.7	4.0	6.0	4.0	8.3	0.9	0.4	5.9	4.0	7.6	4.1	6.9	4.9	16.3	1.7	2.6	2.3	3.0	2.6	1.6	0.9	1.3	1.8	0.1	4.3	3.4	2.3	4.1	2.4	1.9	0.3	0.0	7.5	5.6	1.8	2.1	1.5	25.5	5.2	4.4	0.7	1.4	1.4	2.5	1.8	6.2	4.0	0.0	0.7	2.4	31.7	108.4	0.3	2.5	4.6	33.0	3.4	0.0	2.0	0.3	22.5	3.5	3.8	0.0	13.3	0.5	0.8	20.3	2.2	8.8	1.2	4.8	1.5	0.0	0.0	0.0	0.0	11.6	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.0	5.2	7.9	6.4	3.2	2.6	4.3	3.6	3.3	1.1	6.0	7.6	6.7	6.4	13.1	11.4	0.0	0.0	1.5	0.0	3.4	47.3	4.8	4.3	10.0	8.6	3.7	3.7	22.9	0.1	4.4	2.4	1.9	3.3	0.7	1.4	2.0	6.7	8.4	1.7	15.5	4.0	0.2	7.5	4.1	1.7	0.0	7.3	6.1	3.7	0.6	33.7	18.9	4.7	0.0	2.8	0.0	0.4	7.5	2.8	0.0	2.8	2.5	8.6	0.0	12.5	15.1	2.0	1.7	5.7	0.0	1.8	4.6	1.2	2.2	17.8	0.0	7.6	9.8	1.8	10.0	3.1	0.0	0.0	0.2	4.9	5.4	0.9
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987945-64997018	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 21.2;Intestinal goblet cells: 8.5;Proximal enterocytes: 7.9;Undifferentiated cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.1;intermediate monocyte: 5.3;neutrophil: 7.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.3;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 13.1;BJ hTERT+ SV40 Large T+ RasG12V: 20.0;GAMG: 19.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062496	Approved		Approved	Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA062496: AB_2684783"	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.39e-5)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.2	4.4	2.7	8.7	2.8	0.5	1.4	2.4	2.9	1.7	2.8	8.6	9.3	1.2	0.7	1.0	2.6	3.9	3.0	2.5	2.6	5.7	4.7	7.0	3.2	4.1	2.7	3.1	9.2	0.9	2.3	2.8	4.0	2.8	6.2	0.5	13.4	4.4	4.9	0.4	6.5	2.7	4.0	13.5	4.5	0.7	3.0	1.6	2.0	2.7	1.2	4.6	1.0	2.6	1.5	1.0	0.2	0.0	0.1	0.8	0.0	0.5	6.5	13.1	20.0	1.9	5.8	0.1	2.7	1.0	19.5	0.1	0.0	1.7	0.9	0.2	0.4	1.8	0.0	5.3	4.8	0.0	1.1	0.4	0.4	1.7	2.2	0.5	3.2	0.1	4.3	0.1	0.3	0.4	0.0	0.1	0.5	0.0	0.6	0.0	1.3	0.6	1.6	0.1	0.1	0.0	0.8	0.3	6.9	0.1	0.5	1.0	2.4	0.7	0.7	1.1	0.0	0.1	0.2	0.4	1.1	0.5	0.6	0.0	2.1	1.0	0.0	5.3	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	7.3	0.1	2.8	0.0	0.0	0.8	2.7	2.8	2.4	2.9	2.5	2.6	4.1	2.7	4.0	4.0	3.0	2.6	3.7	3.2	2.0	1.0	1.3	0.0	0.5	1.8	0.0	0.2	1.2	0.5	0.6	4.3	2.6	1.8	0.0	0.0	0.0	21.2	1.9	4.8	0.8	0.4	1.2	2.7	2.4	0.0	0.2	6.6	0.3	1.8	2.6	0.1	0.0	0.1	5.0	0.9	4.7	0.0	0.1	8.5	0.0	3.5	0.3	2.4	0.0	1.0	0.0	1.0	1.0	0.9	0.0	1.0	0.1	4.9	7.6	0.7	0.0	0.2	7.9	4.1	3.5	0.2	0.0	1.7	1.7	0.1	0.6	0.0	0.0	0.0	0.1	1.1	8.4	2.4
BCAS3	FLJ20128	ENSG00000141376	"BCAS3 microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Astrocytes: 241.9;Excitatory neurons: 298.7;Inhibitory neurons: 299.2;Late spermatids: 282.3;Microglial cells: 244.5;Oligodendrocyte precursor cells: 285.0;Oligodendrocytes: 552.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 88.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli		"HPA052409: AB_2681821, HPA057289: AB_2683399"	"unprognostic (2.84e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	9.7	11.6	12.7	4.5	14.2	6.4	9.0	13.8	15.8	9.4	12.0	10.0	4.8	9.3	12.1	9.5	13.9	7.6	9.1	13.6	12.2	11.1	12.4	11.1	6.0	14.3	12.1	7.4	9.3	14.4	6.9	10.0	15.2	11.1	6.1	18.0	9.3	9.2	17.3	14.2	6.8	9.0	10.2	7.4	9.7	14.3	12.1	10.6	8.8	9.8	6.7	10.9	9.6	24.0	5.7	14.5	7.8	28.1	17.2	14.2	9.8	6.6	9.9	7.3	9.3	10.0	13.8	2.5	9.7	12.2	7.6	4.9	4.5	6.1	9.5	6.1	19.4	5.6	7.3	9.5	9.4	2.7	5.6	14.5	6.3	6.2	11.1	14.2	8.3	8.8	5.1	12.9	6.5	88.7	10.0	2.2	7.3	29.1	18.2	11.4	11.2	12.4	6.0	24.4	11.6	10.2	12.1	3.3	10.3	20.9	13.5	5.1	8.1	9.5	7.7	4.2	2.8	29.1	23.6	11.7	11.2	2.3	7.6	27.2	10.1	16.5	15.0	9.3	12.3	11.4	10.2	11.2	8.8	11.2	10.7	9.1	34.5	15.6	10.9	6.8	18.0	9.0	12.7	14.2	13.8	15.8	13.6	12.2	14.3	12.1	15.2	10.2	12.1	24.0	10.1	6.4	12.5	241.9	8.6	5.1	9.9	4.7	12.5	22.6	4.4	4.1	11.4	7.2	9.3	16.5	10.4	6.8	9.3	4.1	9.8	4.7	44.2	20.4	26.1	8.6	7.2	13.2	298.7	3.5	5.5	7.8	5.6	9.1	15.9	11.1	11.7	10.8	4.3	3.3	299.2	4.9	6.1	10.0	2.5	282.3	7.5	5.3	1.8	244.5	8.2	33.3	5.2	285.0	552.6	3.6	5.2	21.1	11.1	2.9	6.0	25.2	35.6	14.2	13.1	7.1	21.2	16.3	6.6	6.8	5.5	7.5	11.4	6.7	3.8	6.0
BLCAP	BC10	ENSG00000166619	"BLCAP apoptosis inducing factor"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 466.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 358.9"	"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli		"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.28e-5)"	65.3	56.2	161.7	27.2	189.7	35.9	59.5	106.0	147.2	49.3	159.6	54.9	51.1	34.5	52.5	86.3	141.0	29.0	75.7	147.4	163.5	60.5	101.0	37.3	40.0	123.5	137.6	40.8	27.3	50.8	149.1	76.0	145.4	59.5	52.2	70.9	57.2	56.3	466.4	88.3	48.0	34.0	108.3	46.8	39.2	30.6	197.8	41.6	45.5	120.2	53.1	72.5	60.0	117.3	138.0	38.8	45.8	48.6	86.2	66.0	63.8	64.3	62.2	56.4	45.5	137.9	109.3	70.7	62.1	90.1	53.7	259.1	34.4	268.1	57.5	14.7	31.5	23.2	94.0	130.5	55.8	46.5	29.9	84.8	283.9	54.3	101.0	46.1	79.6	51.3	22.7	51.9	114.1	77.0	39.0	37.1	36.9	77.6	109.6	36.6	171.0	47.2	64.6	358.9	41.8	50.2	77.3	221.2	54.7	46.5	73.6	44.4	75.2	144.6	37.2	51.3	28.2	28.1	37.5	34.2	60.4	42.4	26.5	74.9	56.6	69.9	45.2	56.0	49.6	93.9	51.3	48.4	52.8	113.6	67.1	52.6	59.3	48.2	53.8	22.6	55.4	52.8	161.7	189.7	106.0	147.2	147.4	163.5	123.5	137.6	145.4	108.3	197.8	117.3	24.4	80.1	31.0	14.0	38.4	147.0	97.3	135.9	137.1	43.0	29.0	60.8	56.8	30.0	68.7	40.5	22.9	115.1	25.5	72.4	82.2	35.7	73.7	58.8	26.3	54.0	40.9	15.6	26.8	33.9	84.8	29.5	17.9	18.1	29.2	32.1	89.6	81.0	55.8	42.1	29.8	58.8	52.9	41.9	36.2	161.7	29.8	29.1	35.6	13.1	30.1	64.0	24.7	16.6	11.4	54.0	31.4	59.5	16.5	88.6	69.9	55.7	63.2	36.2	32.9	28.6	27.0	30.8	27.1	66.8	122.9	65.0	26.1	54.0	33.3	133.4
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2 RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849861	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.0	8.0	6.6	4.6	7.2	14.3	11.0	6.6	7.6	15.2	6.4	11.3	4.1	12.6	6.3	8.2	11.9	4.6	10.8	7.8	6.7	9.8	7.9	7.6	6.7	6.9	7.1	12.8	8.4	6.5	9.7	7.6	7.7	13.7	5.3	5.9	7.9	7.0	28.5	11.2	7.7	5.7	6.6	9.8	8.9	7.8	7.1	11.0	7.2	12.8	5.4	14.0	10.7	7.4	13.1	9.9	9.6	12.4	13.0	9.5	11.2	15.1	12.0	20.1	13.7	12.9	9.2	16.0	21.3	9.6	7.6	13.3	12.5	9.5	10.0	10.0	12.5	19.7	8.3	10.6	13.6	7.9	11.3	12.8	12.3	20.1	8.5	9.8	6.6	14.0	24.6	13.9	6.6	7.5	25.2	9.9	16.1	9.6	13.1	14.7	10.4	8.1	7.4	8.7	8.1	9.7	7.1	10.5	18.3	11.6	22.1	15.0	8.8	10.0	13.7	25.5	15.4	16.5	24.8	18.8	14.5	10.3	18.2	13.9	10.1	11.7	13.5	9.5	13.7	14.2	14.3	13.8	7.9	14.9	20.3	16.6	4.2	20.0	8.7	9.5	13.7	11.7	6.6	7.2	6.6	7.6	7.8	6.7	6.9	7.1	7.7	6.6	7.1	7.4	6.9	12.8	4.8	2.0	4.2	4.5	4.2	6.4	0.6	9.8	6.9	7.5	0.3	7.2	4.7	9.2	0.0	22.6	6.2	5.5	7.9	8.7	0.4	14.2	7.9	7.8	6.6	8.6	3.3	11.0	10.4	8.1	5.6	24.7	2.5	8.6	6.8	2.1	11.6	8.4	3.1	8.6	8.2	7.1	5.4	1.4	9.3	3.9	3.6	1.0	7.1	11.4	10.3	2.5	2.3	6.5	2.2	10.5	7.2	4.3	9.3	5.8	7.1	6.9	6.6	5.5	7.5	12.5	12.4	4.6	3.8	14.1	7.5	11.5	7.2	3.0
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	9.7	5.3	11.0	6.2	12.1	2.0	11.9	7.8	13.1	10.4	7.5	11.1	3.7	10.4	6.3	4.6	10.1	6.8	8.4	12.1	10.7	8.4	8.7	8.9	2.2	9.1	9.2	10.6	19.1	8.1	7.2	8.4	9.2	11.4	5.9	8.5	18.8	6.7	7.0	6.6	5.9	10.2	7.9	4.9	13.1	3.7	12.3	2.5	8.8	7.6	2.2	9.0	7.0	11.5	6.0	2.3	4.8	0.8	7.5	13.4	1.3	8.4	13.4	6.9	7.9	0.1	6.9	0.0	3.9	17.0	7.8	1.1	1.4	1.0	4.5	0.0	0.0	0.0	0.4	0.5	6.2	0.0	0.0	9.3	6.5	4.1	0.0	18.8	5.6	0.0	0.0	1.2	4.2	6.3	0.0	0.1	5.3	0.6	5.3	0.0	0.0	0.4	12.5	4.2	5.3	0.1	3.2	5.5	17.8	5.1	9.3	13.8	12.0	10.0	0.9	7.5	7.3	0.1	0.0	0.0	30.6	1.4	6.8	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.5	0.2	0.0	0.5	11.0	12.1	7.8	13.1	12.1	10.7	9.1	9.2	9.2	7.9	12.3	11.5	14.3	0.0	9.5	23.5	0.4	6.2	7.2	2.7	6.8	11.9	11.7	6.9	5.7	5.7	3.7	7.3	10.4	7.1	0.1	2.3	0.0	6.6	1.1	7.4	6.6	13.6	1.8	2.7	30.2	10.4	1.5	8.1	6.6	7.8	0.0	8.3	10.4	6.4	12.2	5.0	39.8	11.9	0.0	9.7	2.1	1.7	10.8	8.1	8.8	16.9	6.7	9.1	0.0	27.6	20.9	8.7	5.6	11.7	1.1	11.0	0.7	2.3	3.1	11.6	6.6	12.5	9.7	1.6	2.8	1.7	3.1	10.7	0.7	2.0	5.2	6.7
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967752-21995301	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 31.7;pituitary gland: 33.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 170.1;Club cells: 145.9;Early spermatids: 227.5;Late spermatids: 447.9;Pancreatic endocrine cells: 417.7;Respiratory ciliated cells: 221.9"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 49.9;ovarian cancer: 57.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 37.4"	"Group enriched"	"Detected in many"	6	"B-cells: 15.6;T-cells: 37.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 289.2;HEK 293: 389.7;HeLa: 311.1;SK-MEL-30: 318.7"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA		18000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	3.7	10.1	7.4	1.7	8.3	1.3	3.1	5.9	8.5	1.1	31.7	1.9	0.8	0.7	1.0	7.4	2.2	0.5	0.7	6.7	6.4	0.5	0.7	2.3	2.1	7.4	5.8	0.8	1.5	2.1	33.7	2.6	7.2	2.1	0.7	0.1	1.6	1.6	0.6	0.9	3.6	0.3	6.2	5.5	3.9	14.8	8.0	2.1	1.3	0.0	2.5	2.4	2.3	9.2	11.8	0.0	1.7	82.2	0.8	0.9	39.1	15.9	0.0	111.7	196.0	19.1	289.2	47.1	167.7	9.5	0.0	36.0	34.3	211.0	91.4	212.2	389.7	0.1	311.1	13.6	8.8	22.4	17.3	21.2	0.0	112.2	61.9	236.3	11.7	0.0	0.1	188.4	105.7	0.8	1.9	0.0	2.6	24.2	185.9	0.2	80.2	166.3	23.4	0.0	195.2	14.0	219.9	36.6	318.7	9.4	42.8	0.7	39.5	0.9	2.6	0.3	0.5	84.7	49.6	177.8	0.2	62.9	1.0	1.5	2.1	0.3	9.9	1.3	14.1	11.1	11.4	17.6	0.3	15.6	0.6	6.7	0.5	0.8	4.2	0.0	37.4	3.6	7.4	8.3	5.9	8.5	6.7	6.4	7.4	5.8	7.2	6.2	8.0	9.2	1.6	0.0	0.0	1.0	11.5	1.8	2.3	170.1	0.0	0.6	6.1	10.4	4.2	0.0	145.9	11.0	0.0	27.9	6.2	8.1	0.0	29.7	227.5	36.4	6.7	2.6	70.9	0.0	1.2	26.4	43.8	7.7	0.0	6.2	4.5	4.6	1.4	0.3	7.6	0.0	3.5	6.3	122.1	10.5	4.2	447.9	3.1	2.9	8.8	7.5	16.2	0.9	5.2	4.5	6.6	417.7	12.1	1.9	38.7	35.4	32.8	0.0	221.9	0.1	0.0	1.1	20.8	7.2	6.2	7.2	0.4	9.2	12.7	11.0	3.8	54.4
CT47A1	CT47.1	ENSG00000236371	"Cancer/testis antigen family 47 member A1"	Q5JQC4	X	120982476-120985788	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"U-266/70: 2.2"									HPA042483	Supported		Uncertain	Nucleoli		NA	NA					"Cluster 29: U-266 - Adaptive immune response"		Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A10	CT47.10	ENSG00000224089	"Cancer/testis antigen family 47 member A10"	Q5JQC4	X	120938701-120942023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A11	CT47.11	ENSG00000226929	"Cancer/testis antigen family 47 member A11"	Q5JQC4	X	120933840-120937158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"U-266/70: 1.7"									HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A12	CT47.12	ENSG00000226685	"Cancer/testis antigen family 47 member A12"	Q5JQC4	X	120930250-120932301	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"testis: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 78: Testis - Spermatogenesis"			Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A2	CT47.2	ENSG00000242362	"Cancer/testis antigen family 47 member A2"	Q5JQC4	X	120977606-120980928	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A3	CT47.3	ENSG00000236126	"Cancer/testis antigen family 47 member A3"	Q5JQC4	X	120972746-120976068	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A4	CT47.4	ENSG00000230594	"Cancer/testis antigen family 47 member A4"	Q5JQC4	X	120967886-120971208	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A5	CT47.5	ENSG00000237957	"Cancer/testis antigen family 47 member A5"	Q5JQC4	X	120963026-120966348	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A6	CT47.6	ENSG00000226023	"Cancer/testis antigen family 47 member A6"	Q5JQC4	X	120958165-120961487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA						"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A7	CT47.7	ENSG00000228517	"Cancer/testis antigen family 47 member A7"	Q5JQC4	X	120953282-120956600	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A8	CT47.8	ENSG00000230347	"Cancer/testis antigen family 47 member A8"	Q5JQC4	X	120948422-120951744	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47A9	CT47.9	ENSG00000226600	"Cancer/testis antigen family 47 member A9"	Q5JQC4	X	120943561-120946883	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA							Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CT47B1	CT47.13	ENSG00000236446	"Cancer/testis antigen family 47 member B1"	P0C2W7	X	120872603-120875929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	69	"testis: 6.8"	"Group enriched"	"Detected in some"	42	"Spermatocytes: 112.2;Spermatogonia: 76.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042483	Supported		Uncertain	Nucleoli		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli		"HPA042483: AB_2678017"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	76.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665069-108940927	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 133.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 162.3"	"Low region specificity"	"Detected in all"							HPA004691	Approved		Approved	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	7.3	6.8	3.7	6.8	3.9	6.3	9.2	4.2	5.1	7.9	1.6	6.6	5.0	10.4	7.3	7.3	8.5	5.0	6.1	4.4	3.0	11.7	7.0	5.3	8.5	2.2	3.3	10.6	7.5	7.6	4.5	7.8	2.8	7.0	7.7	11.1	6.2	6.8	7.1	7.6	4.7	9.9	2.0	7.2	5.8	15.8	3.7	8.4	7.8	4.7	8.8	10.3	6.9	4.0	21.3	20.7	19.3	27.0	18.5	15.0	20.0	22.6	12.2	26.7	26.3	59.3	30.6	71.8	41.3	17.3	28.7	23.5	55.4	27.3	37.8	27.8	25.0	48.5	11.6	22.3	33.0	49.9	22.4	13.5	21.0	30.4	37.6	15.9	24.6	18.4	70.0	7.8	26.7	14.0	42.7	42.5	24.8	40.0	31.0	35.9	31.3	67.9	16.3	18.2	35.2	18.4	31.7	27.4	12.3	25.4	33.4	17.7	26.0	27.8	28.3	26.8	30.9	11.7	22.0	162.3	9.5	59.7	28.7	1.6	4.4	1.2	7.8	6.7	10.8	10.5	7.0	9.6	8.5	12.0	7.4	7.2	0.4	10.1	6.8	8.0	6.3	4.4	3.7	3.9	4.2	5.1	4.4	3.0	2.2	3.3	2.8	2.0	3.7	4.0	20.2	16.0	28.8	29.0	23.7	28.4	24.5	11.0	28.5	21.1	14.9	11.9	20.5	12.8	17.6	3.7	95.9	24.3	19.8	9.7	19.6	18.7	47.2	16.9	31.4	24.3	15.0	11.6	84.7	21.3	21.3	26.3	15.3	23.3	14.5	28.1	10.4	11.0	14.7	18.5	75.9	9.7	6.1	8.8	12.0	10.9	29.5	15.4	7.2	51.5	20.6	8.9	27.8	67.3	59.5	17.2	5.7	21.4	13.2	24.8	3.7	133.3	13.1	25.1	13.1	32.6	20.3	63.0	45.8	19.3	29.0	25.9	17.7	26.6	15.6	14.8
DDX27	"dJ686N3.1, DRS1"	ENSG00000124228	"DEAD-box helicase 27"		20	49219347-49244077	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047087, HPA053455"	Approved		Approved	Nucleoli		NA	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli		"HPA047087: AB_10964059, HPA053455: "	"unprognostic (4.47e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (2.82e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (6.70e-7)"	"unprognostic (2.28e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	20.4	20.9	15.8	25.8	16.0	46.5	19.5	19.5	20.5	20.4	15.5	21.0	22.6	21.3	15.1	20.7	17.5	19.4	15.6	15.9	17.2	20.7	17.2	18.0	34.3	16.7	16.8	27.3	24.5	20.4	15.4	20.3	17.1	18.7	20.8	10.9	20.5	15.9	24.8	25.0	26.8	18.5	15.5	24.7	20.4	24.4	16.9	29.9	19.1	16.7	35.6	27.6	18.0	17.7	75.2	69.7	34.9	27.4	38.3	35.1	99.6	48.6	39.9	149.7	69.3	228.3	82.2	88.8	88.1	40.0	129.7	103.7	79.1	77.8	111.0	31.6	46.1	67.6	58.4	113.2	55.7	86.1	76.0	37.0	90.2	87.5	67.3	34.0	25.1	67.5	93.7	47.6	49.8	50.6	90.9	114.0	66.9	91.3	89.2	77.6	87.0	82.4	54.9	57.1	45.8	54.0	135.8	194.2	83.0	48.5	102.5	98.5	31.0	96.0	84.3	80.8	102.9	54.1	62.6	115.6	61.4	67.5	63.4	21.1	32.8	39.4	34.2	36.8	36.0	48.6	32.3	31.5	39.2	50.8	41.1	31.4	13.6	32.6	45.7	45.4	46.3	33.9	15.8	16.0	19.5	20.5	15.9	17.2	16.7	16.8	17.1	15.5	16.9	17.7	33.9	28.9	44.7	7.8	93.3	35.7	55.1	41.8	30.7	25.7	28.0	32.3	25.7	21.5	45.7	33.1	14.6	58.1	114.0	45.8	19.6	54.0	176.7	45.4	58.4	28.6	31.0	41.2	10.0	43.6	50.5	44.7	27.0	67.4	113.4	42.2	21.0	23.1	33.7	28.6	9.1	44.3	20.3	25.1	54.1	145.7	39.7	48.5	19.6	5.6	42.9	29.9	63.8	4.5	5.4	55.4	44.6	33.8	57.9	38.2	55.0	44.9	35.4	29.4	26.3	52.4	41.7	69.1	56.6	29.5	32.1	74.6	67.9	37.3	50.7	42.1
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	28.8	24.1	23.2	22.7	23.7	41.2	32.1	24.6	30.8	27.8	24.5	29.3	18.2	30.8	22.3	29.1	29.8	19.9	23.0	22.6	24.0	32.1	37.8	24.8	32.7	23.8	23.6	35.6	30.8	36.5	17.5	28.9	24.1	26.4	26.3	16.9	24.5	29.0	44.6	30.5	21.7	33.4	24.4	23.4	29.3	23.1	23.2	35.5	33.3	41.7	39.8	47.6	25.5	25.2	161.7	68.3	65.6	53.7	63.1	61.7	111.8	67.8	77.0	141.0	131.0	104.1	101.0	82.4	25.9	92.2	87.4	102.6	95.2	78.0	157.7	117.2	68.1	75.5	45.3	59.7	53.5	87.0	46.5	60.0	72.4	84.0	68.8	110.7	110.4	63.9	74.3	18.2	78.3	57.7	71.0	60.1	288.7	74.4	41.4	77.7	127.2	50.0	86.5	114.2	28.6	72.5	82.3	52.1	69.2	161.4	21.4	64.9	49.9	56.5	136.5	36.8	103.4	25.2	49.1	148.1	60.2	44.9	66.8	10.5	32.9	8.4	46.6	43.8	55.5	48.0	40.9	43.2	56.8	44.9	53.0	51.5	3.8	40.6	44.4	33.3	43.4	35.8	23.2	23.7	24.6	30.8	22.6	24.0	23.8	23.6	24.1	24.4	23.2	25.2	5.1	3.2	8.2	9.1	8.4	2.2	2.7	2.4	14.2	0.6	1.4	1.0	0.1	0.0	8.5	0.0	0.0	1.7	2.3	3.2	1.9	22.6	0.1	3.0	4.1	4.3	4.8	3.4	8.2	17.8	1.9	3.2	4.6	5.7	12.0	0.9	1.1	0.9	0.9	0.0	9.4	4.2	2.0	1.0	1.6	0.4	0.6	2.5	0.0	12.2	9.7	0.9	2.1	8.0	12.6	19.0	4.2	0.4	12.3	1.9	2.8	1.1	6.3	1.6	6.6	1.6	3.4	0.7	0.7	9.0	1.8	1.4	6.2	0.6	6.5	2.8
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440917-5468982	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	6.2	5.9	5.5	6.3	5.8	4.4	7.0	5.1	6.0	5.4	3.9	5.3	4.8	6.4	4.1	6.2	5.8	4.1	4.5	5.7	4.9	5.2	7.8	4.4	6.0	4.9	5.2	5.6	6.7	7.6	3.9	6.3	4.8	5.4	5.6	6.4	5.6	5.4	8.0	6.9	5.0	5.9	5.0	6.0	5.5	4.5	5.7	5.2	5.1	5.6	5.9	6.5	5.4	5.5	19.0	27.7	17.4	31.1	7.2	14.4	21.6	18.4	11.4	27.6	22.1	17.6	8.1	46.7	12.5	15.1	11.0	22.0	35.4	28.7	35.3	15.0	34.1	18.5	22.4	30.0	14.1	24.9	15.9	12.2	17.3	29.8	40.4	8.3	20.9	22.0	24.9	22.3	15.5	13.4	25.5	13.6	38.5	12.5	14.0	33.5	25.5	25.3	12.8	14.7	15.1	21.7	19.2	16.4	28.0	14.6	12.8	12.9	19.5	19.0	20.2	15.3	39.6	8.3	9.5	23.5	13.6	29.1	27.7	0.2	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.3	0.4	0.8	0.6	0.6	0.6	0.8	0.3	0.9	0.4	0.2	5.5	5.8	5.1	6.0	5.7	4.9	4.9	5.2	4.8	5.0	5.7	5.5	11.4	12.8	8.6	6.5	8.6	21.0	15.3	8.6	19.9	15.6	18.3	15.7	16.3	17.2	9.9	7.3	20.9	8.3	10.2	8.5	1.9	9.3	81.8	7.6	23.3	16.2	9.1	23.3	14.5	15.3	10.1	13.7	10.7	12.7	3.8	21.0	13.2	28.1	6.3	13.5	15.2	10.9	2.0	16.9	8.7	11.3	7.8	9.9	14.2	6.5	6.8	13.3	9.2	11.6	13.0	12.1	5.1	9.8	10.4	20.9	5.9	5.9	6.1	10.5	0.0	25.1	11.5	10.6	15.7	22.0	19.9	5.1	6.6	19.7	11.9	14.9
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968796-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.7"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 193.3;Inhibitory neurons: 149.3;Oligodendrocyte precursor cells: 276.5;Plasma cells: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.7;U-266/70: 86.8;U-698: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.4	3.5	0.7	7.1	4.4	7.4	3.2	6.0	7.4	4.3	0.0	4.5	5.2	2.5	1.0	2.0	2.0	3.4	1.2	0.7	3.1	3.1	3.4	8.9	12.2	0.9	0.8	4.2	1.1	4.9	2.1	3.8	0.8	2.7	4.0	7.4	3.8	1.6	2.1	4.0	3.8	2.2	0.0	7.1	5.3	10.9	2.4	33.7	16.7	1.6	14.8	4.4	1.4	5.7	5.3	0.8	8.4	2.1	2.5	3.6	1.7	4.4	6.1	2.5	2.4	2.7	1.7	14.3	1.0	3.6	4.3	0.8	7.7	2.3	3.3	7.2	6.0	4.3	10.1	1.9	4.1	6.8	6.0	1.7	2.8	1.7	5.6	4.2	2.3	5.3	15.7	37.7	4.5	3.0	3.1	6.7	20.9	2.3	5.2	15.3	6.3	7.7	2.5	6.0	13.8	26.9	6.7	8.2	0.5	22.3	9.8	17.5	1.9	4.6	2.0	4.1	2.3	86.8	29.8	40.4	4.8	7.0	3.5	2.0	0.0	0.7	1.1	0.1	1.0	0.7	1.1	0.8	0.0	1.4	0.6	0.7	0.5	2.1	0.0	1.0	2.0	0.2	0.7	4.4	6.0	7.4	0.7	3.1	0.9	0.8	0.8	0.0	2.4	5.7	7.2	83.3	49.5	98.9	28.5	10.3	8.2	4.3	5.7	63.4	13.3	11.2	6.9	1.5	21.6	7.3	43.8	11.6	50.2	3.6	1.9	1.2	87.6	9.5	12.8	4.0	19.3	6.9	193.3	1.6	11.4	8.0	4.6	10.2	5.7	41.5	6.4	9.2	13.5	8.4	149.3	7.6	8.2	2.7	4.6	20.5	8.1	9.4	8.8	112.4	3.1	19.4	71.1	276.5	73.2	3.4	2.6	11.3	132.0	19.6	2.4	2.0	15.4	21.5	6.6	6.6	9.8	76.0	36.0	8.1	13.1	28.7	36.1	8.5	4.3	13.6
GTSF1L	"C20orf65, dJ1028D15.4, FAM112A"	ENSG00000124196	"Gametocyte specific factor 1 like"	Q9H1H1	20	43726164-43727002	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	147	"testis: 223.7"	"Group enriched"	"Detected in some"	115	"Early spermatids: 2791.6;Late spermatids: 4158.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.0"	"Cell line enhanced"	"Detected in some"		"REH: 1.1;U-698: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA054694	Enhanced		Uncertain	Nucleoli		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoli		"HPA054694: AB_2682576"	"unprognostic (2.61e-2)"	"unprognostic (4.24e-6)"		"unprognostic (9.96e-3)"		"unprognostic (1.30e-4)"		"unprognostic (3.50e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.45e-7)"	"unprognostic (1.19e-1)"	"unprognostic (9.54e-2)"		"unprognostic (6.07e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	223.7	0.0	0.4	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.5	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2791.6	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4158.1	19.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	30.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 117.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	13.9	17.0	10.4	9.5	11.4	20.0	17.3	10.2	12.0	14.1	14.2	11.8	8.0	14.2	15.3	10.6	14.5	12.4	12.7	11.0	10.6	14.6	13.5	16.5	11.8	10.5	11.4	15.3	13.6	117.1	17.1	12.5	10.3	20.2	11.0	11.6	13.3	12.5	14.6	15.2	11.6	11.4	10.1	16.1	14.1	14.3	12.9	14.9	16.0	13.3	12.0	12.4	11.8	12.3	23.5	27.2	19.4	30.6	27.2	22.6	32.8	22.2	41.1	33.0	41.7	39.7	28.5	22.3	25.4	31.3	70.7	17.0	36.9	39.9	29.0	20.9	26.0	19.4	30.8	20.1	38.3	38.0	42.8	30.1	29.3	48.9	39.1	42.6	24.5	17.8	26.2	23.2	36.4	19.5	23.5	20.9	14.4	16.1	41.2	20.6	26.1	21.9	20.8	29.6	24.1	24.6	19.3	48.2	51.4	16.8	22.3	25.6	20.5	49.3	21.0	24.2	42.2	27.0	27.0	31.5	57.2	29.2	26.0	3.5	2.5	2.3	3.3	3.1	2.6	3.0	2.8	2.4	3.2	2.6	2.1	2.4	0.2	1.2	2.1	2.5	4.4	2.1	10.4	11.4	10.2	12.0	11.0	10.6	10.5	11.4	10.3	10.1	12.9	12.3	34.8	9.6	12.8	14.0	22.0	11.3	27.0	14.2	17.6	29.5	33.2	26.7	8.0	11.5	17.0	9.2	35.5	16.3	36.1	13.3	21.5	22.2	6.2	47.7	37.5	24.7	15.5	12.8	20.4	21.9	12.6	23.9	30.1	47.5	18.3	36.7	15.0	12.6	27.9	72.3	20.0	12.8	6.1	11.9	13.7	3.1	13.4	18.9	3.6	16.9	23.5	19.8	29.9	15.1	18.5	34.3	8.4	12.4	29.5	41.1	7.4	13.8	24.7	43.1	13.1	23.5	19.5	28.9	24.4	15.6	12.1	15.5	23.3	42.8	15.6	29.4
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP U3 small nucleolar ribonucleoprotein 4"	Q96G21	2	130342877-130347967	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 303.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066222: AB_2685638, HPA066673: AB_2685701"	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	29.2	25.4	14.3	20.6	16.1	20.8	25.6	15.3	16.8	14.8	11.4	22.4	19.9	18.0	6.3	20.5	13.9	12.4	37.5	13.7	16.5	19.9	47.7	17.7	24.5	18.5	18.3	12.1	45.4	12.9	11.4	11.5	16.6	15.4	7.2	3.6	31.8	12.0	70.1	18.7	18.5	11.7	15.9	17.3	24.5	11.8	18.1	7.2	11.4	25.5	12.2	23.3	15.7	16.9	88.7	87.1	11.1	59.2	13.5	22.7	61.5	60.8	30.2	54.1	39.8	184.5	55.0	303.2	71.5	30.2	36.0	56.6	64.5	66.5	25.9	64.2	66.0	100.3	33.2	143.8	70.7	99.7	51.8	28.1	48.0	71.9	37.6	10.9	38.5	68.7	103.1	58.8	26.5	157.0	63.2	57.1	85.4	53.0	106.3	73.1	39.4	134.4	27.0	61.0	57.9	51.8	41.3	124.0	62.9	7.2	52.7	47.0	47.5	69.8	74.3	75.2	109.0	77.5	87.8	235.4	56.5	56.5	98.9	12.3	72.7	23.9	71.5	82.6	66.1	115.9	62.7	62.6	84.1	99.7	64.8	64.6	8.0	90.8	79.4	91.5	68.9	89.2	14.3	16.1	15.3	16.8	13.7	16.5	18.5	18.3	16.6	15.9	18.1	16.9	41.4	16.0	24.8	3.3	65.5	106.6	79.3	67.0	58.6	21.9	49.5	46.4	53.7	58.6	46.5	44.1	4.2	63.6	52.3	43.4	101.8	96.4	24.2	19.6	27.3	48.6	54.5	32.6	4.2	110.3	100.5	43.2	45.9	22.3	46.3	26.8	29.6	89.1	76.5	16.8	4.8	49.8	52.9	36.5	54.0	69.9	30.7	37.5	78.2	1.0	66.1	18.9	33.0	4.5	5.0	83.7	54.2	25.6	82.4	148.6	55.5	144.6	22.9	25.5	26.3	43.7	51.6	32.7	48.3	57.6	110.4	49.3	45.9	62.1	77.5	79.2
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium inwardly rectifying channel subfamily J member 14"	Q9UNX9	19	48455574-48466980	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"retina: 58.7"	"Cell type enriched"	"Detected in many"	7	"Rod photoreceptor cells: 326.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"NB-4: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA071765			Approved	Nucleoli		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 24: NB-4 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA071765: AB_2686444"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	0.9	0.3	1.9	0.3	2.7	2.0	0.7	3.1	2.1	0.8	1.7	0.5	0.3	0.6	0.6	1.3	0.9	0.4	0.4	2.1	1.8	0.8	0.9	0.7	0.5	2.8	2.8	1.0	0.6	0.2	0.9	0.3	3.5	1.4	0.3	58.7	0.6	0.2	1.6	2.2	0.6	0.3	1.8	0.6	0.5	1.2	2.9	0.3	1.2	0.2	0.3	0.6	1.0	2.5	0.9	2.3	0.4	1.5	0.9	0.9	1.5	0.3	0.2	0.5	0.7	2.2	1.2	1.1	0.4	0.3	1.1	3.2	0.7	0.4	1.2	0.8	1.2	0.6	1.5	0.6	0.5	0.9	1.8	0.9	1.6	1.1	1.3	0.6	0.3	1.0	1.0	1.1	0.3	1.4	0.4	7.6	0.8	1.2	1.1	1.5	0.9	0.2	0.3	2.7	0.8	1.0	1.0	1.5	0.9	0.8	1.0	0.8	0.5	1.5	2.0	1.6	1.8	1.2	1.9	0.7	0.4	2.4	1.6	1.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.3	0.1	0.2	0.6	0.1	0.0	0.1	0.1	0.0	1.9	2.7	3.1	2.1	2.1	1.8	2.8	2.8	3.5	1.8	2.9	2.5	3.7	0.0	3.4	5.2	1.2	4.5	3.6	1.0	1.8	17.0	4.9	2.4	0.6	2.8	0.7	1.8	41.7	1.4	0.3	1.3	0.0	1.1	4.7	4.1	2.8	2.3	0.0	0.8	2.3	1.1	2.4	1.3	0.5	5.6	0.0	2.4	0.7	0.5	0.6	15.2	3.1	1.4	0.0	0.0	0.7	0.6	1.2	1.0	0.0	1.9	0.6	24.5	0.0	0.0	0.9	3.1	0.3	0.4	0.7	4.4	0.5	0.1	1.8	326.4	0.0	6.5	1.5	3.9	3.3	2.6	5.4	1.0	0.9	1.2	1.7	2.9
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2964216-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 4.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 14.1;Basal squamous epithelial cells: 23.3;Intestinal goblet cells: 14.0;Rod photoreceptor cells: 10.9;Spermatocytes: 9.7;Spermatogonia: 18.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 1.3"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.3;MCF7: 15.0;RPMI-8226: 28.8;T-47d: 14.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.1	0.1	0.7	0.3	0.7	0.7	0.1	0.0	0.6	1.5	0.0	0.3	0.1	0.1	0.1	2.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.0	4.1	0.4	0.0	0.3	7.7	0.6	0.0	0.0	0.2	0.2	1.7	0.0	2.1	0.0	0.0	0.8	0.0	0.5	0.1	1.8	1.1	0.4	10.2	0.0	0.0	1.5	0.6	0.0	0.0	0.0	4.2	1.5	7.8	2.1	0.0	1.1	8.6	1.3	0.7	0.0	1.1	1.2	0.5	2.9	2.6	0.0	0.6	29.3	0.2	0.0	0.0	0.1	0.9	0.0	0.8	3.3	2.9	0.0	15.0	1.8	3.5	2.9	3.0	2.2	4.7	11.8	28.8	0.1	0.3	2.9	1.8	2.0	4.7	5.2	0.4	14.9	2.8	0.2	0.9	12.2	1.0	0.7	5.3	1.3	4.7	0.4	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.7	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.4	14.1	0.9	0.3	23.3	0.4	1.0	0.9	0.9	0.0	0.0	0.0	6.2	0.2	0.0	1.1	0.0	0.1	0.7	0.4	0.1	0.1	0.0	0.0	0.4	2.7	1.8	0.1	0.0	0.9	4.5	0.0	0.0	0.0	0.1	0.0	0.1	14.0	0.0	0.0	0.6	0.6	0.0	0.2	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.2	1.3	0.0	0.1	2.1	0.5	0.0	0.0	10.9	0.0	0.0	0.3	9.7	18.0	1.2	5.5	0.1	0.6	0.0	0.5	0.4
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553085-10566031	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 177.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	12.3	11.5	10.6	20.0	11.3	17.1	12.6	11.0	11.8	16.6	11.6	14.3	10.0	13.8	7.6	16.8	14.4	7.1	12.1	10.2	12.0	12.7	13.6	11.2	22.3	11.3	11.0	14.8	15.6	10.3	13.4	8.7	11.1	15.6	7.5	33.8	13.0	8.7	22.3	20.9	17.4	7.3	10.3	22.3	12.5	16.1	11.2	30.6	14.6	9.7	15.1	15.9	15.9	11.9	37.7	17.6	23.6	35.0	13.2	14.3	16.6	34.0	16.1	21.6	20.2	27.1	13.6	55.7	39.2	14.1	18.4	29.1	30.3	27.3	23.9	60.2	67.1	177.2	39.6	18.1	23.4	69.6	61.7	17.7	21.7	31.8	31.4	18.4	13.9	33.2	50.4	56.4	18.7	33.5	72.7	104.3	38.2	30.3	45.0	30.0	30.7	28.4	18.1	32.6	39.2	18.2	40.2	23.4	25.7	20.7	29.5	50.0	16.8	27.9	23.0	74.4	71.9	38.7	48.5	39.7	23.2	56.3	41.6	2.2	4.9	2.9	11.9	5.7	11.0	7.4	7.9	9.7	6.8	8.3	8.7	9.5	0.8	10.3	3.0	16.0	6.5	4.8	10.6	11.3	11.0	11.8	10.2	12.0	11.3	11.0	11.1	10.3	11.2	11.9	8.9	16.0	25.5	6.2	20.4	13.5	11.4	12.2	40.9	15.4	6.4	9.5	8.6	8.6	17.5	14.7	39.6	11.4	15.0	9.5	1.9	8.5	4.6	9.0	17.6	11.0	9.6	26.1	4.0	7.5	8.9	11.0	16.3	10.4	19.6	12.3	10.4	9.0	8.0	11.8	3.7	10.1	8.2	12.5	6.1	5.8	8.4	10.5	8.8	5.6	9.2	11.6	24.7	6.0	7.7	5.6	7.6	9.1	17.4	10.8	9.0	5.0	16.0	55.0	0.0	13.5	9.3	25.3	16.8	28.1	13.8	4.5	26.8	9.0	12.7	8.2
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39209116-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"myeloid DC: 6.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 255.1;HSkMC: 186.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	143.2	55.1	46.3	18.6	49.9	1.1	128.7	59.2	45.2	51.6	57.2	51.7	10.8	78.8	47.5	37.0	88.9	74.5	99.7	45.6	57.3	31.9	14.2	82.6	39.1	54.9	56.8	49.6	17.2	18.2	26.9	134.6	51.4	30.8	16.7	11.9	34.7	36.9	32.1	37.9	29.0	68.9	47.8	30.4	27.9	20.4	64.3	17.0	64.2	89.2	17.6	49.1	48.3	44.3	11.5	4.0	118.3	5.1	255.1	115.1	51.6	61.8	88.3	30.8	23.1	0.5	11.6	17.5	1.3	86.6	40.0	17.3	15.0	36.2	25.3	16.9	17.2	47.3	3.7	0.0	26.7	0.8	0.9	186.4	4.7	27.7	45.7	27.6	29.1	1.1	0.0	0.1	59.9	9.9	0.0	14.5	8.8	0.2	15.8	7.7	51.3	0.1	20.9	15.0	0.7	3.8	5.6	7.2	16.8	67.4	6.7	0.1	54.3	77.9	11.7	24.4	33.9	0.9	0.0	48.9	32.4	0.2	57.2	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.3	46.3	49.9	59.2	45.2	45.6	57.3	54.9	56.8	51.4	47.8	64.3	44.3	195.2	3.2	12.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.4	28.6	0.0	0.0	9.9	0.0	0.0	5.0	1.4	0.0	1.9	0.6	0.0	2.7	78.1	32.0	0.0	0.0	0.0	0.6	156.9	113.0	0.0	2.8	2.5	22.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	3.6	2.2	0.0	0.0	0.0	131.6	0.0	0.0	0.0	0.0	6.2	1.2	45.8	0.0	0.0
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026564	Approved		Approved	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	9.7	8.4	5.7	9.0	6.6	16.3	11.0	8.3	8.4	7.7	2.3	9.0	14.6	10.3	6.5	9.5	5.4	8.4	11.7	7.0	6.3	14.1	23.6	8.2	13.2	4.6	4.8	8.3	7.1	6.8	3.5	12.0	5.1	8.6	9.7	9.9	5.6	6.9	7.4	7.7	13.5	11.2	5.3	9.3	6.9	11.9	5.3	14.0	8.2	10.0	12.6	9.8	5.1	6.8	26.4	10.9	42.1	33.3	15.1	16.6	25.4	25.0	18.2	37.0	45.4	16.0	14.5	35.4	21.4	19.6	36.6	19.0	100.0	22.3	50.2	28.5	20.0	26.8	18.6	25.9	19.0	35.4	6.2	13.8	12.7	24.7	24.6	17.1	21.7	22.2	33.6	16.7	31.7	6.8	42.8	27.4	55.5	17.3	22.5	33.8	43.5	22.9	34.1	16.0	21.5	21.7	30.2	29.9	28.6	29.6	14.3	19.8	27.2	26.0	20.8	39.7	28.7	14.0	14.4	57.2	21.0	36.6	27.3	5.4	4.6	5.5	5.5	6.0	7.3	7.2	5.8	5.3	6.0	6.7	6.8	5.8	0.7	7.6	5.8	4.6	7.8	4.5	5.7	6.6	8.3	8.4	7.0	6.3	4.6	4.8	5.1	5.3	5.3	6.8	13.9	12.8	12.6	22.2	15.1	12.9	7.8	10.5	17.1	16.4	6.9	6.0	10.4	8.6	9.2	14.7	6.2	16.9	23.2	6.9	11.7	12.7	1.3	6.0	12.1	11.3	23.3	17.2	41.1	8.9	13.3	12.7	5.1	10.8	15.2	11.3	13.2	21.4	11.9	15.2	40.1	6.5	20.3	11.7	12.1	3.0	10.2	9.4	5.4	15.9	13.4	7.6	8.2	22.6	30.9	9.2	4.1	10.1	11.7	5.1	13.2	24.1	6.4	12.5	19.7	12.9	12.9	25.1	28.3	11.7	11.1	7.3	15.8	10.4	8.1	5.0
MCEE	"GLOD2, MCE"	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 92.0;Proximal tubular cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		29000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	17.8	30.0	8.9	12.3	9.7	9.1	32.7	10.5	12.5	22.1	15.4	20.1	20.1	13.1	30.5	26.3	14.8	14.2	35.9	8.9	9.4	33.7	69.8	13.7	14.7	9.5	9.1	18.5	36.1	35.6	24.1	17.6	9.9	23.9	23.9	12.3	42.8	17.8	36.5	28.4	16.9	12.2	9.7	16.0	23.5	6.0	9.4	13.3	14.1	61.7	15.5	16.5	21.9	11.7	12.1	5.2	10.6	7.6	34.3	46.6	30.2	18.5	23.3	9.2	13.9	14.7	14.8	18.7	5.5	18.5	7.0	12.5	12.4	9.6	9.5	17.1	10.7	12.7	16.3	42.5	19.5	14.5	10.3	31.3	13.5	6.2	12.3	20.5	10.6	14.6	17.1	31.9	9.1	15.5	10.9	16.9	9.6	33.1	14.6	12.8	12.3	35.2	14.8	10.4	11.9	8.8	6.9	40.1	18.1	12.1	31.7	13.4	13.7	10.6	8.3	10.9	7.5	30.7	13.1	20.0	17.5	23.7	9.9	20.3	23.2	27.6	15.4	25.6	21.9	21.6	19.3	15.5	19.9	16.7	17.6	15.0	6.1	16.5	25.3	23.9	35.3	14.6	8.9	9.7	10.5	12.5	8.9	9.4	9.5	9.1	9.9	9.7	9.4	11.7	11.1	25.6	13.4	13.7	12.8	8.5	10.5	18.4	21.6	2.6	37.5	27.3	75.2	25.8	18.2	5.5	2.1	36.2	11.2	14.0	92.0	13.3	1.1	17.2	16.2	9.0	9.0	12.0	13.3	18.4	36.8	23.3	17.3	20.2	0.0	5.2	12.8	73.0	15.1	5.0	14.5	32.5	18.3	10.4	8.7	1.0	29.2	9.4	14.2	14.0	9.1	7.3	5.2	16.1	20.8	9.6	16.2	17.7	42.0	11.0	35.0	77.1	19.4	8.6	26.3	12.7	17.9	3.7	5.1	25.6	20.9	11.4	10.1	16.9	23.0	11.9
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12L"	Q86YW9	3	151085697-151437072	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 24.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 383.3;Excitatory neurons: 302.4;Inhibitory neurons: 120.7;Oligodendrocyte precursor cells: 225.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.3;plasmacytoid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.5;HEL: 20.9;JURKAT: 13.0;MOLT-4: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	0.7	1.5	0.7	0.4	2.6	4.3	0.2	0.3	5.6	1.0	24.1	0.2	1.0	0.4	1.9	0.1	0.3	0.5	0.2	2.4	0.7	0.1	0.0	0.2	1.0	0.2	0.9	0.2	0.1	0.2	1.7	1.2	0.0	0.6	0.0	3.0	0.3	0.3	0.3	0.1	0.4	0.3	0.0	0.4	0.2	4.5	3.6	0.5	0.4	0.0	1.0	0.3	0.4	0.6	0.9	0.4	2.9	0.2	0.1	0.1	18.5	0.0	0.3	0.7	0.8	1.0	0.3	0.0	0.2	0.1	2.1	0.1	3.8	0.3	0.8	0.0	1.8	20.9	0.1	0.1	0.0	0.7	7.1	0.0	0.1	0.1	0.1	0.1	0.0	13.0	0.0	3.1	0.0	3.1	9.9	0.0	3.4	0.1	0.7	0.1	1.1	0.5	0.3	3.0	4.9	0.7	0.4	0.2	0.0	5.2	1.0	0.1	0.0	0.0	2.2	0.0	1.5	5.9	0.0	7.3	0.2	1.8	1.1	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.7	2.6	0.3	5.6	2.4	0.7	0.2	0.9	0.0	0.0	3.6	0.6	0.1	0.0	0.0	383.3	1.0	1.1	1.1	0.3	2.8	11.1	0.5	0.4	1.2	0.0	1.3	1.8	4.2	18.6	0.4	0.2	0.0	0.1	13.2	1.1	0.4	0.4	0.0	13.0	302.4	0.6	1.5	0.9	0.0	0.3	0.0	0.2	0.4	0.2	1.9	33.7	120.7	0.0	0.0	1.6	1.1	7.3	0.9	1.7	0.0	52.5	1.3	26.2	0.0	225.7	9.6	0.2	0.0	0.4	1.3	1.1	0.0	0.5	0.9	1.9	0.0	0.3	0.5	8.2	4.3	0.4	0.1	27.0	0.2	1.1	0.0	0.4
MED16	"DRIP92, THRAP5, TRAP95"	ENSG00000175221	"Mediator complex subunit 16"	Q9Y2X0	19	867630-893218	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030685, HPA046495"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA030685: AB_10601872, HPA046495: AB_2679674"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-2)"	"unprognostic (4.93e-3)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (4.83e-2)"	"unprognostic (5.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-2)"	49.7	38.2	33.8	19.4	32.9	13.9	41.1	27.0	57.4	46.9	24.3	38.2	15.4	34.6	1.9	44.3	35.0	11.8	34.9	33.4	29.5	44.2	68.6	32.7	16.2	32.9	31.3	44.3	55.3	12.8	39.3	13.5	29.0	54.1	5.8	5.0	36.1	10.1	44.5	43.0	35.7	8.6	28.5	46.0	39.7	36.4	32.8	10.5	38.2	10.0	7.5	45.0	41.3	29.6	29.4	25.1	24.7	17.0	10.2	10.8	27.5	20.3	19.1	29.7	22.4	32.6	27.3	29.8	23.6	18.1	9.9	23.4	9.3	24.3	5.0	37.8	29.6	29.9	18.5	30.4	20.3	29.0	26.6	18.9	12.1	18.2	11.7	17.4	23.1	31.5	36.3	69.8	17.9	44.5	47.3	34.1	38.3	11.0	33.5	48.1	17.9	38.3	20.5	45.3	30.6	29.5	27.2	18.3	22.5	9.2	21.4	22.3	22.4	30.1	30.2	46.3	23.6	50.6	19.8	28.4	39.2	27.2	22.7	53.0	31.5	40.7	50.2	34.2	45.4	53.7	56.0	57.8	40.7	44.0	46.2	43.8	44.1	40.4	36.6	27.3	82.3	52.7	33.8	32.9	27.0	57.4	33.4	29.5	32.9	31.3	29.0	28.5	32.8	29.6	15.5	35.3	24.8	6.5	19.0	11.6	11.3	15.6	12.0	15.9	16.9	17.7	7.1	15.7	15.2	22.0	6.2	62.6	11.9	57.5	17.6	24.4	3.6	15.5	16.9	15.2	25.7	14.1	3.2	24.3	32.3	19.4	44.9	27.3	14.5	32.4	14.6	24.0	25.3	15.2	2.6	34.8	18.3	16.1	5.7	6.5	13.7	14.6	10.6	4.7	23.8	15.8	12.3	3.0	4.7	23.0	29.4	14.7	23.2	11.3	34.6	17.4	12.9	20.4	6.6	12.3	16.4	13.9	28.8	12.0	16.1	63.8	19.7	30.4	34.1	15.0
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 149.5;Extravillous trophoblasts: 259.9;Fibroblasts: 183.3;Leydig cells: 176.1;Peritubular cells: 183.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"naive CD8 T-cell: 6.4"	"Lineage enriched"	"Detected in single"	64	"T-cells: 6.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.0;BJ: 143.6;BJ hTERT+: 66.9;fHDF/TERT166: 71.9;HSkMC: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		760000	"Cluster 32: T-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	103.6	11.7	2.9	8.2	2.5	0.6	70.0	1.1	2.9	100.4	1.7	58.2	6.3	117.2	2.6	17.6	57.4	19.4	42.8	4.0	2.4	26.4	7.4	53.9	2.5	5.9	4.5	81.9	8.7	1.1	21.7	11.6	2.6	39.0	1.7	0.8	32.4	11.4	16.6	41.6	29.5	6.4	2.3	26.4	28.9	14.7	3.2	0.6	46.6	5.0	0.8	52.8	59.3	3.0	4.1	0.8	1.2	1.0	16.5	46.0	42.3	143.6	66.9	16.6	19.9	8.0	3.3	1.7	0.6	71.9	0.1	3.0	1.0	0.0	3.2	3.2	1.3	1.2	3.1	12.8	43.4	0.2	1.6	54.8	0.0	6.2	0.0	32.4	0.0	0.9	17.3	1.4	21.5	0.4	0.4	0.5	14.0	0.3	4.7	0.6	0.3	0.4	0.0	0.7	3.2	8.9	0.5	1.4	0.1	10.4	11.1	0.7	1.3	0.7	23.1	21.8	0.6	3.3	0.3	0.2	5.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	2.9	2.5	1.1	2.9	4.0	2.4	5.9	4.5	2.6	2.3	3.2	3.0	22.2	3.2	0.0	7.5	0.5	10.7	1.1	0.7	2.2	0.7	7.0	47.9	3.5	0.0	0.0	9.2	0.0	9.5	1.1	0.0	0.0	5.7	1.7	4.3	149.5	5.1	0.0	0.0	0.3	0.0	259.9	183.3	2.6	3.7	0.0	0.5	6.4	0.1	9.3	0.0	0.4	0.0	0.0	0.0	19.7	11.4	176.1	1.7	10.6	6.5	0.7	50.7	0.0	0.0	0.1	1.1	0.0	183.6	1.4	0.6	0.0	1.4	0.0	1.5	13.1	65.8	74.7	0.7	5.4	1.3	10.5	29.4	2.2	0.8	0.0	0.3
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor like"	Q96LU7	12	69825227-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"intestine: 23.0"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 102.3;Late spermatids: 30.4;Oligodendrocyte precursor cells: 70.4;Proximal enterocytes: 30.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 5.2;SK-BR-3: 2.6;T-47d: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.4	1.3	0.0	1.2	0.0	0.5	3.1	1.7	0.1	1.3	0.2	23.0	0.1	0.9	0.1	0.1	0.1	0.4	1.5	1.3	2.0	0.3	0.2	0.2	2.1	1.1	0.0	0.7	0.0	0.9	0.2	2.1	0.7	0.1	0.5	0.6	0.4	0.0	1.4	21.2	0.1	0.9	0.1	0.1	2.5	1.5	0.2	0.2	0.0	0.4	0.0	0.1	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.2	0.1	0.0	0.0	0.0	0.9	0.8	0.0	0.2	0.1	0.0	2.6	0.0	0.9	11.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	3.1	1.7	1.5	1.3	2.1	1.1	2.1	0.9	1.5	1.4	0.0	0.0	0.0	3.6	0.0	0.1	0.1	0.0	0.0	0.7	0.7	0.1	1.5	0.0	0.3	5.5	0.0	0.2	0.0	0.3	3.9	0.7	13.9	0.4	0.0	0.0	0.0	0.4	9.4	0.0	0.0	0.4	1.1	0.7	0.0	0.1	0.0	0.0	0.1	0.0	102.3	3.2	0.0	0.0	0.0	30.4	0.9	0.1	0.0	1.0	0.0	0.2	0.0	70.4	10.8	0.4	4.8	0.4	0.0	0.1	30.8	0.8	0.7	0.2	0.0	0.5	0.2	1.0	0.6	0.0	1.1	0.0	0.1	0.1	4.7	0.0
NAA50	"FLJ13194, MAK3, NAT13, NAT5, San"	ENSG00000121579	"N-alpha-acetyltransferase 50, NatE catalytic subunit"	Q9GZZ1	3	113716458-113746300	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 320.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074489	Approved		Supported	Nucleoli		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoli		"HPA074489: "	"unprognostic (9.74e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.51e-5)"	"unprognostic (1.62e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (7.92e-5)"	"unprognostic (2.97e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.59e-2)"	"unprognostic (7.13e-3)"	"unprognostic (2.43e-1)"	88.2	64.2	21.8	72.0	24.7	87.3	58.4	25.2	29.4	49.2	27.2	62.5	48.9	50.1	31.4	93.4	38.5	50.6	50.9	23.7	24.4	64.4	90.3	43.5	84.9	23.6	25.0	51.7	58.7	59.8	23.1	45.0	25.3	52.8	54.1	31.5	69.7	42.1	320.7	53.4	47.5	51.2	25.2	52.6	65.6	53.2	26.6	56.8	58.5	154.4	90.7	87.6	46.3	28.2	589.6	250.7	135.2	158.5	179.4	144.6	281.4	308.5	172.4	186.0	212.4	362.3	205.7	403.4	185.8	164.6	146.9	236.5	238.0	211.1	338.6	85.2	121.5	435.7	182.7	220.3	164.4	459.1	135.7	124.0	163.0	208.8	298.3	122.1	168.7	167.3	279.3	157.8	194.3	277.0	306.2	99.3	303.4	228.3	365.3	309.5	207.2	318.9	141.7	439.9	207.4	119.6	223.6	164.1	229.0	116.5	228.1	150.4	156.9	255.1	253.9	109.1	235.7	174.1	314.2	736.0	200.2	253.2	160.6	17.7	40.8	22.5	45.5	40.5	40.6	55.2	33.7	43.1	44.4	37.1	29.4	39.1	51.8	31.8	38.1	25.6	39.9	52.5	21.8	24.7	25.2	29.4	23.7	24.4	23.6	25.0	25.3	25.2	26.6	28.2	33.9	48.1	39.9	24.8	75.7	168.4	86.6	42.6	76.2	24.8	52.3	31.6	47.5	25.8	45.8	36.8	8.4	46.0	78.2	51.3	78.2	52.9	68.0	44.4	53.1	45.7	19.9	79.5	41.5	55.1	94.6	55.2	35.7	94.3	47.5	45.5	29.3	66.1	61.9	40.4	39.0	31.5	42.7	55.3	148.8	50.7	30.7	60.1	62.2	20.6	49.9	29.7	29.9	33.2	28.4	65.2	36.8	31.2	74.9	142.0	31.4	71.0	30.0	18.4	19.7	53.1	64.1	53.5	60.8	99.8	177.9	62.5	74.7	37.7	49.3	193.3
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570754-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 189.3;Late spermatids: 163.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA035286: AB_2674552, HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	12.6	14.8	6.6	10.1	8.0	16.2	11.3	10.2	8.2	9.6	5.1	10.8	8.1	9.3	11.0	13.7	7.8	6.6	11.2	7.5	7.1	13.7	14.4	9.0	10.3	6.2	6.6	9.1	16.0	12.1	8.3	10.9	6.1	10.0	10.6	6.2	12.9	8.6	19.4	13.1	9.0	8.8	6.3	9.6	11.7	13.1	7.3	9.9	10.2	11.9	11.7	12.3	10.7	8.8	19.7	33.2	18.6	32.6	22.1	24.2	34.9	33.1	25.8	36.9	27.5	37.5	24.0	45.4	19.5	32.1	30.8	24.5	43.8	38.7	43.6	32.2	33.8	43.8	20.3	46.6	28.0	52.8	23.9	22.6	28.7	40.7	39.1	16.7	25.5	25.0	59.4	28.5	33.9	38.2	36.4	37.4	49.7	51.8	28.8	32.0	49.2	41.4	26.1	30.6	31.6	34.3	24.2	39.4	29.1	20.2	20.8	20.4	24.2	33.8	41.1	33.6	53.9	37.9	63.7	52.4	28.1	49.7	41.5	1.5	3.9	2.2	4.0	5.2	5.9	4.8	4.2	4.2	4.9	3.7	3.2	4.8	0.5	4.8	5.9	3.1	6.0	2.8	6.6	8.0	10.2	8.2	7.5	7.1	6.2	6.6	6.1	6.3	7.3	8.8	22.2	16.0	16.7	31.6	17.1	33.0	29.9	17.2	17.1	13.0	16.3	12.8	19.2	11.5	16.1	12.9	12.5	32.7	16.4	9.9	15.6	27.5	189.3	8.9	19.5	22.9	11.4	19.8	72.9	24.1	33.7	20.2	13.3	17.8	14.0	20.2	12.5	12.2	15.4	16.8	57.6	12.4	18.3	9.8	13.0	163.0	17.1	12.2	8.8	36.5	23.8	13.9	20.6	54.3	54.2	19.0	7.0	16.6	22.1	30.3	10.6	17.0	7.3	16.7	13.1	36.4	22.5	26.4	42.1	17.8	34.2	29.6	17.7	30.4	18.3	22.3
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717931-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	12.4	8.2	5.0	14.4	5.5	20.8	16.3	9.6	13.0	14.8	6.1	14.8	12.2	15.0	12.7	14.9	14.5	12.7	12.3	5.0	5.3	15.5	18.9	9.8	22.9	5.8	5.4	14.8	14.4	15.6	3.3	17.8	5.9	11.9	15.5	10.3	9.4	11.3	15.5	11.9	10.9	15.6	5.8	12.6	10.2	11.5	5.8	19.7	15.2	17.0	24.5	18.4	6.0	8.9	54.3	63.4	45.7	29.6	21.1	25.3	52.2	37.1	28.6	71.0	58.5	53.5	36.2	86.5	26.8	36.4	47.1	38.4	112.9	54.0	105.7	26.8	92.7	57.9	36.3	48.3	24.7	74.8	34.0	19.8	34.2	52.7	36.9	20.7	67.8	39.1	96.6	25.8	58.8	49.2	89.1	29.6	50.6	61.0	74.4	63.6	101.4	59.8	31.0	57.6	39.4	37.8	32.8	84.7	40.3	63.3	60.5	44.0	26.5	64.3	44.7	21.7	75.7	16.2	45.5	93.7	26.4	54.8	37.6	12.8	6.3	4.6	9.7	7.6	10.4	10.6	10.2	11.9	8.9	13.0	16.4	11.9	0.8	13.1	7.7	6.5	11.8	9.4	5.0	5.5	9.6	13.0	5.0	5.3	5.8	5.4	5.9	5.8	5.8	8.9	25.5	28.9	18.6	10.4	33.7	33.4	38.9	30.5	27.9	21.9	15.8	11.8	18.6	21.5	27.8	9.2	14.6	45.4	33.8	13.1	11.7	23.5	1.7	17.1	28.9	26.0	27.5	24.2	11.3	17.8	37.1	25.0	20.4	18.7	24.1	31.9	16.8	25.3	20.3	25.2	11.4	16.8	26.4	11.8	11.8	4.3	20.8	15.7	17.8	8.4	19.5	15.8	21.6	13.0	16.3	16.6	9.2	19.2	17.4	24.9	12.2	28.6	24.8	32.7	6.6	25.9	21.8	30.2	35.0	26.8	33.2	33.0	32.0	27.0	21.9	25.4
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949712-156973176	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	5.0	4.4	2.5	4.7	2.6	6.8	4.4	2.7	3.3	4.7	2.5	5.1	3.4	4.8	3.3	5.2	4.6	2.7	3.7	2.5	2.4	3.7	5.0	3.9	5.7	3.2	2.3	5.2	5.9	4.3	3.1	4.0	3.1	3.8	3.7	3.2	4.2	3.0	7.5	6.1	4.4	4.6	1.8	4.7	4.3	4.1	2.8	4.2	3.8	4.3	5.0	4.8	4.7	3.1	13.5	11.4	8.2	12.3	8.1	8.4	11.3	13.2	6.5	10.5	8.5	12.4	11.1	23.4	12.9	10.8	10.7	10.7	14.9	15.9	12.8	10.7	12.9	19.6	9.9	11.5	6.5	34.7	11.6	6.0	7.7	9.4	12.1	6.1	8.9	12.9	30.3	12.2	9.6	17.7	22.1	28.9	19.9	11.9	12.2	15.7	12.4	18.1	6.8	15.8	10.0	12.3	12.0	9.4	9.2	9.2	4.6	18.5	14.5	11.2	3.7	21.1	17.2	15.7	12.1	21.1	14.4	24.4	10.8	0.8	0.8	0.4	0.6	0.5	0.3	1.3	0.7	0.8	0.8	1.8	0.9	0.5	0.2	0.7	0.7	0.8	0.3	0.3	2.5	2.6	2.7	3.3	2.5	2.4	3.2	2.3	3.1	1.8	2.8	3.1	15.3	9.6	18.3	7.2	16.1	39.4	46.9	10.5	12.0	16.8	9.5	7.9	11.7	8.6	15.5	5.5	20.9	16.2	19.3	20.0	3.9	19.2	9.6	17.9	20.7	16.0	7.8	19.1	9.6	13.6	20.5	16.9	13.3	18.6	21.5	21.2	6.8	13.6	14.3	11.8	10.8	16.2	6.1	10.4	26.0	4.4	17.4	13.3	24.9	13.1	18.3	7.5	21.6	7.1	10.2	15.9	14.1	13.2	15.3	36.3	8.7	6.3	15.3	29.8	0.0	28.9	18.0	33.5	37.6	20.0	42.5	7.3	21.0	26.6	21.8	37.3
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388927	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 202.1;Suprabasal keratinocytes: 205.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	32.9	24.3	17.6	23.7	17.4	24.8	21.6	17.4	18.1	15.2	15.0	22.1	18.0	14.0	10.7	43.6	15.5	12.5	29.0	17.9	17.2	25.1	31.7	14.1	26.8	17.1	16.9	15.6	21.5	15.3	10.6	15.7	17.4	14.1	18.8	4.8	14.8	12.0	70.9	29.8	16.3	14.5	16.3	17.3	19.9	15.1	17.6	16.6	11.6	30.6	29.9	44.6	21.1	18.2	85.2	135.1	30.3	134.2	49.6	53.3	122.1	70.2	42.4	103.1	89.4	190.7	85.6	145.6	91.6	53.4	101.0	76.5	162.7	242.7	74.5	184.5	115.8	77.7	103.5	159.5	98.7	156.5	80.4	51.8	113.5	98.3	126.1	31.5	79.2	64.4	155.5	69.6	78.9	261.2	121.8	208.7	111.9	127.9	170.3	95.5	44.7	152.1	101.2	75.9	96.0	76.5	41.1	165.1	94.3	28.8	71.9	110.8	68.4	76.9	75.9	68.8	177.1	85.7	122.4	165.1	58.0	218.7	67.2	7.6	51.9	9.5	52.9	86.5	69.4	81.9	58.5	56.7	78.9	85.4	62.6	65.2	4.4	80.0	45.9	97.1	44.1	44.7	17.6	17.4	17.4	18.1	17.9	17.2	17.1	16.9	17.4	16.3	17.6	18.2	21.8	6.4	19.6	2.3	34.4	202.1	145.6	66.4	114.4	3.7	37.2	35.3	35.6	25.8	48.8	1.8	4.2	46.2	17.3	31.8	37.2	53.6	11.0	13.8	30.6	37.6	20.9	20.8	3.1	53.6	60.3	43.3	53.0	20.2	26.6	15.1	12.1	36.9	38.1	0.0	2.9	32.3	32.6	8.3	46.4	5.5	19.6	17.1	56.9	1.9	20.8	4.9	4.1	3.0	1.7	56.4	18.0	14.7	23.8	134.2	20.1	72.6	16.5	3.0	6.6	90.5	46.1	38.4	32.1	112.9	205.3	38.3	22.2	35.9	57.7	116.6
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA040119	Supported		Enhanced	Nucleoli		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	28.4	22.6	14.6	22.6	15.1	34.6	19.8	15.2	18.5	20.5	14.7	20.8	14.2	20.8	10.2	28.6	21.2	10.9	18.8	15.0	15.1	21.7	26.7	20.6	28.3	14.9	14.6	20.2	21.6	9.9	21.2	12.2	15.0	25.0	14.2	6.6	19.2	8.6	42.2	25.7	24.5	14.7	14.4	32.3	20.6	23.1	15.3	22.8	23.5	12.2	28.7	21.7	21.0	15.4	69.0	107.2	29.5	101.8	37.4	32.1	159.8	61.4	40.4	71.8	61.6	130.5	69.0	144.7	16.7	30.8	75.5	84.9	113.9	69.6	68.0	175.3	105.2	143.7	110.8	78.5	49.0	141.2	79.9	33.0	67.3	87.9	135.8	31.3	50.2	76.9	102.7	22.8	58.1	83.7	77.1	124.7	247.6	93.6	59.9	108.4	84.1	72.8	53.1	92.1	22.7	44.5	94.1	102.5	50.2	116.2	17.1	70.4	47.6	49.1	64.1	63.7	143.2	31.2	49.7	217.9	45.0	81.3	88.6	2.4	14.0	1.5	23.6	19.5	32.7	21.0	22.4	27.1	28.7	15.8	27.2	28.2	5.1	22.2	19.0	24.8	16.8	19.9	14.6	15.1	15.2	18.5	15.0	15.1	14.9	14.6	15.0	14.4	15.3	15.4	3.9	12.8	6.8	7.8	20.5	23.8	17.7	12.9	47.8	5.8	6.0	4.4	6.8	5.7	6.4	3.7	2.1	12.6	6.6	13.1	1.9	12.0	17.9	4.2	4.4	11.4	7.2	19.4	9.1	11.8	13.4	10.3	26.0	4.3	7.6	1.4	7.9	8.3	11.8	6.7	7.3	11.1	16.2	7.7	15.7	7.3	9.3	11.7	8.8	2.8	7.7	3.0	18.6	5.5	5.7	13.5	5.3	4.9	19.2	19.2	2.1	1.3	5.2	2.9	13.1	22.7	9.7	11.3	21.4	43.4	21.3	7.3	16.2	1.2	16.4	16.7
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745546-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 605.5;Breast myoepithelial cells: 415.5;Cytotrophoblasts: 454.3;Exocrine glandular cells: 989.2;Extravillous trophoblasts: 570.3;Syncytiotrophoblasts: 506.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 311.8;NK-cells: 96.7;T-cells: 244.1"	"Cell line enhanced"	"Detected in all"		"NB-4: 1305.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA018999: AB_1849733, HPA049600: AB_2680831"	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	400.7	245.3	101.7	175.2	105.0	242.1	420.4	97.4	125.9	589.9	106.6	440.5	185.0	405.7	77.3	320.0	424.5	39.4	273.8	93.6	99.7	259.3	224.7	219.1	213.6	114.7	103.5	790.1	1016.5	123.0	201.7	78.4	105.4	386.3	64.1	70.2	397.0	104.5	308.6	635.8	333.6	60.1	108.4	358.9	445.3	116.5	107.3	225.3	302.8	110.0	128.3	411.8	422.5	105.6	99.7	103.0	90.7	214.6	110.6	184.2	176.8	60.6	110.5	57.8	85.3	95.5	194.8	440.3	87.0	71.2	44.2	139.8	52.9	88.8	30.2	133.0	177.8	142.6	85.1	113.5	163.0	207.4	271.6	162.5	198.9	50.8	136.1	188.0	92.3	183.1	176.8	206.5	52.3	86.9	577.2	1305.4	209.4	173.4	60.0	380.4	160.8	209.8	112.6	151.9	96.8	340.9	50.6	330.7	330.0	65.8	156.2	493.7	114.4	56.4	150.2	49.2	125.8	306.3	290.6	120.9	71.2	145.4	92.4	21.5	23.3	26.3	55.3	35.3	74.5	311.8	108.2	96.0	33.1	238.5	244.1	108.6	3.3	96.7	25.1	41.6	120.0	15.8	101.7	105.0	97.4	125.9	93.6	99.7	114.7	103.5	105.4	108.4	107.3	105.6	229.4	41.7	120.7	0.0	210.4	0.0	0.0	0.0	0.0	0.0	605.5	415.5	0.0	0.0	69.3	104.8	0.0	454.3	224.1	0.0	266.1	266.5	0.0	100.6	156.9	94.5	0.0	0.0	0.0	989.2	570.3	107.2	0.0	115.5	68.1	268.3	0.0	0.0	259.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.1	0.0	0.0	269.8	0.0	0.0	0.0	0.0	348.1	0.0	0.0	61.8	0.0	0.0	369.7	18.2	0.0	0.0	0.0	108.6	0.0	0.0	0.0	0.0	506.8	131.3	226.3	0.0	0.0
NSMAF	"FAN, GRAMD5"	ENSG00000035681	"Neutral sphingomyelinase activation associated factor"	Q92636	8	58583508-58659853	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 89.7;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023067, HPA023148, HPA023151"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	Nucleoli		"HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.86e-3)"	"unprognostic (2.69e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (4.61e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.69e-1)"	16.8	14.9	8.5	16.1	9.5	7.9	13.5	9.0	9.8	14.2	9.7	15.7	9.3	13.9	9.1	13.1	10.8	10.7	11.9	8.4	9.1	9.4	5.7	12.0	21.6	9.3	9.0	12.1	17.1	17.5	10.4	13.4	9.2	12.1	14.5	4.8	11.3	12.5	18.5	19.2	14.8	14.1	8.7	16.8	14.0	5.5	10.5	35.8	13.5	15.4	22.2	16.2	13.3	10.0	33.7	32.7	14.3	20.1	53.8	43.3	24.8	26.8	58.5	36.3	33.9	17.8	20.6	40.5	21.6	41.6	37.6	26.6	24.7	21.2	41.3	46.0	13.7	75.7	19.8	20.5	67.8	33.7	51.1	29.2	33.7	26.2	99.5	29.6	36.5	36.9	32.9	29.1	41.6	25.7	71.5	26.6	25.7	27.0	12.6	26.7	21.2	11.6	19.8	26.4	13.1	16.5	22.4	8.3	24.8	18.6	20.1	41.8	34.4	35.7	21.7	48.2	27.3	5.5	2.6	31.6	52.3	25.6	23.1	8.3	7.1	4.7	6.0	5.0	6.2	4.2	6.4	6.5	14.0	4.0	4.4	4.3	14.6	6.4	3.6	4.7	8.6	4.7	8.5	9.5	9.0	9.8	8.4	9.1	9.3	9.0	9.2	8.7	10.5	10.0	9.6	9.6	5.9	68.9	28.4	18.4	10.4	7.2	26.2	9.7	7.8	6.9	15.8	1.5	9.6	9.2	4.2	12.1	17.4	8.9	3.9	7.7	0.3	5.9	14.5	12.1	14.4	12.2	89.7	8.8	8.3	13.8	14.8	7.8	28.5	15.8	5.3	4.0	17.8	32.0	94.9	10.4	2.0	31.0	35.3	2.1	16.4	33.9	10.6	54.4	22.6	6.3	13.4	102.1	51.2	7.4	9.1	12.8	18.3	13.0	8.0	4.9	3.8	6.3	6.6	18.0	10.8	2.0	3.5	16.1	17.8	9.3	22.7	10.6	10.7	11.0
NVL	NVL2	ENSG00000143748	"Nuclear VCP like"	O15381	1	224227334-224330189	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	7.0	7.7	5.5	8.7	5.7	9.8	10.7	7.8	7.5	9.5	6.5	9.1	6.3	9.0	7.7	7.2	8.8	5.6	5.9	5.3	6.4	8.7	6.1	8.0	12.5	5.4	5.3	10.6	8.8	9.5	10.3	13.0	5.6	9.0	10.6	12.8	7.4	7.9	6.5	15.7	8.2	8.1	4.7	10.4	7.2	6.6	5.6	13.0	10.2	5.2	12.1	8.8	8.9	7.5	28.8	15.8	31.2	25.2	11.5	16.6	31.6	22.0	16.5	30.6	27.0	23.4	23.4	39.6	22.5	14.7	11.7	26.1	37.3	22.2	31.5	30.5	47.0	16.4	25.5	11.3	20.3	39.1	28.8	13.5	16.9	26.8	28.5	14.3	19.2	23.0	48.9	23.8	19.1	21.3	30.6	18.3	47.5	20.0	26.1	34.2	37.3	24.8	17.8	19.2	27.5	22.9	34.2	53.1	31.9	25.6	24.3	32.1	19.8	23.2	14.9	27.1	42.9	15.6	33.3	39.3	15.1	30.2	24.8	13.9	7.8	8.4	11.5	11.8	11.7	13.5	11.8	9.1	8.7	9.0	9.9	10.0	0.8	11.9	16.4	9.0	9.3	7.8	5.5	5.7	7.8	7.5	5.3	6.4	5.4	5.3	5.6	4.7	5.6	7.5	10.2	22.4	23.1	21.2	14.3	5.2	4.6	7.8	4.0	14.5	7.9	8.3	10.5	7.2	12.2	1.8	10.4	21.5	12.6	26.9	13.7	9.5	10.1	10.0	11.6	9.3	4.2	7.2	32.1	8.4	14.0	9.3	5.6	7.3	16.4	13.4	4.6	4.5	10.7	10.1	31.0	12.6	10.2	6.5	5.7	3.1	9.6	8.1	5.4	26.2	8.7	9.7	15.5	24.6	43.0	7.0	23.4	10.9	12.3	3.7	7.0	8.1	16.7	20.4	0.0	8.5	10.1	17.5	11.3	7.3	4.5	18.3	12.9	11.4	14.7	3.7
OSGIN2	"C8orf1, hT41"	ENSG00000164823	"Oxidative stress induced growth inhibitor family member 2"	Q9Y236	8	89901849-89927888	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 246.6;Granulosa cells: 144.4;Late spermatids: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 22.2"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 149.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028515, HPA050595"	Approved		Approved	Nucleoli		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA028515: AB_10602014, HPA050595: AB_2681186"	"unprognostic (3.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (3.91e-6)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.25e-2)"	19.2	7.6	9.6	8.6	9.3	51.9	12.1	10.9	12.1	8.6	7.0	10.5	7.9	18.4	5.7	8.3	5.9	16.3	14.8	10.6	17.9	17.1	18.5	16.4	10.8	12.4	11.4	17.8	7.9	33.2	9.8	7.0	12.5	10.0	8.9	12.9	7.4	7.8	15.2	5.2	7.1	21.1	14.9	9.3	6.0	23.1	10.2	8.9	14.1	18.8	10.0	11.0	4.7	18.3	32.1	30.6	7.9	16.2	17.5	14.0	9.9	23.5	49.9	21.7	22.2	14.3	29.6	21.9	45.7	13.0	26.1	11.6	16.0	18.8	34.6	33.3	11.7	34.2	11.7	8.0	31.9	17.0	20.4	16.1	23.2	24.5	22.6	20.9	28.6	28.7	19.7	38.3	16.2	24.8	29.7	11.7	4.4	33.6	16.7	13.1	11.5	18.6	33.2	24.2	7.1	18.1	17.3	149.6	29.5	12.9	30.1	27.9	20.2	23.2	20.2	20.1	22.2	35.0	32.2	24.2	38.6	21.9	17.5	22.2	1.6	7.5	1.9	1.2	2.7	3.5	2.8	1.7	1.8	2.0	2.3	2.6	12.4	2.5	1.5	1.3	3.1	1.6	9.6	9.3	10.9	12.1	10.6	17.9	12.4	11.4	12.5	14.9	10.2	18.3	9.8	64.1	14.8	49.3	10.4	6.0	6.9	9.2	2.8	9.0	13.3	6.7	13.9	17.2	12.5	7.3	2.1	6.8	10.6	4.2	9.8	13.6	246.6	11.6	10.8	7.4	9.6	8.6	14.9	16.0	8.4	13.7	2.0	14.1	17.1	144.4	13.6	17.6	16.5	3.3	14.9	3.8	20.3	19.1	9.4	216.8	12.5	15.7	7.2	9.4	13.3	25.3	5.2	7.5	7.8	14.0	3.4	12.4	6.1	7.2	3.0	14.8	15.2	6.0	13.1	18.9	9.0	28.9	8.8	4.5	4.3	1.6	8.3	3.0	5.1	7.6
OSMR	"OSMRB, OSMRbeta"	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 74.9;Pancreatic endocrine cells: 72.4;Prostatic glandular cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 154.3;GAMG: 162.7;HSkMC: 192.7;U-2197: 158.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA		51000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	59.3	29.8	7.8	25.3	7.6	0.1	37.3	7.4	8.4	26.0	9.7	25.2	5.5	22.9	7.6	17.1	27.8	28.8	27.6	6.5	10.5	29.9	19.2	46.2	16.0	13.4	10.8	24.6	16.4	6.5	10.4	35.3	10.2	24.6	10.5	4.3	27.4	13.5	11.8	21.9	15.1	39.0	9.3	17.9	18.4	5.6	11.5	13.9	23.9	8.5	15.1	40.9	22.3	8.1	32.6	41.2	6.9	17.7	72.6	154.3	23.4	51.7	81.7	49.8	66.4	0.1	85.9	0.0	23.9	55.3	162.7	43.9	8.9	63.6	79.8	0.1	5.1	2.2	31.2	31.6	82.4	0.0	0.6	192.7	37.3	111.9	94.9	92.3	7.7	0.0	0.0	0.2	31.8	8.8	0.1	0.1	1.1	6.8	13.3	0.0	2.3	0.0	99.8	9.5	0.1	0.3	116.8	0.2	0.2	9.5	35.4	0.3	12.2	120.6	45.1	158.1	28.0	0.0	0.1	0.1	96.8	0.1	26.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	7.6	7.4	8.4	6.5	10.5	13.4	10.8	10.2	9.3	11.5	8.1	41.5	44.8	56.8	13.4	0.6	30.3	74.9	55.0	27.3	0.2	21.7	10.8	5.0	15.7	51.4	12.9	0.0	6.9	0.2	0.2	0.0	48.7	0.6	6.6	38.9	47.0	0.0	0.4	2.0	48.6	6.8	37.2	6.6	9.2	1.3	2.6	55.0	16.6	1.6	0.0	1.8	0.0	8.2	6.1	7.6	1.4	41.7	1.1	7.2	46.9	1.6	0.7	0.0	13.6	3.6	72.4	0.0	7.5	0.6	73.8	0.0	5.9	19.3	0.6	19.7	32.4	33.6	0.3	1.6	10.5	24.0	17.1	1.7	4.7	0.0	57.7
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694972-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	13.5	10.3	5.6	7.6	5.7	10.6	12.4	5.7	8.1	9.3	5.5	8.4	4.2	10.3	7.2	16.3	8.4	5.2	9.6	5.7	6.2	9.3	11.3	7.3	7.8	5.7	6.0	8.0	9.6	5.7	6.7	7.0	5.9	37.8	7.3	4.9	9.2	5.7	15.2	8.8	7.1	8.1	5.8	8.2	7.8	5.7	5.9	7.0	7.5	9.7	9.6	11.5	9.9	6.9	35.3	13.7	17.2	29.9	21.3	19.4	24.9	22.4	18.7	33.7	32.9	30.2	15.4	35.6	54.9	19.4	41.4	18.4	35.8	29.2	48.1	20.9	23.3	19.4	12.4	35.2	31.1	54.5	24.3	17.9	25.2	32.6	55.3	11.1	22.9	19.2	60.2	10.0	28.3	21.2	27.4	49.5	37.4	32.7	24.1	27.9	22.4	55.0	24.4	21.0	25.7	22.4	16.8	42.7	51.1	28.9	18.9	19.6	19.6	26.9	19.5	29.2	56.4	23.3	68.7	38.9	11.0	36.3	51.7	2.0	8.1	2.9	9.4	12.4	9.6	10.0	8.3	9.4	11.7	7.2	11.1	13.5	0.4	9.9	10.3	13.7	5.9	6.8	5.6	5.7	5.7	8.1	5.7	6.2	5.7	6.0	5.9	5.8	5.9	6.9	22.6	19.2	12.3	8.8	18.5	66.4	54.2	47.3	30.1	13.2	18.6	28.3	18.6	17.2	35.0	11.0	4.2	24.9	24.8	10.3	19.6	43.3	12.4	26.0	35.0	24.1	5.4	31.1	9.9	26.9	32.0	32.0	14.8	34.3	35.5	16.6	15.0	21.7	36.6	13.5	10.9	12.7	42.7	16.1	12.6	8.4	21.5	18.2	12.4	6.5	22.1	12.0	12.3	9.5	12.5	31.3	7.7	20.7	18.2	56.5	5.1	27.0	17.7	11.8	6.6	40.9	31.4	27.3	44.2	29.3	49.9	17.5	16.3	23.1	24.0	28.6
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 40.4;monocytes: 25.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	1.8	2.5	5.1	4.0	5.5	14.8	1.9	6.1	6.3	3.3	3.4	3.3	18.4	2.0	18.0	7.3	1.6	1.6	1.5	5.1	6.5	3.5	1.7	4.2	1.5	6.8	6.4	3.3	11.2	3.2	5.2	10.2	6.9	3.6	3.4	16.1	2.7	1.3	5.4	3.8	20.8	2.4	5.9	10.3	1.3	24.0	7.7	1.3	1.6	3.4	1.1	2.0	5.8	6.7	12.0	3.9	8.3	8.1	2.8	4.0	16.6	6.1	10.4	11.9	29.3	6.0	4.2	5.5	5.8	4.6	28.4	3.5	3.6	10.6	10.6	3.5	2.9	12.3	9.3	6.7	2.5	2.3	5.1	4.2	15.6	19.4	1.9	52.5	2.9	6.7	4.4	4.5	9.7	2.8	0.8	17.3	5.0	2.3	8.0	0.9	4.1	5.9	4.5	11.4	2.5	5.4	6.6	3.0	23.6	8.2	6.3	5.3	0.9	12.0	4.7	1.6	36.7	21.6	4.4	3.2	83.9	4.3	74.8	0.0	12.5	21.9	0.4	13.8	0.1	0.3	0.6	0.1	5.1	0.2	1.0	0.3	40.4	0.5	25.1	0.6	0.0	4.9	5.1	5.5	6.1	6.3	5.1	6.5	6.8	6.4	6.9	5.9	7.7	6.7	0.1	0.0	1.3	13.1	0.3	3.2	0.3	7.0	1.8	6.3	1.6	1.3	1.0	2.8	2.1	0.0	2.1	13.8	0.2	1.3	0.0	2.9	2.8	1.9	2.4	0.8	4.2	0.4	4.5	1.5	40.3	1.2	0.5	3.3	1.3	2.0	1.1	1.0	6.0	6.7	7.3	13.0	2.0	7.8	0.5	2.6	0.9	7.3	1.8	3.7	3.5	3.3	1.0	6.0	13.9	2.9	1.4	0.7	1.8	0.4	43.6	0.2	2.7	4.4	0.0	0.1	1.5	0.5	0.8	2.5	1.7	5.5	0.9	1.3	3.7	0.1
PHLDA2	"BWR1C, HLDA2, IPL, TSSC3"	ENSG00000181649	"Pleckstrin homology like domain family A member 2"	Q53GA4	11	2928273-2929420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;placenta: 79.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 4600.4;Extravillous trophoblasts: 2222.5;Syncytiotrophoblasts: 9959.7;Urothelial cells: 2892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.9;monocytes: 1.2;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 395.9;PC-3: 326.0;SK-MEL-30: 289.9;WM-115: 358.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003994			Uncertain	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli		"HPA003994: AB_1855311"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.16e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.01e-3)"	"prognostic unfavorable (4.22e-5)"	"unprognostic (1.24e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.59e-1)"	9.3	2.8	1.6	3.6	1.7	1.2	5.3	2.2	2.6	12.6	1.5	14.7	7.3	4.7	0.7	42.6	4.7	3.0	2.9	1.6	2.7	21.8	5.9	7.8	0.3	5.1	3.4	2.4	4.1	0.4	2.8	79.7	4.7	15.4	1.7	0.0	10.2	0.9	0.9	21.4	6.4	0.8	1.9	2.7	17.8	0.8	2.4	0.1	5.6	0.4	1.3	12.7	18.7	2.4	42.2	31.1	1.9	0.5	0.4	9.8	43.4	72.4	21.4	12.9	11.8	15.4	91.8	0.0	41.9	12.1	32.2	51.8	0.1	42.8	2.4	395.9	14.1	0.0	13.9	10.4	32.7	0.1	23.5	13.9	20.2	11.1	12.1	8.8	10.9	0.0	9.2	0.7	6.5	148.9	0.1	6.1	16.5	26.8	326.0	0.0	0.0	29.6	32.2	13.7	4.1	0.3	31.6	25.0	289.9	2.0	7.4	3.3	51.9	31.2	13.6	45.7	32.1	0.6	0.8	0.3	28.2	5.4	358.2	0.0	1.2	0.0	0.3	1.1	0.4	0.0	1.8	0.3	1.9	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.5	1.6	1.7	2.2	2.6	1.6	2.7	5.1	3.4	4.7	1.9	2.4	2.4	27.1	19.2	28.9	1.0	13.0	394.7	1494.1	518.9	116.1	0.0	274.4	221.4	6.0	64.3	328.3	44.1	0.0	4600.4	9.2	506.0	9.8	164.7	2.4	84.9	28.6	37.8	197.3	2.7	2.1	143.7	2222.5	92.0	278.8	175.6	82.6	0.4	15.7	6.2	405.9	0.0	1.0	384.5	258.4	12.9	303.6	0.8	3.7	79.6	103.2	1.9	10.5	0.1	0.0	0.0	0.4	502.3	871.7	3.0	13.2	1318.1	201.9	1.7	133.0	0.4	52.6	10.5	293.5	0.4	3.8	545.6	685.5	9959.7	50.5	0.2	292.8	2892.3
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027734-135034813	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 711.6;vagina: 199.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 121.0;Basal squamous epithelial cells: 409.2;Squamous epithelial cells: 1069.0;Urothelial cells: 257.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 141.4;HeLa: 108.9;K-562: 112.1;T-47d: 157.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA008743	Approved		Approved	Nucleoli		Yes	No				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	1.5	1.9	0.7	7.7	0.6	0.3	0.6	0.9	0.7	83.5	4.7	11.4	12.1	0.8	0.0	711.6	0.5	1.1	0.2	0.9	1.1	0.1	0.3	0.4	0.1	0.8	0.9	0.6	0.4	0.0	164.7	2.7	0.7	20.1	2.0	0.1	137.5	0.0	14.1	2.0	7.9	0.4	0.5	0.2	41.9	2.2	0.7	0.0	0.2	20.1	12.6	85.0	199.0	0.8	57.5	36.9	0.0	44.7	1.4	0.9	13.4	9.6	14.6	5.1	2.3	141.4	32.5	59.9	17.6	0.9	12.6	17.6	6.4	25.5	0.3	0.7	48.2	13.4	108.9	38.4	15.6	5.8	0.1	1.4	18.4	0.0	4.9	0.3	0.1	10.1	112.1	0.2	1.9	18.4	0.6	12.3	0.1	4.8	31.8	18.5	1.1	1.2	0.6	17.9	20.2	0.1	48.4	24.1	0.0	0.5	157.5	4.2	1.5	6.1	13.4	3.5	17.0	0.1	0.2	40.7	8.1	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.9	0.7	0.9	1.1	0.8	0.9	0.7	0.5	0.7	0.8	0.1	0.0	0.0	0.0	0.2	1.3	121.0	12.8	409.2	1.0	2.5	2.7	2.3	1.5	8.6	0.0	0.0	0.8	0.0	4.2	0.0	0.2	4.2	0.3	0.6	1.2	0.0	50.8	0.0	0.4	2.1	28.8	0.5	0.2	0.0	2.7	0.0	0.0	0.9	0.0	0.0	2.4	6.1	0.0	0.3	5.7	0.3	1.0	0.0	0.0	0.0	0.4	1.0	0.0	0.1	16.9	3.4	0.0	3.1	101.6	0.3	0.2	6.1	1.8	0.0	2.1	4.5	2.2	5.6	1069.0	6.8	7.7	0.9	0.7	2.5	257.3
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365282-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 604.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 310.7;Hofbauer cells: 220.3;Kupffer cells: 213.9;Langerhans cells: 456.5;Macrophages: 412.7;monocytes: 178.3;NK-cells: 355.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 552.9;HL-60: 126.7;HMC-1: 202.5;NB-4: 187.5;THP-1: 215.6;U-266/84: 147.8;U-698: 147.1;U-937: 342.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		380000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	36.4	9.8	4.9	99.4	7.1	604.8	8.2	6.0	10.0	6.9	6.5	13.2	10.4	4.7	3.3	6.0	7.2	21.0	5.4	4.9	5.3	4.0	27.5	35.6	129.9	8.0	6.1	2.6	2.7	2.7	1.9	29.2	8.1	4.2	18.8	0.5	5.7	3.1	1.7	3.4	13.0	22.2	7.3	93.5	11.3	3.2	7.2	33.7	3.8	5.2	118.2	52.3	2.5	12.3	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	552.9	0.0	0.0	0.0	126.7	202.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.3	58.9	0.0	0.0	0.2	187.5	0.0	0.0	0.0	1.5	0.1	27.3	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	215.6	0.1	0.0	0.4	0.1	0.5	7.9	147.8	147.1	0.2	342.5	0.1	231.9	297.5	429.2	298.5	351.6	157.6	157.7	52.2	218.7	229.6	103.6	14.5	161.8	573.9	249.5	390.8	474.8	5.7	606.9	4.9	7.1	6.0	10.0	4.9	5.3	8.0	6.1	8.1	7.3	7.2	12.3	3.4	19.2	24.6	0.0	77.0	6.5	0.3	0.0	0.0	0.0	1.4	3.7	2.3	1.5	15.5	1.8	0.0	1.2	310.7	0.0	0.0	0.2	1.5	0.2	0.3	6.3	0.0	21.9	0.6	0.6	1.8	10.2	1.5	0.3	62.0	0.0	5.7	1.5	220.3	0.0	0.2	0.0	0.0	213.9	456.5	5.1	0.6	412.7	17.8	20.6	178.3	0.0	355.3	0.0	0.1	0.1	0.1	0.4	48.4	0.0	0.0	0.7	13.1	0.1	13.1	1.1	1.8	0.8	0.9	0.6	6.7	2.6	78.3	0.4	0.0	0.3
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117293-98159835	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	2.1	1.6	1.7	3.5	1.5	1.5	2.1	3.4	2.3	1.4	1.2	1.9	1.5	1.7	1.4	3.0	1.8	1.3	1.6	1.3	1.2	2.0	1.9	1.6	3.6	1.1	1.4	2.9	1.7	1.7	1.5	1.2	1.1	1.5	4.8	2.4	1.4	1.3	1.7	3.0	1.6	1.8	0.8	2.1	1.9	3.1	1.6	2.6	1.5	1.2	4.4	2.5	1.5	1.8	21.9	12.9	13.8	12.8	4.8	3.3	9.1	18.3	15.2	18.7	13.8	13.4	13.8	15.3	25.6	12.9	9.0	14.3	40.3	18.2	18.9	11.1	17.0	30.0	10.2	9.2	2.1	16.4	18.4	2.8	3.3	20.8	8.2	5.7	14.8	7.2	17.0	13.5	17.7	17.4	23.8	8.3	10.4	25.1	17.6	19.4	7.5	11.0	13.5	11.5	32.8	7.7	8.4	14.2	6.4	7.9	19.2	6.0	18.4	16.3	11.6	20.8	36.5	13.3	13.6	32.7	12.8	17.3	14.6	9.4	5.1	3.9	7.4	5.7	6.0	4.9	5.4	5.0	5.0	8.1	6.8	6.5	0.8	3.8	2.9	6.2	4.9	2.1	1.7	1.5	3.4	2.3	1.3	1.2	1.1	1.4	1.1	0.8	1.6	1.8	2.3	3.2	3.9	10.7	4.7	3.7	8.2	3.8	4.0	7.0	2.5	2.3	3.9	0.0	3.8	5.5	0.0	4.1	4.1	2.7	5.9	8.8	13.8	2.4	6.4	4.2	0.0	5.0	17.7	5.9	3.4	5.8	6.6	2.9	1.3	5.9	1.8	5.4	3.4	1.7	19.0	1.7	2.0	2.4	0.8	3.0	5.3	3.3	0.0	3.7	7.9	2.7	10.3	8.5	11.0	7.8	1.0	4.5	5.2	4.8	1.1	8.5	2.6	9.5	6.6	4.0	6.1	7.7	19.1	9.8	2.4	3.0	4.4	6.1	3.9	5.1
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36874803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062916			Supported	Nucleoli		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	12.4	21.7	20.3	19.1	21.9	11.4	18.4	22.6	27.3	15.0	23.8	14.7	13.2	15.7	19.1	17.0	23.0	10.7	42.8	20.0	25.2	18.9	21.5	10.5	21.9	22.0	22.0	17.7	14.3	21.7	12.0	22.3	23.3	16.8	17.6	29.1	19.5	17.6	18.5	9.5	11.3	22.9	24.1	9.5	12.9	23.2	22.2	18.6	33.2	20.7	24.6	20.5	8.0	22.8	69.2	50.0	111.2	78.5	19.7	31.5	77.5	60.9	41.0	82.7	70.0	89.7	39.7	87.7	75.5	41.9	105.5	55.4	135.1	92.7	96.2	81.3	114.6	102.7	33.6	147.7	53.5	89.3	40.8	24.7	48.7	62.3	118.9	31.8	75.5	79.1	202.4	48.0	63.3	71.2	101.9	69.8	92.3	108.5	57.9	79.4	100.2	92.0	63.2	53.5	140.0	68.5	41.8	51.4	102.5	83.5	76.3	100.2	44.0	66.7	69.0	58.5	98.8	57.0	145.2	153.0	23.7	183.7	139.4	1.6	4.8	1.3	14.7	6.2	19.7	10.3	12.1	13.9	9.2	7.4	13.4	15.9	1.2	7.3	3.4	7.8	10.2	9.8	20.3	21.9	22.6	27.3	20.0	25.2	22.0	22.0	23.3	24.1	22.2	22.8	5.7	6.4	7.5	2.9	10.8	3.1	18.6	12.2	5.7	16.9	9.0	10.5	45.8	8.6	8.3	5.5	4.2	58.7	6.6	3.3	23.5	25.7	32.0	10.3	14.2	12.3	3.6	22.7	6.5	20.3	72.3	12.2	7.7	7.7	10.8	16.3	5.0	8.2	30.1	16.8	8.6	11.4	4.1	3.3	3.6	11.7	6.8	6.4	7.2	1.9	9.2	41.0	11.3	7.5	5.4	22.1	5.5	12.4	15.0	13.5	3.3	17.1	13.5	15.5	6.6	6.1	12.8	25.7	51.0	10.6	4.5	25.3	9.2	21.1	11.9	8.6
PPP1R7	sds22	ENSG00000115685	"Protein phosphatase 1 regulatory subunit 7"	Q15435	2	241149576-241183652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 968.8;Late spermatids: 1709.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA034500, HPA034501"	Supported		Approved	Nucleoli		NA	NA		960000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA034500: AB_2674192, HPA034501: AB_10670965"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.07e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.23e-1)"	59.0	55.9	71.3	54.4	94.7	68.1	50.2	65.5	82.4	46.4	68.3	66.0	58.8	48.5	61.4	80.3	81.3	40.2	100.5	77.5	69.4	64.6	76.0	53.9	78.7	67.2	67.2	37.5	60.0	55.8	42.6	44.5	65.7	94.5	64.2	58.0	63.1	54.0	100.4	64.3	61.0	55.0	66.5	48.7	58.9	158.2	67.2	66.8	65.1	64.4	80.8	58.9	52.9	75.1	117.6	69.5	77.4	98.3	149.7	149.0	106.4	126.3	114.7	85.2	119.8	38.1	145.6	60.0	37.1	108.9	128.0	112.1	127.9	119.6	130.2	156.4	126.1	105.1	112.4	151.4	96.3	147.0	105.9	116.0	92.7	101.1	74.2	115.7	128.5	121.0	108.0	86.2	202.0	155.8	132.0	112.6	106.3	185.7	64.5	90.4	200.9	121.9	159.6	116.7	104.6	82.8	67.6	157.4	120.3	86.4	93.8	156.7	127.7	76.8	72.5	146.1	103.4	90.8	59.6	162.8	215.2	154.1	103.7	107.9	84.9	108.9	64.6	87.6	68.3	71.6	76.5	77.1	81.3	66.5	58.5	67.6	66.5	75.8	96.2	48.4	121.5	89.9	71.3	94.7	65.5	82.4	77.5	69.4	67.2	67.2	65.7	66.5	67.2	75.1	50.5	57.7	54.5	17.6	47.9	27.8	48.6	126.2	25.6	41.5	44.6	36.8	98.4	45.8	105.5	44.1	16.7	89.6	46.9	53.4	121.3	90.6	968.8	83.6	39.3	45.9	25.7	48.0	33.8	145.9	92.4	47.5	34.7	53.4	59.5	48.9	32.9	49.9	100.5	32.0	19.4	68.7	109.9	40.7	46.3	1709.4	51.0	49.4	87.2	13.1	63.7	78.6	80.3	18.1	21.9	94.5	71.3	67.4	54.5	52.1	81.7	120.8	112.2	58.9	72.3	35.1	65.6	315.5	122.5	45.9	38.1	71.6	57.9	117.2	55.3	56.0
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004305	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 58.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 57.4;Respiratory ciliated cells: 89.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5;REH: 3.7;TIME: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051264			Uncertain	Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	2.0	0.3	3.2	0.5	2.5	0.3	2.2	1.8	1.2	6.1	12.7	0.4	0.2	0.6	0.3	0.2	58.2	0.7	1.5	4.1	4.2	1.9	0.2	10.4	0.4	12.7	16.0	0.6	0.3	0.9	10.7	0.3	7.3	0.7	0.0	0.0	0.5	0.6	0.6	0.4	0.7	0.2	9.0	5.7	0.3	13.9	4.0	0.2	4.7	0.0	0.3	0.8	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.2	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	1.0	0.5	0.0	0.0	0.0	1.3	0.0	0.1	0.7	0.1	3.7	0.0	1.5	0.3	0.0	0.2	1.0	0.0	0.1	0.2	0.5	0.5	0.0	2.8	0.1	1.1	0.4	0.1	0.4	0.1	0.2	0.4	0.1	0.0	0.9	0.2	0.0	0.4	0.5	0.1	0.1	0.4	0.2	0.1	0.2	0.7	0.4	0.2	0.2	0.4	0.0	0.2	0.3	3.2	2.5	1.8	1.2	4.1	4.2	12.7	16.0	7.3	9.0	4.0	3.9	3.3	0.0	2.8	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.2	1.5	9.9	3.7	0.0	0.0	0.7	0.0	0.0	0.1	12.4	57.4	0.5	2.1	0.0	0.0	0.5	0.0	0.1	0.6	0.0	1.1	0.0	1.6	1.8	0.5	0.3	0.0	0.4	0.0	0.0	0.0	0.0	10.5	0.0	0.9	0.0	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.1	89.6	0.0	0.0	0.3	0.3	18.1	1.4	0.0	0.0	0.3	0.7	3.5	0.0	0.1
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, Puf-A, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844095	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 338.4;HEL: 327.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.5	16.7	6.2	22.3	5.9	19.0	24.7	8.1	5.6	13.8	4.9	15.8	12.8	14.7	9.8	24.8	13.5	11.7	12.0	5.5	5.7	21.8	15.2	15.4	23.2	5.0	4.7	18.3	14.8	12.2	10.1	18.0	5.3	12.5	18.7	7.4	16.8	10.6	11.1	16.6	11.7	13.6	4.2	14.7	13.2	15.4	5.2	17.1	11.9	9.4	22.0	30.7	16.0	6.7	78.9	56.7	47.0	48.2	38.6	40.8	53.5	71.7	37.6	72.3	67.3	43.6	36.0	86.4	16.1	49.5	43.2	38.8	85.8	62.0	93.5	338.4	30.7	327.8	59.3	52.9	51.0	146.2	58.7	33.3	26.8	58.8	83.5	33.0	54.3	55.6	35.0	38.1	63.8	36.0	74.6	119.9	120.4	59.9	25.1	86.7	36.8	37.3	48.8	52.7	48.4	46.4	43.2	39.8	40.3	52.0	25.2	78.4	52.1	48.6	40.2	46.8	97.1	17.7	31.0	120.5	36.8	52.4	36.1	7.7	13.7	4.1	18.8	19.9	26.3	23.4	19.3	18.9	18.5	22.4	21.2	20.7	1.9	25.2	17.1	20.8	15.7	11.8	6.2	5.9	8.1	5.6	5.5	5.7	5.0	4.7	5.3	4.2	5.2	6.7	27.7	48.1	41.4	0.0	35.8	0.0	59.6	0.0	62.6	28.0	27.5	26.7	0.0	14.3	41.5	23.9	10.4	34.7	25.5	1.9	46.9	41.2	4.8	36.7	79.1	28.3	8.5	23.8	0.0	26.5	45.4	30.9	35.2	54.9	17.7	39.8	20.0	22.1	21.6	26.9	0.0	9.2	0.0	15.8	0.0	4.9	47.2	20.6	0.0	0.0	29.4	14.2	25.7	0.0	0.0	29.1	8.0	23.0	29.2	57.7	7.6	108.3	32.1	24.0	0.0	50.2	26.8	43.7	45.3	54.3	0.0	35.0	26.5	44.5	12.7	38.2
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966325	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	11.5	14.1	7.4	12.5	8.5	16.4	13.5	5.7	8.8	13.8	7.9	13.8	8.7	13.1	8.3	12.5	12.9	6.4	11.6	6.5	7.1	13.4	12.3	12.2	14.0	8.7	7.9	18.9	14.2	10.1	12.7	9.9	8.8	15.1	8.9	7.7	12.6	8.4	16.7	12.5	13.5	9.0	5.1	13.3	13.3	11.9	10.3	10.4	20.8	9.3	12.9	14.4	12.4	11.1	13.0	25.6	15.0	29.3	14.7	11.7	22.7	22.9	17.9	25.3	18.5	34.4	17.7	23.1	13.9	19.5	18.5	18.1	35.4	22.1	19.8	42.0	20.8	49.6	28.0	33.4	11.1	37.9	22.7	14.6	14.3	31.0	11.2	16.2	18.6	17.8	54.3	9.3	15.9	19.4	21.4	28.6	32.8	12.9	21.6	28.2	14.4	20.1	17.3	24.9	17.9	14.4	20.5	29.3	14.2	12.4	32.3	10.9	21.3	16.6	20.3	14.4	14.3	16.7	13.5	22.7	22.3	26.7	21.5	0.1	4.4	1.3	7.7	7.7	6.0	7.3	5.5	6.4	6.1	5.9	4.4	6.0	0.2	7.6	12.4	4.2	5.4	4.8	7.4	8.5	5.7	8.8	6.5	7.1	8.7	7.9	8.8	5.1	10.3	11.1	8.1	16.0	9.6	18.9	15.6	13.8	14.6	5.1	10.8	11.8	10.3	8.3	20.4	7.2	9.2	11.0	8.4	10.6	13.2	6.5	1.9	11.7	7.2	9.1	11.7	11.2	9.0	12.4	13.8	13.3	9.2	13.6	10.2	9.8	15.2	15.5	4.6	6.9	12.3	6.7	13.1	8.4	6.1	7.6	8.7	9.5	10.8	9.8	3.6	24.4	16.8	5.4	8.2	11.1	15.5	14.5	5.6	7.2	15.1	15.3	6.4	9.8	12.8	13.5	0.0	14.1	12.9	16.6	15.1	11.8	11.5	11.4	15.1	10.4	7.8	11.4
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		NA	No			"Cluster 15: NK-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	17.6	13.0	6.1	14.9	9.2	12.2	14.6	7.6	8.6	12.5	7.2	12.2	10.3	12.8	6.3	11.8	11.4	8.2	20.3	6.6	9.2	8.5	15.2	10.6	14.9	7.6	7.7	14.9	12.4	10.5	13.5	11.2	7.9	10.3	9.3	10.4	10.1	7.7	29.6	13.6	9.2	10.7	6.1	10.8	11.9	16.3	8.7	11.3	12.6	17.6	12.5	12.2	11.6	13.1	56.2	60.5	35.9	103.0	25.1	15.9	49.0	50.3	20.7	44.6	48.0	50.7	47.9	74.0	26.8	23.0	64.8	37.0	53.2	42.6	57.4	37.1	51.0	74.4	43.0	47.1	22.3	94.7	63.9	18.1	27.4	59.4	35.5	16.8	41.9	40.3	141.6	42.0	35.1	45.2	68.3	54.0	68.5	38.5	47.0	53.4	42.8	70.7	21.8	37.5	40.0	48.4	65.0	107.2	34.8	42.6	27.6	28.7	40.4	64.4	33.6	57.7	61.9	42.8	39.5	126.0	42.4	78.2	70.8	3.8	11.0	4.6	12.6	9.2	8.7	12.8	10.7	11.6	11.5	13.4	9.7	11.1	9.7	12.3	8.1	14.1	7.4	5.8	6.1	9.2	7.6	8.6	6.6	9.2	7.6	7.7	7.9	6.1	8.7	13.1	22.7	16.0	31.4	33.3	23.2	16.2	17.1	16.2	24.5	54.9	16.3	17.8	28.8	10.0	27.7	12.9	93.8	20.8	27.5	9.1	25.4	22.3	2.5	21.3	50.3	25.3	11.4	20.4	13.1	22.9	26.5	25.7	21.4	22.5	36.7	30.3	9.7	14.8	19.1	40.4	17.6	14.9	14.2	12.9	10.2	3.3	27.7	17.9	5.4	7.5	18.9	18.6	37.0	18.6	15.3	18.7	8.2	20.7	17.7	19.0	8.1	16.7	17.1	56.1	6.6	51.3	26.4	42.6	44.7	19.1	14.5	18.6	24.4	34.6	16.4	14.8
RETSAT	FLJ20296	ENSG00000042445	"Retinol saturase"	Q6NUM9	2	85341955-85354531	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 247.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 264.9;Proximal enterocytes: 249.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 197.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007961, HPA046513"	Uncertain		Uncertain	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	Nucleoli		"HPA007961: AB_1079802, HPA046513: AB_2679680"	"unprognostic (6.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.95e-10)"	"unprognostic (2.73e-2)"	"unprognostic (5.34e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.90e-2)"	247.0	52.3	16.5	17.6	20.9	3.8	63.9	19.8	15.8	18.9	27.3	89.6	167.0	16.0	38.4	36.9	15.7	32.0	20.3	14.9	20.0	54.9	115.9	24.6	11.7	21.0	20.0	17.0	37.5	36.9	7.2	11.6	20.0	32.5	73.5	9.5	27.8	23.6	68.3	48.8	142.4	22.0	19.2	11.7	60.9	14.6	19.9	12.2	47.4	55.1	19.9	19.0	23.7	23.7	52.7	30.1	16.8	40.0	197.8	37.0	22.1	37.8	46.5	22.5	31.5	20.9	36.2	18.5	30.3	29.6	17.9	42.6	22.9	65.6	21.6	22.8	15.9	9.0	23.5	50.6	47.6	17.9	19.3	48.6	87.2	28.7	38.1	51.4	37.6	15.4	9.7	43.1	42.0	11.0	12.5	9.0	5.6	52.6	36.2	8.1	33.7	23.9	39.1	30.1	8.3	13.8	31.4	59.9	101.8	11.2	28.2	2.9	30.0	25.3	13.8	23.5	19.9	23.0	22.9	7.2	30.9	20.5	17.6	0.0	3.8	1.8	4.8	4.0	6.2	2.6	3.5	6.0	4.0	1.5	2.5	2.5	3.7	5.1	8.7	2.7	4.2	3.4	16.5	20.9	19.8	15.8	14.9	20.0	21.0	20.0	20.0	19.2	19.9	23.7	7.3	28.9	29.6	5.9	4.5	11.3	10.8	18.6	12.5	3.7	13.0	7.9	21.7	21.5	15.5	12.9	18.8	10.9	4.3	264.9	0.0	23.7	27.6	9.7	6.8	9.7	10.8	2.5	5.7	36.1	6.5	9.0	56.1	16.6	10.8	5.5	7.5	54.7	9.9	11.8	4.5	45.0	8.2	10.4	8.6	60.0	14.6	7.4	30.2	7.5	8.3	8.3	10.3	6.6	12.1	32.7	79.2	12.4	10.3	11.8	249.9	17.8	11.9	4.9	0.0	7.7	8.8	2.9	3.1	24.9	14.9	8.5	7.7	9.9	56.6	9.8
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 174.8;Spermatocytes: 256.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013739			Approved	Nucleoli		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.60e-1)"	6.4	7.2	1.1	6.5	1.1	5.6	4.2	1.5	1.6	4.1	1.9	6.1	8.0	2.6	11.3	3.4	2.6	4.1	3.5	1.1	1.3	4.9	17.4	6.7	6.7	1.6	1.2	2.6	5.6	6.9	1.7	6.2	1.3	4.4	7.1	1.6	4.8	2.2	3.6	3.1	7.1	4.4	1.2	4.0	3.7	64.9	1.4	5.0	5.4	2.1	7.4	7.3	1.8	1.2	7.1	3.2	3.5	4.4	12.6	8.3	6.3	8.6	5.5	8.1	9.3	9.5	2.7	10.9	14.2	8.1	16.0	8.0	11.7	6.9	11.9	9.7	11.2	9.2	7.2	9.3	8.0	13.3	13.1	9.6	3.9	7.0	3.3	3.7	7.7	3.0	23.7	6.3	6.1	8.5	6.0	6.2	1.2	10.9	7.6	7.6	24.1	5.7	5.5	4.9	2.0	3.8	12.0	3.0	17.2	4.9	14.3	25.8	4.8	12.6	11.1	7.2	7.7	9.3	26.4	6.0	8.8	7.7	6.5	32.5	17.3	31.4	7.6	21.8	10.7	14.3	7.2	8.8	15.5	8.8	9.1	8.3	8.6	13.9	28.0	9.9	9.9	11.9	1.1	1.1	1.5	1.6	1.1	1.3	1.6	1.2	1.3	1.2	1.4	1.2	12.5	0.0	7.4	5.5	23.3	11.3	14.5	15.1	9.6	9.5	13.4	10.2	6.3	4.3	12.4	9.2	20.9	36.1	23.2	17.0	5.9	14.0	174.8	12.5	9.3	7.5	4.2	13.3	24.7	14.4	36.4	16.6	12.8	8.4	19.0	24.5	13.2	29.5	44.5	18.5	19.7	7.6	12.2	24.5	16.6	77.3	9.0	26.6	17.8	23.4	35.1	4.9	16.5	14.6	8.0	13.3	25.0	11.7	14.1	9.3	17.2	10.4	23.0	8.6	19.7	8.2	11.0	256.4	44.2	15.8	9.7	28.9	16.8	12.5	11.4	10.2
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229302	"Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 82.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 26.7"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009861, HPA074448"	Approved		Supported	Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"CAB009861: AB_2180141, HPA074448: "	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.2	38.0	19.9	6.2	11.7	17.5	13.6	51.1	13.1	10.5	10.2	6.9	2.6	6.0	4.7	17.3	6.8	9.1	7.2	3.7	12.6	12.6	28.7	11.2	6.2	7.8	36.0	9.9	14.0	10.1	7.6	2.9	5.9	5.7	3.5	37.8	8.5	5.5	41.4	82.8	6.3	5.4	4.5	9.3	6.2	13.9	49.6	4.3	12.8	20.3	7.5	5.2	9.2	4.2	0.1	0.8	2.7	0.0	3.4	1.7	0.9	1.3	1.5	1.2	1.4	1.8	0.5	0.0	0.6	3.4	3.6	0.5	6.1	2.6	2.2	2.9	5.2	0.0	0.4	2.9	1.3	0.0	0.3	7.8	0.6	3.3	0.0	1.1	11.6	11.2	0.2	73.2	5.1	0.2	0.6	0.0	2.1	1.9	1.1	0.1	2.4	1.1	2.4	0.5	1.9	4.4	0.3	0.6	0.1	7.3	0.0	0.0	0.3	10.1	4.5	4.2	0.1	41.7	62.1	0.2	17.0	0.0	1.2	0.2	0.1	0.0	23.2	0.0	26.7	1.4	17.4	16.0	0.0	0.1	5.4	11.5	0.5	6.5	0.1	0.7	16.3	4.7	19.9	11.7	51.1	13.1	3.7	12.6	7.8	36.0	5.9	4.5	49.6	4.2	32.5	41.7	31.7	2125.3	23.4	185.2	30.1	17.0	55.2	167.5	24.7	16.1	26.3	30.0	23.4	58.8	454.5	0.7	185.3	1.4	13.7	21.4	148.8	26.9	52.9	40.8	18.5	42.5	627.1	12.3	1.9	69.4	11.7	36.1	2.5	7.9	34.2	97.2	0.8	126.2	1056.8	3.3	10.2	9.1	35.8	97.1	46.6	8.3	60.5	757.0	4.7	50.4	250.3	1524.0	114.9	8.2	0.5	87.3	88.7	24.0	0.7	44.6	16.0	160.0	39.5	57.9	32.2	1.9	3.8	73.2	423.4	4.7	237.6	11.5	2.1	61.9
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84498352	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	24.4	21.6	13.7	19.0	17.4	44.9	24.7	14.7	19.4	23.5	15.8	28.1	17.7	26.0	23.0	27.0	23.2	14.1	34.2	13.5	15.4	28.0	26.1	20.5	26.8	13.7	14.0	20.7	22.8	18.8	21.0	14.9	13.8	20.8	20.9	16.8	21.9	15.5	42.7	26.1	23.2	18.1	13.4	26.2	25.6	25.3	13.9	29.4	23.3	23.9	28.1	24.9	23.3	14.8	43.1	29.2	36.6	30.2	27.1	35.5	40.5	46.8	36.5	53.2	47.0	21.4	17.6	31.9	50.1	33.9	89.0	31.7	54.3	43.2	57.7	51.0	57.6	85.2	30.7	37.8	37.2	80.0	25.4	29.0	63.0	56.0	39.2	30.7	42.6	60.7	79.9	40.7	46.9	21.8	76.3	53.0	91.5	43.0	62.5	48.3	58.5	25.7	51.3	47.6	45.2	42.2	27.7	52.7	107.3	32.8	29.6	53.4	30.3	40.1	41.3	64.8	90.4	29.5	39.0	73.0	19.2	71.0	37.0	64.0	35.2	34.6	41.4	41.0	45.4	65.4	46.0	42.0	37.4	58.6	51.3	50.7	14.7	52.6	46.3	39.5	52.9	47.4	13.7	17.4	14.7	19.4	13.5	15.4	13.7	14.0	13.8	13.4	13.9	14.8	28.2	38.5	39.5	7.2	35.8	34.7	41.5	71.6	12.0	15.7	20.4	19.6	39.3	30.0	43.0	16.5	16.7	35.5	51.7	18.0	74.3	60.3	72.7	34.9	27.6	35.0	33.5	17.2	10.1	64.1	33.1	25.0	16.8	26.5	65.2	18.6	28.9	36.6	44.0	8.4	9.8	29.6	28.5	31.7	30.2	13.2	32.6	28.4	28.4	9.4	37.0	30.1	60.8	8.5	10.4	53.0	23.6	35.0	16.2	26.8	21.7	67.4	53.8	25.6	46.0	23.4	43.3	94.7	63.7	18.0	32.7	27.5	40.3	21.4	36.0	39.7
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 555.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	14.0	12.9	9.1	12.3	9.4	12.4	19.8	12.4	11.7	14.0	15.1	16.3	15.8	15.0	16.7	16.2	19.3	11.2	13.0	9.4	9.5	17.2	19.4	13.8	20.1	8.9	9.0	14.6	15.2	14.2	13.4	11.5	8.9	13.9	16.7	13.4	14.4	12.1	19.0	17.2	16.6	12.5	8.8	17.7	15.4	48.1	9.3	15.6	16.2	14.8	18.0	17.6	13.3	10.1	40.6	29.4	15.6	20.3	20.7	21.2	27.9	18.7	14.0	29.0	29.3	29.6	40.3	33.2	19.3	17.6	23.7	36.2	31.8	32.4	26.2	26.0	28.6	34.3	17.3	26.2	44.4	19.5	27.5	25.3	43.8	23.4	20.5	21.9	23.2	33.0	40.1	22.7	22.0	32.6	34.9	20.9	18.0	49.0	14.0	28.3	15.9	41.5	37.0	15.3	14.7	18.5	25.7	44.4	53.6	25.6	39.7	30.8	18.8	13.1	22.8	28.3	25.2	31.6	36.5	44.9	25.8	23.3	12.6	21.9	48.5	49.7	49.1	49.0	48.6	58.7	49.7	60.8	51.9	66.0	57.2	52.4	16.2	41.5	40.8	52.3	47.3	43.4	9.1	9.4	12.4	11.7	9.4	9.5	8.9	9.0	8.9	8.8	9.3	10.1	15.5	16.0	22.0	4.2	24.0	31.5	41.9	34.7	14.2	14.2	22.5	26.0	7.1	11.5	40.3	9.2	6.2	30.2	18.6	18.6	27.4	34.2	555.3	54.4	18.7	19.2	13.2	15.2	3.3	33.2	42.1	15.7	16.8	16.0	12.7	15.5	19.6	32.4	24.7	8.4	3.5	25.4	36.7	18.8	12.6	231.1	23.6	13.4	8.8	5.6	21.6	17.7	33.0	4.5	5.5	29.6	16.8	19.9	14.5	46.8	26.9	33.9	89.2	31.0	13.1	14.9	14.6	68.0	34.6	17.2	36.1	32.2	21.5	23.6	24.0	43.8
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator 1 homolog"	Q15050	8	66429014-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Supported	Nucleoli		NA	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	18.6	14.6	9.8	12.0	9.9	6.5	14.4	9.1	8.9	14.3	10.3	15.5	8.2	19.2	3.8	18.3	16.6	3.6	16.7	8.1	8.5	14.0	14.9	9.8	10.2	14.5	9.9	17.2	41.0	6.0	6.2	5.9	9.9	10.9	5.2	4.4	11.4	6.9	50.0	16.9	12.0	7.4	9.7	13.1	19.0	5.1	11.4	6.5	8.4	14.5	9.5	18.6	13.8	8.6	68.2	83.7	16.9	35.7	17.8	14.3	27.2	41.7	18.3	31.6	23.3	37.7	43.8	91.3	14.2	22.1	44.6	62.5	41.7	47.5	34.7	50.6	70.2	72.8	25.4	67.8	26.3	43.6	37.2	18.9	37.7	34.9	46.1	12.9	20.8	27.5	64.7	37.6	23.3	78.6	87.3	79.2	109.5	76.0	97.2	18.4	21.6	38.3	44.8	54.9	23.0	50.6	20.4	33.4	48.9	17.4	57.6	38.5	36.0	58.5	53.4	49.5	97.5	67.1	64.7	69.8	27.2	68.0	40.4	0.0	13.1	1.0	14.1	17.5	24.8	9.3	17.6	16.5	22.7	8.8	16.1	18.8	0.4	17.3	12.1	10.6	14.2	10.2	9.8	9.9	9.1	8.9	8.1	8.5	14.5	9.9	9.9	9.7	11.4	8.6	8.6	32.1	16.2	3.6	10.0	70.0	42.9	17.9	20.5	9.7	11.8	9.9	29.6	8.6	18.3	12.9	12.5	21.2	13.1	7.1	11.7	28.7	0.2	6.9	16.4	14.6	6.7	13.2	1.5	28.3	23.1	13.6	11.7	8.9	7.6	11.5	12.5	14.8	20.3	6.7	2.8	13.4	8.2	12.2	11.9	1.0	19.0	9.8	23.2	0.0	15.6	8.6	26.8	0.5	2.0	22.1	9.5	17.3	8.7	37.9	3.4	30.0	9.6	13.1	19.7	28.9	21.6	6.2	16.8	19.6	59.8	38.6	20.1	17.9	22.1	30.6
RSPH14	RTDR1	ENSG00000100218	"Radial spoke head 14 homolog"	Q9UHP6	22	23059415-23145021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.0"	"Group enriched"	"Detected in many"	6	"Early spermatids: 139.7;Late spermatids: 252.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 7.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 7.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;RPTEC TERT1: 4.2;U-266/70: 4.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA018420, HPA050425"	Approved		Uncertain	Nucleoli		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA018420: AB_1856496, HPA050425: "	"unprognostic (8.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.28e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.73e-2)"	0.3	2.0	7.7	0.2	9.4	0.2	0.4	5.9	11.8	1.0	9.4	0.6	0.2	0.8	3.5	0.4	12.4	1.3	0.4	8.3	9.9	7.3	0.4	1.5	0.2	8.6	10.9	3.9	0.9	2.4	3.7	0.1	7.7	0.8	0.2	11.4	0.6	1.7	0.7	1.1	0.3	0.3	7.6	0.5	0.7	25.0	7.2	0.1	1.9	0.1	0.2	0.2	0.4	9.5	0.2	2.5	1.9	2.0	0.0	0.9	0.1	0.0	0.5	0.4	0.4	0.4	0.7	0.5	0.7	0.0	3.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.1	0.1	1.0	0.0	0.2	0.4	0.0	1.2	0.0	0.8	0.0	1.0	0.0	0.3	0.3	0.4	0.0	0.6	0.0	0.1	0.0	2.0	4.2	0.0	2.7	0.9	0.0	0.0	0.1	0.1	0.3	0.5	0.0	1.5	0.5	0.1	0.0	4.9	1.9	1.6	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	7.7	0.1	1.8	0.0	0.0	0.6	7.7	9.4	5.9	11.8	8.3	9.9	8.6	10.9	7.7	7.6	7.2	9.5	1.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	1.1	0.2	0.5	0.1	1.5	3.7	0.0	4.2	0.0	0.2	0.0	7.9	1.0	139.7	17.8	0.5	0.4	0.0	0.0	3.5	0.2	0.0	0.5	0.0	0.5	0.0	1.2	0.7	0.0	0.1	11.8	2.8	0.1	0.0	0.0	0.0	252.0	2.1	0.3	0.0	0.0	0.0	4.6	0.0	1.0	1.1	0.4	0.0	1.9	0.1	0.2	0.0	17.7	29.2	5.1	0.0	0.8	0.9	29.4	8.3	0.0	0.0	0.0	0.4	2.8	0.1	0.3
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364304-151372707	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 509.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 525.6;Distal enterocytes: 1056.9;Erythroid cells: 590.9;Hepatocytes: 501.5;Paneth cells: 451.4;Undifferentiated cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.9;HEL: 120.5;HSkMC: 75.9;OE19: 92.8;SK-BR-3: 274.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		59000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	128.3	18.7	49.8	24.9	53.0	95.9	76.3	45.5	54.8	57.0	47.4	509.3	74.7	31.3	43.4	31.8	132.7	52.2	69.1	47.1	48.2	77.2	261.7	181.0	10.9	47.8	51.0	49.4	29.0	11.9	15.0	20.4	46.5	44.2	471.7	3.9	61.6	48.8	72.9	25.2	94.2	49.5	46.9	51.1	126.4	6.1	51.0	7.1	115.1	138.1	6.8	58.3	29.3	45.7	0.0	17.2	31.9	1.8	144.9	59.1	8.4	5.9	2.6	3.1	6.5	18.1	5.4	0.0	30.7	10.7	0.0	0.4	0.0	0.4	2.8	0.1	14.8	120.5	53.1	28.9	30.5	0.2	0.0	75.9	1.0	5.3	0.1	0.4	19.0	0.0	12.4	0.0	8.0	13.2	0.0	0.0	26.6	92.8	32.2	0.1	1.7	0.7	7.1	0.0	0.4	0.7	0.5	274.4	0.0	25.1	49.4	1.8	1.8	0.0	1.1	16.8	0.1	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	49.8	53.0	45.5	54.8	47.1	48.2	47.8	51.0	46.5	46.9	51.0	45.7	36.6	294.9	525.6	38.2	4.0	10.8	27.7	56.4	30.7	0.3	73.0	59.9	135.7	75.8	123.9	5.5	0.0	2.4	1.9	1056.9	115.4	17.1	0.7	30.9	14.9	27.5	155.0	590.9	0.1	9.1	2.1	85.2	163.6	14.1	27.3	10.9	26.0	501.5	15.3	0.0	0.1	137.2	79.3	39.6	12.4	4.2	66.5	3.9	33.8	13.1	0.2	37.4	0.0	0.0	2.0	6.5	451.4	80.9	0.8	25.6	251.0	148.3	101.5	1.4	52.6	15.6	102.3	0.1	0.3	22.7	9.9	4.0	5.7	30.5	452.4	71.0
SERTAD3	RBT1	ENSG00000167565	"SERTA domain containing 3"	Q9UJW9	19	40440844-40444335	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068262			Approved	Nucleoli		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA068262: AB_2685965"	"unprognostic (1.56e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.50e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-3)"	31.9	21.5	10.9	18.7	12.5	22.7	23.3	12.1	11.8	19.9	12.3	29.8	21.5	22.5	26.6	25.9	24.8	25.5	27.9	10.7	12.3	21.2	17.3	24.0	21.8	14.1	12.6	25.8	14.9	22.4	17.7	31.4	13.0	29.1	22.9	2.5	18.0	27.0	27.5	19.4	19.8	27.4	12.4	24.8	24.4	16.1	12.3	16.0	24.8	37.1	16.2	26.1	24.5	14.2	36.6	65.3	22.4	30.4	25.7	38.4	32.6	28.3	38.8	39.7	34.3	24.9	27.2	16.6	12.6	37.9	23.9	12.6	23.0	28.3	21.7	19.2	10.7	11.4	21.5	21.3	31.4	3.2	34.7	35.7	37.3	24.6	17.9	31.7	33.3	8.0	34.6	11.9	32.0	55.4	7.1	14.2	12.7	30.8	17.5	10.1	15.1	14.6	31.4	27.6	3.6	15.1	25.6	42.1	22.9	33.7	37.3	30.6	28.7	34.2	27.7	27.4	23.2	19.0	10.5	14.7	27.5	12.7	15.6	44.8	59.0	66.1	18.5	59.2	19.0	39.9	20.4	20.5	64.7	36.6	14.8	17.7	80.3	22.5	51.7	69.8	17.6	40.0	10.9	12.5	12.1	11.8	10.7	12.3	14.1	12.6	13.0	12.4	12.3	14.2	78.4	9.6	12.0	2.9	42.0	46.1	55.8	139.9	91.6	4.6	81.5	50.9	10.5	11.5	45.4	23.9	4.2	89.8	44.2	40.7	31.3	32.1	11.4	26.0	24.8	42.1	49.1	3.0	0.3	30.5	105.4	38.9	27.5	30.7	21.0	13.2	33.9	6.6	35.0	3.3	0.5	50.8	42.7	27.0	55.3	6.9	28.6	32.1	33.8	8.4	29.1	19.3	4.1	1.5	3.7	37.1	48.5	30.5	16.3	50.5	47.8	22.7	28.0	0.8	59.2	20.2	50.4	15.7	20.0	64.2	43.0	187.4	33.6	17.6	30.6	49.8
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	6.5	3.7	2.6	2.2	4.3	2.6	8.5	4.2	3.3	8.4	1.9	3.9	2.7	10.3	4.6	4.5	8.5	5.3	3.4	3.0	2.3	6.4	3.3	2.7	2.9	3.6	2.8	12.1	5.1	3.4	3.7	3.7	3.4	7.9	4.3	2.1	5.7	6.1	3.8	4.8	3.1	10.4	2.5	2.8	3.7	4.2	4.0	6.0	7.4	5.1	2.8	5.5	5.2	6.5	3.7	3.2	9.8	2.1	23.1	7.6	9.9	4.1	1.2	3.9	3.7	3.5	2.9	9.9	4.2	2.3	7.2	3.1	8.9	6.1	4.3	6.8	7.6	12.5	6.1	5.6	2.7	5.9	5.1	9.1	4.7	3.0	0.9	3.6	5.7	11.2	8.3	3.6	6.2	5.2	8.9	3.7	9.5	2.4	5.7	10.3	9.6	4.1	3.6	5.1	7.8	11.4	4.9	6.1	5.3	6.2	5.9	3.4	3.8	5.8	8.0	4.9	5.4	4.9	12.3	24.1	2.1	6.7	4.9	0.7	0.4	0.5	0.8	1.2	0.7	1.0	1.0	1.1	0.4	1.3	1.6	2.0	0.0	0.2	0.8	0.6	0.7	0.6	2.6	4.3	4.2	3.3	3.0	2.3	3.6	2.8	3.4	2.5	4.0	6.5	4.8	0.0	5.0	4.9	2.4	2.4	8.0	12.0	10.8	5.8	6.6	13.7	6.6	2.8	10.8	0.0	0.0	25.5	1.9	2.7	13.7	11.2	0.7	3.8	6.3	5.6	3.6	5.5	6.4	13.4	12.1	8.9	5.6	4.4	1.3	13.9	4.2	2.6	5.7	0.0	6.9	2.8	10.2	2.1	1.5	1.9	9.6	2.7	0.0	4.7	4.1	4.6	2.1	7.1	11.7	6.6	4.4	13.2	1.8	4.4	2.0	6.0	6.7	2.8	6.6	7.0	8.1	7.5	6.4	6.0	0.6	16.3	2.8	16.9	5.6	3.6
SMKR1		ENSG00000240204	"Small lysine rich protein 1"	H3BMG3	7	129502531-129512918	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"testis: 123.6"	"Group enriched"	"Detected in many"	50	"Early spermatids: 1894.5;Late spermatids: 6100.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 19.7;SCLC-21H: 32.8"					"Low region specificity"	"Detected in all"			HPA078358			Approved	Nucleoli		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoli		"HPA078358: AB_2686883"	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.67e-2)"	0.3	1.1	5.2	0.4	5.9	0.1	1.9	4.2	5.8	0.5	4.1	0.1	0.4	0.3	1.4	0.4	6.6	0.2	0.1	5.4	5.5	0.8	0.1	0.3	0.9	4.5	5.0	0.2	2.3	6.4	6.1	0.2	4.7	0.4	0.2	0.7	0.2	0.3	0.1	0.4	0.4	0.1	4.5	0.5	0.4	123.6	6.4	0.3	0.7	0.1	0.8	0.1	0.2	5.2	13.4	13.0	0.4	11.1	0.0	0.0	0.1	0.0	0.4	1.1	1.1	0.1	3.4	0.0	1.1	0.7	7.2	1.6	2.3	0.1	1.6	12.6	1.3	0.0	2.5	0.0	2.3	0.2	8.2	0.1	5.5	3.3	2.3	1.4	0.4	7.9	0.7	0.3	0.6	19.7	2.5	1.2	1.5	3.4	11.2	1.3	0.0	2.9	4.7	0.0	32.8	9.0	9.6	1.1	0.8	2.1	3.0	1.7	0.1	0.0	0.3	7.3	2.8	3.2	4.5	0.2	4.5	0.5	0.9	0.0	0.0	0.0	1.3	0.0	0.6	1.0	0.2	0.7	0.0	0.8	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.1	5.2	5.9	4.2	5.8	5.4	5.5	4.5	5.0	4.7	4.5	6.4	5.2	0.1	3.2	0.0	1.0	6.4	0.1	2.2	1.1	2.2	1.4	8.9	10.9	0.3	0.0	1.4	5.5	0.0	0.0	7.7	0.1	9.8	2.3	1894.5	21.1	0.3	1.9	9.0	0.4	2.9	6.2	0.3	1.0	1.5	0.9	0.0	2.1	0.7	0.0	0.1	0.0	2.3	0.0	4.1	0.3	0.4	6100.1	37.6	2.3	1.8	0.0	0.8	1.1	40.2	0.5	0.3	3.0	0.0	27.4	2.4	5.3	0.0	1.9	12.6	0.6	0.0	1.1	0.7	78.8	29.7	1.4	0.3	0.1	5.3	0.1	0.2	1.2
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123458088-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Supported	Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli		"HPA059145: AB_2683926, HPA067031: AB_2685766"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	19.0	20.0	33.1	16.0	34.8	17.6	18.7	36.2	46.3	24.2	33.4	20.8	15.4	22.2	15.1	26.2	19.0	10.3	41.2	32.7	35.3	29.2	26.4	19.1	20.1	34.6	34.0	17.1	19.2	20.5	24.5	16.8	34.1	24.9	17.8	18.3	23.7	12.7	79.5	26.5	23.3	16.2	32.0	30.8	22.9	16.4	34.8	18.7	23.3	43.3	19.3	18.4	21.4	37.2	22.8	23.7	28.1	14.4	20.0	18.6	24.6	19.5	28.4	20.1	14.6	14.9	15.3	45.0	14.0	28.4	14.5	23.0	24.3	34.9	17.2	33.0	19.7	21.1	22.0	34.6	14.0	21.8	32.5	22.7	24.0	18.0	17.1	36.3	27.8	14.0	27.5	8.9	28.4	48.0	23.6	49.1	19.6	30.5	22.4	18.0	12.3	24.0	46.8	45.2	23.9	35.3	17.3	36.1	28.2	27.8	43.6	29.1	32.4	13.3	24.3	16.9	17.7	22.0	23.8	26.6	21.7	21.1	18.6	81.0	45.6	74.3	43.3	48.5	43.0	71.5	54.3	49.2	47.0	66.2	41.9	45.2	70.2	47.9	47.0	47.8	79.3	36.8	33.1	34.8	36.2	46.3	32.7	35.3	34.6	34.0	34.1	32.0	34.8	37.2	21.4	51.3	20.1	14.0	25.0	14.0	19.1	57.3	13.1	30.9	16.3	19.3	29.5	18.6	36.7	33.1	12.5	51.6	31.3	26.9	50.9	35.2	38.3	26.1	21.2	22.5	14.9	29.2	8.4	33.6	34.8	19.3	27.0	22.9	13.3	19.9	23.9	27.1	33.1	15.2	12.1	22.4	44.7	17.0	10.2	10.9	24.2	19.3	16.0	11.2	35.9	37.1	39.1	12.1	27.1	35.0	33.4	25.9	15.9	20.6	37.4	48.9	32.5	28.6	32.9	19.0	24.1	25.3	24.2	18.9	14.5	42.0	24.4	18.3	18.1	25.4
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891084-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 310.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	32.0	10.9	21.6	38.3	19.8	64.2	23.0	14.6	19.7	50.4	44.7	123.8	30.7	139.8	46.4	22.9	61.1	44.6	56.1	26.8	12.3	83.5	26.2	32.4	53.8	17.8	14.3	24.7	28.3	134.2	16.8	41.3	15.4	22.7	28.3	9.6	20.5	40.2	110.0	12.2	35.3	91.2	14.4	39.8	34.3	48.1	13.0	59.0	56.7	149.9	41.3	51.6	23.8	16.8	23.2	26.1	46.7	50.5	16.4	45.3	40.2	61.9	103.6	57.3	58.0	15.0	73.8	118.6	15.0	41.5	72.1	1.0	35.8	45.0	87.6	9.4	20.2	45.9	17.1	31.6	26.2	85.7	50.0	55.4	8.9	35.3	24.4	47.7	89.4	81.6	57.0	19.8	60.3	17.7	119.5	80.5	26.3	3.6	23.6	104.9	75.8	34.7	47.3	42.4	40.7	36.5	23.0	21.1	25.6	104.9	20.5	65.4	61.4	75.1	84.3	19.0	91.4	48.1	63.7	310.4	32.8	76.9	68.2	2.9	7.6	23.2	3.8	25.2	6.2	7.1	3.7	3.1	7.4	9.0	3.3	4.2	20.5	9.7	28.2	6.2	3.3	3.9	21.6	19.8	14.6	19.7	26.8	12.3	17.8	14.3	15.4	14.4	13.0	16.8	38.3	12.8	6.7	50.9	42.0	7.9	14.0	5.0	4.6	12.4	15.1	9.8	73.9	22.8	8.3	27.6	0.0	20.1	30.7	26.0	76.3	13.8	27.6	19.4	27.6	39.9	44.3	11.6	75.9	40.8	27.6	15.5	7.1	25.8	2.5	24.3	27.8	19.8	31.0	10.1	37.7	11.9	36.7	68.6	21.4	50.2	23.3	52.2	10.6	91.8	51.0	9.8	25.7	45.8	9.2	38.7	17.6	19.9	40.7	37.3	13.1	77.3	14.8	1.1	39.5	17.4	79.5	13.0	19.4	3.4	8.7	29.1	32.0	7.4	11.9	35.9
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787253-128810430	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 55.5;Oligodendrocytes: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 23.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No		9300	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	13.5	21.6	32.3	9.1	30.8	14.7	13.4	23.2	32.3	13.8	19.9	15.3	12.3	13.9	14.0	11.8	14.5	8.6	18.7	30.9	28.1	27.8	16.6	11.2	10.8	29.8	28.9	18.7	17.5	28.4	15.4	9.9	29.6	17.3	8.3	7.1	18.6	13.8	20.7	12.2	15.9	12.9	25.6	19.3	17.0	7.2	29.9	10.9	17.8	13.6	10.9	14.1	10.9	30.0	9.5	22.5	23.1	23.2	29.3	14.1	22.5	22.4	19.0	22.7	14.7	24.6	12.5	15.9	15.2	26.6	22.6	25.1	14.2	17.8	13.3	12.6	16.1	17.0	27.4	22.7	18.1	25.9	33.3	19.8	20.7	19.7	11.8	20.1	29.6	16.6	26.7	10.5	27.4	20.5	15.8	15.2	22.0	26.3	33.5	17.7	21.4	36.1	16.7	12.3	23.2	16.3	31.1	19.7	13.4	22.3	21.0	24.1	23.7	28.3	17.7	23.2	18.4	13.3	18.5	15.5	20.7	15.4	20.8	23.0	2.7	4.8	4.2	2.7	4.4	4.7	3.3	4.2	3.0	3.2	2.9	5.0	2.0	3.4	2.1	8.3	2.6	3.6	32.3	30.8	23.2	32.3	30.9	28.1	29.8	28.9	29.6	25.6	29.9	30.0	6.9	3.2	9.0	9.4	7.2	2.3	2.6	3.4	4.6	10.1	9.6	9.1	12.1	2.8	4.2	16.5	10.4	5.2	6.6	8.8	9.8	6.1	1.5	4.2	6.7	9.4	5.4	7.8	11.2	9.9	4.7	6.4	9.7	5.9	8.2	10.9	16.1	14.8	17.6	6.7	10.5	4.7	4.1	8.5	2.5	2.9	9.3	6.7	0.0	5.6	55.5	6.5	9.2	11.1	36.6	8.5	5.2	7.5	5.4	3.5	15.9	26.0	4.8	5.8	6.6	5.6	4.9	5.1	8.6	5.7	3.1	2.5	6.5	9.7	6.8	2.1
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972053-1982929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 113.8;Late spermatids: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	3.6	3.5	1.8	3.2	2.2	2.1	3.9	4.5	2.7	3.4	1.0	3.4	2.4	3.8	0.6	4.9	3.0	1.4	4.7	2.3	2.3	3.3	3.1	2.8	2.3	3.3	2.0	3.7	5.9	2.8	2.4	1.2	3.4	2.8	1.0	1.5	4.8	1.1	10.6	5.4	3.5	1.4	1.7	3.0	3.7	6.8	1.8	2.0	3.1	3.1	1.5	3.3	3.5	2.7	7.1	13.4	3.6	7.2	3.5	2.8	11.8	6.4	4.2	5.4	4.4	17.3	13.3	9.4	14.6	4.9	4.9	18.8	5.9	7.5	2.8	6.9	8.5	5.9	7.1	6.6	4.0	10.3	5.4	2.8	5.5	6.7	3.9	4.3	6.8	5.6	12.1	6.7	3.2	11.3	13.2	5.8	8.6	6.2	5.4	23.1	6.7	15.7	2.6	2.7	8.4	6.5	5.8	14.6	6.0	3.5	11.1	6.9	10.8	7.4	8.8	6.6	12.6	12.1	5.6	15.0	4.5	6.5	8.7	4.5	9.4	5.5	10.6	11.0	9.3	6.4	7.6	10.4	10.4	6.9	9.7	7.4	2.2	14.5	11.8	5.3	9.2	8.5	1.8	2.2	4.5	2.7	2.3	2.3	3.3	2.0	3.4	1.7	1.8	2.7	9.1	3.2	12.2	2.3	11.9	13.0	15.8	21.9	12.0	13.0	12.6	10.4	16.4	7.2	16.4	18.4	8.4	26.4	10.7	23.4	7.9	25.4	113.8	7.4	8.5	11.2	13.8	18.5	2.0	22.5	26.0	10.5	20.4	9.7	14.7	14.5	7.1	12.7	19.6	10.1	2.1	16.1	18.3	8.9	6.6	72.1	14.9	8.5	7.2	0.0	24.1	13.6	9.2	2.0	2.0	24.0	22.0	10.9	13.5	15.6	31.9	16.9	8.8	9.8	26.3	11.1	24.7	21.8	20.8	13.7	18.3	22.4	11.1	11.6	24.2	14.4
TENM2	"KIAA1127, ODZ2, Ten-M2, TEN2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 9.8;heart muscle: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No		11000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.1	0.5	2.9	0.0	4.7	0.0	1.9	0.0	9.8	1.3	0.0	0.2	0.4	0.0	0.5	1.9	0.1	0.4	35.1	6.0	1.2	0.8	1.3	0.2	0.0	0.6	0.1	0.7	0.1	0.0	0.7	0.0	1.6	2.2	0.1	4.1	0.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.1	1.3	4.3	2.2	0.4	0.5	1.0	0.1	2.0	0.0	0.1	0.0	13.4	0.0	0.0	0.4	0.0	1.9	0.0	0.7	1.8	0.0	0.0	0.0	0.0	66.1	1.7	0.0	0.0	43.0	0.8	43.3	0.0	0.0	0.2	0.0	2.0	0.0	0.0	3.0	7.4	0.3	5.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	9.8	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.1	2.4	3.8	0.1	0.0	74.6	64.0	0.1	50.0	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.7	0.0	9.8	6.0	1.2	0.6	0.1	1.6	0.0	4.3	0.0	0.5	0.0	0.0	512.9	0.0	14.8	1.1	20.3	33.6	15.5	0.3	13.0	144.0	0.0	1.4	0.0	18.8	0.0	0.0	1.0	0.0	3.4	23.5	0.1	0.3	1.7	0.0	0.0	706.2	0.2	0.0	2.2	0.0	0.2	1.3	1.6	0.4	5.1	0.1	121.1	965.9	0.7	0.0	0.0	1.2	18.2	4.4	0.2	1.8	36.5	0.0	2.3	0.0	21.6	12.8	0.0	0.0	61.7	0.0	1.4	0.3	0.0	0.6	1.8	0.0	0.4	1.5	1.2	1.1	1.4	1.7	0.0	0.1	0.0	0.4	0.1
TNFAIP1	"B12, B61, BTBD34, EDP1, MGC2317"	ENSG00000109079	"TNF alpha induced protein 1"	Q13829	17	28335602-28347009	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Pancreatic endocrine cells: 112.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 166.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013333, HPA014641"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoli		"HPA013333: AB_1858160, HPA014641: AB_1858159"	"unprognostic (4.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.32e-2)"	"prognostic unfavorable (7.48e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.43e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.02e-2)"	36.1	30.4	32.4	19.3	31.1	8.1	30.3	28.5	32.0	22.0	38.6	19.9	17.7	21.7	14.9	39.6	19.2	28.9	46.7	30.9	29.1	35.9	54.8	40.9	17.0	30.3	30.1	17.4	37.6	23.0	17.5	44.7	29.4	20.5	16.9	26.3	23.9	20.5	23.3	29.0	17.7	30.9	28.9	50.2	25.4	17.2	35.7	22.0	24.0	23.8	19.5	35.1	23.4	28.9	43.3	61.3	40.2	28.4	34.3	30.1	39.0	50.4	62.4	60.6	47.6	166.1	25.8	8.7	34.4	67.0	29.4	49.1	22.3	86.9	46.5	24.0	28.0	7.7	66.0	24.2	45.9	13.5	12.5	38.9	99.7	47.7	37.0	56.9	71.7	17.4	20.0	12.8	28.8	25.8	25.6	7.4	9.3	36.4	22.3	11.3	50.8	15.5	89.5	45.9	29.3	31.7	62.3	102.5	25.8	55.8	42.9	11.4	76.4	44.2	43.7	34.4	39.3	20.8	18.7	9.3	34.3	9.0	28.5	1.7	7.2	9.5	6.5	7.0	7.7	5.3	4.7	5.9	9.3	3.9	4.5	5.5	2.5	9.1	8.7	4.5	4.3	5.0	32.4	31.1	28.5	32.0	30.9	29.1	30.3	30.1	29.4	28.9	35.7	28.9	66.6	38.5	12.9	5.5	4.6	24.6	47.5	32.0	12.5	25.6	18.2	11.9	21.8	20.0	17.5	22.0	16.7	31.5	6.2	14.3	23.5	60.5	40.1	23.0	13.9	62.4	17.4	7.4	11.7	82.5	34.9	13.5	12.8	30.2	7.0	14.0	60.3	29.5	11.0	11.8	7.5	11.0	10.2	12.5	12.1	6.9	7.8	7.0	0.0	9.4	30.1	10.0	4.1	7.1	7.2	112.9	15.1	7.9	7.1	46.9	13.6	16.9	20.2	9.8	13.1	10.9	22.3	5.4	5.6	15.9	28.4	69.2	5.0	18.1	9.7	43.0
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048932-69136316	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.5;Melanocytes: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	5.8	3.8	2.2	4.8	2.9	4.4	5.2	4.8	3.1	8.9	0.2	11.7	7.6	8.9	3.2	4.6	8.5	3.8	3.9	2.2	1.3	7.5	11.1	4.5	5.8	0.7	0.2	5.8	3.6	2.7	4.2	3.0	0.8	7.2	3.9	4.4	4.1	5.7	4.2	10.0	7.2	4.8	0.1	6.3	4.7	3.2	1.5	3.0	4.3	1.4	4.2	6.3	5.9	3.2	4.6	8.8	3.5	4.9	2.7	3.0	10.5	3.6	3.9	4.7	2.4	8.5	12.4	3.5	5.0	6.9	3.2	9.6	3.2	5.8	2.0	2.7	3.3	7.7	13.7	1.9	3.2	6.5	8.5	4.0	3.2	2.2	2.8	2.4	4.9	8.4	4.7	16.7	2.7	6.9	4.4	9.4	2.4	11.5	3.1	4.6	3.3	6.8	5.1	8.0	2.8	3.6	5.9	11.4	17.0	4.3	7.0	9.1	5.2	3.5	4.5	6.4	4.0	6.8	2.9	4.0	7.7	5.5	8.3	2.9	10.2	2.6	0.9	9.9	0.8	2.4	1.8	2.1	7.7	1.8	1.8	1.9	7.0	6.2	11.7	3.1	2.7	4.4	2.2	2.9	4.8	3.1	2.2	1.3	0.7	0.2	0.8	0.1	1.5	3.2	4.5	9.6	1.5	10.1	6.7	4.0	2.7	3.0	2.2	1.8	2.8	2.5	3.1	5.7	2.3	12.9	2.1	2.6	6.1	4.4	17.6	7.2	17.7	2.1	5.6	4.2	0.0	8.2	30.5	8.6	4.8	4.0	8.6	3.4	2.5	7.3	5.3	18.4	11.9	0.0	22.4	2.6	2.0	12.6	5.5	2.7	6.2	10.2	35.6	4.7	7.7	2.5	3.1	26.2	4.5	4.8	2.6	6.8	8.3	1.5	8.8	9.1	0.8	4.9	6.6	5.1	5.7	2.2	4.4	1.9	3.4	1.9	3.6	3.2	3.6	2.1
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	7.5	6.2	5.3	7.5	5.3	11.4	7.0	6.3	7.2	5.9	1.1	5.2	4.5	5.1	5.5	8.7	4.7	8.1	8.3	6.1	3.0	11.2	12.6	7.3	7.1	2.8	2.1	5.4	6.7	8.6	4.6	7.3	3.4	6.0	5.9	10.4	5.7	5.2	8.5	5.5	4.7	6.3	1.6	6.7	5.5	9.5	3.3	7.0	9.1	10.0	7.1	9.7	6.2	4.2	10.3	7.0	8.2	8.0	13.0	14.4	6.8	10.8	12.6	10.6	10.8	5.9	11.1	4.8	8.6	11.7	15.7	10.0	11.2	11.7	16.7	7.7	7.2	10.3	6.5	9.0	8.9	5.6	12.9	10.6	12.2	12.4	21.9	8.5	13.4	5.6	5.1	9.7	16.1	8.7	11.8	6.4	6.2	14.3	13.0	3.8	7.5	4.1	19.7	11.6	5.6	6.5	8.5	26.4	13.2	8.4	13.4	10.0	11.8	12.2	9.4	9.7	8.2	8.7	9.5	3.6	11.2	8.2	11.2	23.8	13.1	17.4	4.7	12.8	5.8	6.8	4.8	3.6	9.1	6.8	4.3	5.0	33.1	7.0	14.4	11.9	6.1	6.9	5.3	5.3	6.3	7.2	6.1	3.0	2.8	2.1	3.4	1.6	3.3	4.2	28.7	16.0	14.0	40.1	30.3	55.3	26.4	32.1	19.4	35.5	26.7	14.7	24.3	37.1	22.9	53.3	16.7	18.4	35.0	14.2	50.9	23.2	154.5	18.3	21.0	35.3	23.3	26.5	117.0	17.4	20.0	24.9	13.3	26.9	21.0	16.8	26.0	28.7	39.9	42.1	91.8	12.1	22.4	50.3	107.9	56.8	20.5	45.7	42.7	104.9	67.0	28.8	21.6	66.9	67.7	20.9	12.4	18.8	21.3	34.1	14.7	76.1	19.2	32.2	19.7	27.3	39.9	39.4	30.4	20.9	64.5	55.1	31.0	30.6	12.9	40.9
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis homolog"	Q14146	1	229626247-229660200	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	4.9	2.8	2.2	3.9	2.6	4.5	3.2	2.6	2.4	2.1	1.9	2.6	2.2	3.2	1.8	3.7	2.8	2.6	2.6	2.0	2.3	2.2	2.8	2.1	4.5	2.6	2.7	2.9	4.7	2.5	4.3	3.3	2.5	2.0	2.4	2.6	2.3	1.8	6.9	3.0	2.5	3.3	2.6	3.0	2.7	5.7	2.5	4.6	2.2	4.5	4.7	4.9	2.2	3.1	13.6	20.1	12.8	17.2	7.9	6.5	39.1	10.6	6.6	16.1	12.1	20.1	10.4	28.0	11.9	7.6	8.6	18.3	32.0	13.0	14.6	13.8	30.4	17.5	16.8	11.9	7.5	25.8	14.5	6.4	9.3	16.0	12.4	4.1	7.8	16.2	37.7	12.7	10.1	10.7	29.0	12.6	43.1	24.1	13.2	32.0	18.2	27.9	7.1	17.0	19.1	23.4	12.5	12.9	10.6	4.4	14.6	14.6	8.6	13.1	16.6	16.8	30.8	13.9	14.4	41.6	7.0	19.0	24.4	0.1	0.9	0.2	1.2	1.7	2.2	0.8	1.1	1.4	1.1	1.0	1.6	1.3	0.1	0.8	0.6	0.7	1.4	1.4	2.2	2.6	2.6	2.4	2.0	2.3	2.6	2.7	2.5	2.6	2.5	3.1	5.4	0.0	1.1	3.6	6.0	10.1	8.6	1.8	4.0	6.4	5.1	4.3	2.7	1.5	2.6	5.5	29.2	5.3	4.5	2.0	0.0	2.4	0.4	2.8	5.0	4.6	6.6	6.9	7.1	2.7	11.7	3.6	4.1	3.2	0.0	3.5	3.9	3.7	2.8	3.3	7.2	2.5	4.1	1.3	2.7	0.9	2.1	2.8	5.4	6.5	2.7	2.6	2.1	10.1	7.0	2.7	0.8	3.4	4.4	8.7	0.6	2.3	1.3	16.7	0.0	11.6	4.0	8.0	4.0	5.5	9.1	3.3	4.2	3.1	3.1	5.5
UTP23	"C8orf53, MGC14595"	ENSG00000147679	"UTP23 small subunit processome component"	Q9BRU9	8	116766505-116849463	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044418	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA044418: AB_10961139"	"prognostic unfavorable (5.18e-5)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.45e-3)"	"unprognostic (7.73e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.27e-2)"	11.8	7.9	5.6	10.1	6.6	33.2	9.6	8.1	6.7	7.8	4.3	7.1	6.2	9.6	6.5	7.2	8.1	7.9	7.1	5.7	6.0	6.8	7.4	7.8	15.4	5.6	5.5	13.7	9.7	8.1	4.8	9.6	5.7	8.1	5.6	9.6	9.0	6.4	8.6	8.0	7.8	7.4	6.1	10.3	7.7	6.8	5.4	8.2	12.3	6.2	8.9	7.9	5.9	9.0	22.0	22.7	12.9	11.3	17.9	21.3	9.8	21.9	13.3	14.1	15.6	23.8	14.2	34.4	20.5	10.5	14.1	16.1	18.2	12.8	17.4	33.5	35.3	42.5	18.3	16.2	19.1	21.2	19.7	18.6	13.8	15.7	19.1	9.2	15.4	25.9	27.7	22.6	14.1	38.3	50.2	12.4	11.8	35.9	44.1	28.1	14.2	29.7	8.9	19.8	22.7	18.3	14.2	53.8	21.5	6.5	25.8	14.6	16.4	14.7	20.3	35.7	30.9	30.8	48.9	39.7	18.8	27.4	17.4	49.7	24.6	32.6	39.5	26.6	34.2	43.1	35.2	31.2	22.1	41.6	47.7	33.2	24.6	28.1	37.0	36.1	43.6	26.4	5.6	6.6	8.1	6.7	5.7	6.0	5.6	5.5	5.7	6.1	5.4	9.0	33.6	41.7	33.1	36.2	31.0	21.9	27.0	17.4	31.9	23.2	16.7	29.2	23.4	27.1	23.4	7.3	6.2	28.3	24.8	9.9	27.4	17.3	13.9	18.0	37.0	28.7	12.0	12.4	62.6	20.7	17.9	32.9	21.9	20.6	41.8	24.3	25.0	13.8	16.6	16.8	62.2	16.6	14.2	12.6	10.5	4.8	28.9	18.5	10.6	15.9	24.0	27.4	20.6	42.3	43.0	12.4	9.4	28.6	32.0	28.7	9.0	16.2	19.2	22.4	13.1	39.5	26.4	44.0	20.3	26.6	16.2	19.8	29.5	28.8	16.6	19.1
VSX1	"PPCD, PPCD1, PPD"	ENSG00000100987	"Visual system homeobox 1"	Q9NZR4	20	25070885-25082141	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Sensory transduction, Transcription, Transcription regulation, Vision"	"Developmental protein, DNA-binding"	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 14.8;retina: 35.5"	"Cell type enriched"	"Detected in some"	23	"Bipolar cells: 465.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	4	"cerebellum: 14.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Karpas-707: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079607			Approved	Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli		"HPA079607: "	"unprognostic (1.93e-1)"	"unprognostic (6.63e-2)"		"unprognostic (9.68e-3)"	"unprognostic (4.33e-2)"		"unprognostic (2.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-9)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.38e-1)"	0.0	0.9	3.4	0.0	3.3	0.5	0.1	14.8	2.8	0.1	1.7	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.2	2.9	3.5	0.0	0.2	0.0	0.1	3.2	3.3	1.4	0.4	0.7	2.9	0.0	3.2	0.2	0.1	35.5	0.1	0.3	0.5	0.2	0.1	0.0	3.0	0.1	0.1	0.2	3.4	0.7	0.2	0.2	0.0	0.2	0.0	3.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	3.4	3.3	14.8	2.8	2.9	3.5	3.2	3.3	3.2	3.0	3.4	3.4	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	0.0	465.9	0.1	0.0	1.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	5.3	0.0	19.6	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease variant, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 113.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA037796: AB_2675673, HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.91e-2)"	9.1	6.3	3.5	9.4	3.5	9.9	10.1	4.7	4.5	7.4	4.1	7.0	6.5	9.0	6.6	7.9	6.8	7.2	6.0	3.9	4.1	7.5	14.1	6.3	11.3	3.6	4.0	10.1	6.4	7.3	4.5	7.5	3.8	8.3	8.1	4.7	6.0	7.0	9.1	10.1	6.8	7.5	3.8	8.8	7.3	6.3	3.9	9.1	9.7	7.2	12.0	9.8	6.1	4.2	17.0	14.9	13.7	36.6	24.7	32.2	19.2	14.6	13.9	19.5	27.9	19.1	19.7	53.8	17.0	12.2	22.7	19.2	26.8	33.8	34.8	15.9	15.7	26.6	17.2	19.5	26.3	25.6	38.8	19.2	21.4	34.6	37.5	36.5	20.3	18.4	32.3	18.1	25.8	14.3	31.7	24.9	18.3	16.8	15.6	25.6	29.9	42.4	18.1	19.3	24.3	19.5	18.6	15.2	22.4	15.0	15.2	21.3	19.1	28.1	15.6	20.0	30.5	18.1	14.0	48.6	22.4	37.9	22.2	0.3	2.5	1.0	3.3	3.3	3.8	2.7	3.0	3.7	4.0	2.4	4.3	3.6	0.1	3.3	5.0	2.1	3.8	2.6	3.5	3.5	4.7	4.5	3.9	4.1	3.6	4.0	3.8	3.8	3.9	4.2	17.2	19.2	13.8	15.3	26.0	61.1	15.4	18.3	113.3	9.9	14.5	12.1	15.6	18.6	19.6	16.5	6.2	9.4	15.4	5.3	7.9	9.5	5.1	10.6	26.0	20.4	6.0	20.6	30.5	13.8	9.9	20.7	13.7	16.2	14.0	16.9	12.5	35.1	14.7	11.8	24.8	12.9	16.2	24.1	16.0	4.2	8.7	18.2	21.4	20.6	18.3	5.7	16.5	27.6	22.3	9.9	6.4	11.3	27.5	20.8	5.3	11.3	12.3	8.6	19.7	20.2	17.3	18.5	17.8	42.3	57.8	5.3	18.0	18.1	13.4	11.2
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289247	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043004, HPA055425"	Uncertain		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA043004: AB_10967417, HPA055425: "	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	19.4	19.0	2.2	14.1	2.4	12.6	18.9	1.8	3.8	21.2	2.5	16.4	13.5	23.6	13.6	19.1	17.4	3.2	12.8	2.7	2.7	15.6	17.1	14.7	10.6	2.2	2.4	17.3	19.2	3.0	19.7	5.5	2.6	16.8	11.2	3.0	18.7	2.7	26.1	23.9	15.6	9.6	2.2	20.4	16.7	14.8	2.5	6.3	16.4	12.6	18.8	19.6	17.8	3.5	0.9	21.1	15.3	61.2	11.4	1.6	56.2	42.3	4.9	0.2	7.0	27.8	15.5	49.4	35.5	22.5	60.2	23.4	3.9	31.0	19.3	31.6	32.2	65.6	20.3	54.0	10.4	56.6	74.2	12.5	5.2	18.4	9.5	15.6	0.0	26.6	37.5	13.8	6.8	23.3	32.1	46.8	45.1	8.5	18.3	47.1	28.1	40.3	9.3	20.7	30.9	40.3	20.4	44.4	46.9	18.3	17.2	37.8	30.9	37.9	42.8	31.6	64.3	56.5	104.3	83.5	16.4	55.9	35.3	12.1	17.3	6.2	24.9	28.7	21.4	16.1	18.2	22.4	27.9	18.9	17.0	21.7	1.2	28.1	33.9	13.7	18.6	20.1	2.2	2.4	1.8	3.8	2.7	2.7	2.2	2.4	2.6	2.2	2.5	3.5	21.0	0.0	11.7	2.9	30.4	43.7	30.8	40.7	28.5	14.4	23.8	20.2	7.2	17.2	25.7	23.9	6.2	44.0	33.9	20.4	11.7	43.5	65.0	19.0	30.9	22.9	13.8	13.7	11.1	43.0	48.7	27.7	20.4	24.3	21.6	35.1	14.6	26.4	28.9	13.5	6.5	21.5	22.4	19.0	24.1	23.3	25.7	22.0	17.8	5.6	29.0	17.9	36.0	2.5	2.8	33.1	15.6	23.0	25.0	38.0	18.2	37.8	14.7	10.1	13.1	35.7	28.3	42.3	37.2	23.6	42.6	38.2	26.1	46.8	31.9	30.0
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573670-9593457	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 213.9;Glandular and luminal cells: 262.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	12.7	5.6	1.5	14.1	1.3	23.0	46.1	2.4	2.3	21.5	2.8	18.4	10.6	62.6	24.5	46.3	18.6	49.0	43.0	1.2	2.3	16.8	57.8	11.6	24.8	2.8	4.0	10.9	10.1	17.8	8.4	34.6	3.6	21.2	14.4	4.5	17.4	12.7	10.4	57.1	13.5	35.0	2.2	8.1	17.2	31.5	2.0	23.7	26.6	7.2	30.2	53.0	15.4	1.9	43.1	16.4	69.1	38.8	65.2	29.8	125.9	48.8	44.8	29.3	29.8	33.8	53.3	100.7	18.0	27.6	30.8	48.8	49.0	23.3	41.1	33.3	30.7	43.1	30.1	26.2	7.0	66.6	39.7	12.0	25.3	13.8	53.8	34.9	21.6	43.6	64.0	75.8	55.7	13.2	63.5	39.4	97.6	36.9	18.5	57.6	54.5	24.6	28.1	100.0	25.0	31.8	39.9	48.6	29.2	89.3	27.1	32.9	21.7	51.1	35.2	23.0	42.2	14.4	51.1	140.1	23.3	36.5	41.0	0.0	0.0	6.0	1.7	0.0	0.2	8.0	1.7	3.0	0.1	4.7	0.1	1.3	0.1	1.9	0.0	0.1	7.1	0.6	1.5	1.3	2.4	2.3	1.2	2.3	2.8	4.0	3.6	2.2	2.0	1.9	17.2	51.3	33.9	0.0	36.8	176.4	170.4	38.5	213.9	1.8	168.5	67.2	61.1	65.8	53.5	42.3	0.0	94.8	11.2	54.7	13.7	24.9	25.0	160.1	86.2	18.7	61.1	40.4	0.1	13.6	200.1	39.2	52.5	262.4	7.0	28.5	9.7	85.0	17.0	1.7	0.4	65.6	18.3	2.5	21.9	41.7	11.8	10.0	17.8	1.0	2.4	9.9	8.2	2.0	0.1	24.8	38.5	10.9	17.2	82.7	35.9	8.3	62.6	7.1	6.6	180.7	23.7	61.4	44.4	181.4	191.1	137.2	19.0	11.8	55.5	85.5
ZNF136	pHZ-20	ENSG00000196646	"Zinc finger protein 136"	P52737	19	12163064-12189871	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA054120			Approved	Nucleoli		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoli		"HPA054120: AB_2682389"	"unprognostic (1.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.46e-3)"	"prognostic favorable (4.75e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	5.6	5.6	1.9	5.9	2.7	15.5	7.6	6.1	3.7	5.8	2.6	4.4	2.7	8.4	6.0	4.1	6.5	5.4	3.9	1.7	2.8	5.8	3.9	6.0	7.6	2.7	2.4	12.0	4.6	7.2	3.0	7.0	3.1	6.7	5.4	7.2	4.4	5.2	2.2	4.5	4.6	6.4	2.1	7.9	6.7	7.4	2.7	7.9	9.0	4.3	7.1	5.3	4.7	4.0	2.7	1.6	9.3	9.8	4.9	5.6	5.5	5.2	5.4	5.3	5.1	1.8	1.0	13.4	6.8	3.7	4.7	3.0	4.3	3.0	6.0	6.8	6.8	7.4	4.5	3.0	3.6	15.6	13.1	5.9	5.5	4.4	5.6	7.0	3.4	11.5	6.0	20.6	6.1	3.6	11.4	7.5	11.0	1.0	5.8	10.1	12.0	5.1	5.1	9.6	9.8	8.7	7.8	1.7	6.1	7.7	4.1	8.9	7.3	12.9	4.6	5.6	5.2	14.6	26.1	14.7	5.2	6.0	6.6	15.3	3.4	7.9	6.3	3.3	7.9	7.8	7.5	7.3	3.9	8.1	8.1	7.0	9.4	8.2	3.9	4.4	5.4	3.8	1.9	2.7	6.1	3.7	1.7	2.8	2.7	2.4	3.1	2.1	2.7	4.0	9.3	6.4	7.0	4.6	16.4	5.5	10.5	4.7	4.0	18.6	6.3	5.8	3.1	8.6	8.2	9.2	18.8	7.6	16.5	5.4	5.9	6.0	2.2	5.9	6.4	9.0	10.2	10.8	5.0	3.8	6.8	10.1	4.1	6.6	8.2	23.4	8.9	3.1	5.7	20.2	6.7	5.6	4.1	10.0	6.9	3.1	13.4	7.8	1.8	2.8	11.6	14.3	22.6	8.0	6.0	4.2	7.4	14.7	6.1	8.9	5.0	4.1	3.5	15.9	6.6	11.3	9.5	31.5	23.7	2.4	3.1	9.9	12.5	13.6	3.9	11.2
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238771	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	25.9	21.1	22.6	25.6	30.4	12.5	41.6	26.6	33.9	33.7	20.5	26.8	23.1	37.0	21.9	24.7	28.1	22.4	23.7	21.5	26.4	29.2	32.4	23.4	35.3	28.4	30.7	40.5	22.8	33.4	28.2	32.4	30.9	30.5	31.5	31.2	24.4	26.4	46.3	27.0	21.8	32.6	24.0	27.0	25.2	12.1	27.9	39.6	33.9	46.4	37.5	34.4	23.2	36.2	70.2	96.0	79.8	77.1	57.8	64.5	42.5	60.2	55.4	57.1	56.2	43.5	49.6	67.7	94.6	56.0	37.4	31.8	102.6	70.5	102.3	105.5	57.2	113.0	37.4	52.7	67.4	180.1	74.9	52.8	106.5	55.1	156.0	60.0	71.7	72.6	122.2	72.3	69.4	45.9	84.1	42.2	108.1	122.2	57.7	96.1	80.3	58.2	69.4	67.7	100.7	63.5	74.7	93.0	66.1	81.6	41.5	90.9	55.0	64.0	76.8	50.6	107.1	50.2	63.7	95.2	44.9	88.0	83.1	7.9	11.2	8.7	15.8	13.8	22.7	19.1	18.1	16.0	13.6	17.4	23.2	21.4	2.6	14.9	22.4	6.9	16.8	14.9	22.6	30.4	26.6	33.9	21.5	26.4	28.4	30.7	30.9	24.0	27.9	36.2	21.4	44.8	29.0	21.5	29.7	23.6	30.8	20.5	22.8	10.8	26.7	22.1	45.4	21.5	28.4	20.2	10.4	34.3	26.3	11.6	35.2	27.7	18.3	16.7	35.5	22.8	14.5	25.0	29.2	18.0	48.7	26.9	16.3	23.6	20.8	28.5	20.3	20.8	18.9	11.8	33.4	24.6	14.2	17.8	14.0	20.9	25.1	15.5	10.6	19.7	18.8	9.0	28.8	37.2	121.1	25.0	13.7	19.2	18.6	38.1	9.0	21.2	23.7	10.3	6.6	30.2	29.6	13.0	10.7	24.5	29.8	23.5	29.9	20.0	26.4	29.6
ZNF275		ENSG00000063587	"Zinc finger protein 275"	Q9NSD4	X	153334147-153360110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.5"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 76.3;Peritubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 57.3"									HPA000566	Approved		Approved	Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA000566: AB_1080700"	"unprognostic (6.96e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.14e-2)"	8.5	77.5	10.1	5.1	10.5	3.1	7.6	10.6	9.7	7.9	10.1	5.2	3.9	8.4	17.6	2.8	8.5	7.2	4.4	9.5	11.9	5.5	13.5	4.1	6.3	11.3	10.8	42.6	10.1	32.3	11.0	3.1	11.1	7.2	4.3	5.2	6.5	14.5	4.8	2.4	6.1	7.3	11.7	11.1	6.0	8.5	12.9	6.3	6.9	7.3	8.0	4.7	3.0	12.7	10.2	4.1	8.4	6.1	10.0	9.6	4.1	7.0	11.7	4.4	6.6	4.3	2.1	17.0	14.0	13.3	6.7	1.7	10.1	6.2	6.5	4.1	7.8	5.7	3.8	6.6	13.4	7.0	4.8	11.4	4.5	3.7	7.2	7.2	5.5	9.2	8.5	0.0	8.1	7.4	8.2	5.8	3.7	10.3	7.2	9.6	9.3	6.0	3.3	6.1	4.3	5.8	3.5	0.3	8.4	5.2	1.5	13.0	5.8	6.5	7.8	10.9	9.1	57.3	16.9	32.9	5.9	13.5	4.6	0.3	0.8	0.1	1.6	0.7	1.9	1.9	1.5	1.5	0.7	2.0	2.1	1.8	0.0	1.4	0.7	1.3	2.4	1.0	10.1	10.5	10.6	9.7	9.5	11.9	11.3	10.8	11.1	11.7	12.9	12.7	26.1	0.0	4.6	7.8	10.9	3.3	4.0	3.6	3.4	6.5	6.2	3.9	5.2	10.0	2.3	9.2	12.5	1.4	9.8	2.6	7.9	2.8	1.3	4.5	15.3	6.6	0.0	8.2	3.8	5.0	4.4	10.5	8.6	8.8	2.5	76.3	7.5	28.3	2.5	0.0	4.8	5.8	4.1	6.0	3.5	4.4	14.3	3.5	3.6	2.8	4.5	6.5	6.2	7.5	3.7	3.9	3.2	39.5	28.7	6.1	2.1	8.3	1.6	2.8	13.1	12.8	11.8	3.5	3.7	4.3	2.3	0.8	7.0	21.5	5.3	2.1
ZNF286A	"KIAA1874, ZNF286"	ENSG00000187607	"Zinc finger protein 286A"	Q9HBT8	17	15699577-15720787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Oligodendrocytes: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 120.0"									HPA021594			Approved	Nucleoli		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 59: Non-specific - Transcription"	Nucleoli		"HPA021594: AB_2670768"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.47e-4)"	"unprognostic (4.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.94e-2)"	5.4	7.8	8.9	6.7	11.2	3.8	8.1	12.0	10.4	9.3	6.6	5.8	3.8	12.7	11.7	10.1	8.6	9.0	15.9	9.5	10.4	7.8	4.1	5.1	8.6	10.8	10.4	17.4	3.9	14.4	5.7	5.7	10.7	8.4	4.7	11.3	5.0	8.7	4.0	5.6	3.8	10.8	9.0	5.6	5.5	11.0	10.0	12.9	10.3	10.0	8.7	8.9	5.9	14.9	37.4	40.5	56.3	26.4	16.6	23.9	18.7	17.9	14.1	28.1	20.7	24.6	12.8	33.9	13.9	12.5	23.5	31.4	42.4	19.7	34.6	25.1	32.3	23.8	42.2	20.6	16.1	11.0	10.0	21.2	12.1	25.5	26.1	30.8	37.3	54.0	19.7	5.9	39.5	10.2	49.5	9.9	54.5	21.6	9.4	37.0	85.3	16.6	19.5	13.9	18.9	41.1	35.4	15.4	12.1	120.0	15.0	6.3	16.1	16.3	18.0	14.6	24.9	14.0	24.2	0.2	20.4	0.3	19.8	1.2	1.5	1.0	6.1	1.7	6.4	3.7	7.0	6.3	2.5	6.8	8.1	8.6	1.0	6.0	3.9	2.2	9.4	2.5	8.9	11.2	12.0	10.4	9.5	10.4	10.8	10.4	10.7	9.0	10.0	14.9	2.4	19.2	0.0	5.9	5.5	7.0	5.1	2.5	15.4	1.6	3.5	2.7	4.3	1.5	5.5	1.8	2.1	1.3	3.0	0.4	1.9	4.1	16.1	1.3	5.0	4.4	5.4	4.6	9.5	1.6	1.8	5.2	4.1	1.5	3.8	3.4	2.5	0.8	1.3	3.3	9.9	2.2	0.0	0.8	1.5	13.0	5.0	1.5	1.8	2.8	1.1	1.6	3.1	17.6	17.9	3.7	1.5	5.3	7.8	4.8	0.7	2.7	3.4	2.0	0.0	2.3	4.1	11.9	5.3	9.0	5.5	1.2	5.9	3.5	1.7	4.9
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.5;Excitatory neurons: 118.2;Inhibitory neurons: 122.4;Oligodendrocyte precursor cells: 54.3;Oligodendrocytes: 86.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	1.1	6.0	23.0	0.7	23.3	3.6	2.7	42.0	20.6	2.4	0.7	1.6	0.9	5.0	8.3	0.9	3.0	2.2	2.1	20.6	39.4	2.2	0.8	1.6	1.5	3.4	14.6	5.6	1.8	3.9	5.9	0.5	10.3	3.6	0.8	11.7	1.5	3.8	1.4	1.7	1.2	2.3	5.5	2.3	1.4	5.2	32.2	1.0	6.0	0.7	1.1	1.3	1.7	14.8	0.2	2.0	2.1	3.4	0.5	0.5	0.6	0.4	1.0	2.0	1.7	0.2	0.9	0.3	0.3	0.8	1.5	0.7	1.1	0.9	1.2	0.1	1.3	1.0	3.2	2.3	0.6	0.4	0.2	0.8	0.5	1.1	0.5	1.7	1.8	1.4	0.8	0.5	0.5	2.2	0.1	0.4	9.7	1.3	0.7	0.2	2.9	0.3	1.1	0.8	4.8	2.2	1.0	0.5	0.4	2.1	1.2	0.3	0.5	0.6	1.0	1.1	1.5	0.4	1.3	0.2	0.8	0.3	0.3	3.1	0.4	0.3	2.7	0.2	1.6	0.8	1.7	1.3	0.1	1.2	3.3	3.6	1.5	1.1	0.4	0.5	1.1	0.8	23.0	23.3	42.0	20.6	20.6	39.4	3.4	14.6	10.3	5.5	32.2	14.8	1.6	0.0	6.3	33.0	1.4	0.8	6.3	1.5	2.2	46.5	2.0	7.6	4.0	1.5	4.0	7.3	20.9	1.1	3.0	0.2	5.9	1.0	20.3	2.6	1.9	2.0	3.0	0.0	118.2	2.0	0.5	6.1	1.5	3.5	0.0	4.9	1.4	2.1	0.3	35.3	122.4	0.1	0.0	0.9	1.9	8.6	4.7	0.6	1.8	13.1	0.4	19.1	5.2	54.3	86.8	1.0	1.1	10.1	0.2	4.2	0.8	0.2	1.6	26.8	6.6	5.5	3.5	11.0	4.1	0.6	1.4	0.7	2.6	6.3	0.2	3.7
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 83.3;Inhibitory neurons: 64.3;Oligodendrocyte precursor cells: 30.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 5.5;SCLC-21H: 6.6"									HPA028982	Uncertain		Approved	Nucleoli		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	0.9	0.5	0.3	0.3	0.3	0.3	0.9	1.3	1.0	2.4	0.0	2.4	0.1	1.9	0.3	1.7	1.5	0.4	0.8	0.3	0.2	0.3	0.4	0.5	0.6	0.2	0.2	2.0	0.6	0.2	0.8	0.2	0.3	1.2	0.5	0.4	0.8	0.4	0.4	0.9	1.0	0.7	0.2	0.9	0.7	0.8	0.2	0.6	0.9	0.3	0.4	1.6	1.7	0.4	0.6	0.0	2.3	2.2	0.0	0.5	0.9	0.4	0.3	1.7	1.6	0.7	0.6	1.2	0.8	0.2	0.5	0.6	2.3	0.3	2.5	1.0	1.4	2.7	1.3	0.4	0.0	5.5	0.8	0.1	0.6	1.2	0.3	0.3	0.2	1.9	0.9	1.8	0.7	0.3	3.7	0.8	0.9	1.2	0.7	3.3	2.9	1.6	0.3	0.4	6.6	1.2	1.2	0.1	0.8	1.8	0.4	0.8	0.2	2.7	2.5	1.1	0.9	0.3	0.6	1.3	0.7	1.8	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	1.3	1.0	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.4	4.6	6.4	9.5	17.6	7.6	2.0	2.4	2.5	11.4	15.0	2.8	3.8	4.9	1.5	1.3	0.0	2.1	3.2	3.3	0.6	1.9	2.5	1.1	0.6	11.2	3.2	1.2	8.0	83.3	2.0	4.2	7.6	3.1	1.1	3.8	18.2	2.9	0.7	1.7	3.3	64.3	1.9	4.1	3.1	1.9	1.8	6.5	2.3	1.8	23.4	1.6	5.9	6.2	30.2	15.9	1.0	0.4	9.1	6.0	1.2	0.3	0.7	2.0	7.4	0.0	8.4	4.2	10.7	12.2	18.3	1.3	0.8	6.4	3.6	2.4	1.4
ZNF57	ZNF424	ENSG00000171970	"Zinc finger protein 57"	Q68EA5	19	2900898-2918473	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 30.7;Early spermatids: 95.2;Late spermatids: 64.7;Squamous epithelial cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA061915			Approved	Nucleoli		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 34: Spermatids - Unknown function"	Nucleoli		"HPA061915: AB_2684635"	"unprognostic (3.59e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.91e-2)"	"unprognostic (8.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.07e-2)"	"unprognostic (7.66e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.04e-2)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.34e-3)"	"prognostic favorable (4.11e-9)"	"unprognostic (6.26e-3)"	"unprognostic (2.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.49e-3)"	2.8	2.5	1.8	2.0	1.9	4.0	6.4	8.0	3.2	5.5	1.3	8.2	7.2	2.6	3.6	9.1	4.2	1.9	3.0	2.1	1.8	4.6	3.4	3.3	2.8	2.0	1.9	3.7	4.0	4.0	2.9	4.8	2.2	3.9	9.2	4.2	4.4	3.5	1.7	18.3	6.2	1.8	1.5	2.4	11.7	25.9	2.1	3.8	4.6	2.4	3.3	3.3	7.9	2.1	7.4	3.4	4.7	6.8	4.4	3.8	7.8	3.1	2.5	4.9	5.1	7.1	2.9	6.3	3.8	2.5	7.1	8.5	7.5	10.7	6.0	0.0	3.9	3.7	3.8	9.6	3.3	0.0	6.5	3.0	11.8	4.3	9.3	4.0	3.7	14.8	6.6	0.1	3.8	7.5	9.7	4.1	3.0	8.7	5.9	8.9	14.1	1.4	6.7	12.0	2.3	3.5	4.6	8.4	3.1	6.6	5.2	6.1	2.9	3.3	3.2	7.7	4.4	1.3	7.4	3.0	2.7	1.0	2.7	0.0	2.4	1.1	4.4	4.2	3.6	3.2	4.8	4.5	2.6	3.6	5.4	4.8	0.9	5.1	2.3	2.5	5.5	3.0	1.8	1.9	8.0	3.2	2.1	1.8	2.0	1.9	2.2	1.5	2.1	2.1	2.2	0.0	5.3	1.6	0.8	21.4	20.3	8.1	30.7	2.2	3.4	3.8	4.1	1.5	7.8	0.0	6.2	4.4	1.9	13.5	3.9	3.1	95.2	7.4	3.4	2.1	0.0	0.4	2.6	2.3	3.7	2.8	7.7	12.3	0.0	2.3	1.4	1.9	2.3	1.7	2.7	7.4	8.2	1.0	2.7	64.7	2.5	1.3	5.4	0.0	1.7	1.9	0.0	1.0	1.5	1.5	9.5	3.0	0.2	5.4	19.8	3.4	4.2	2.8	0.0	0.8	2.5	5.7	9.7	36.6	28.7	6.6	1.7	3.1	8.1	9.7
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887456-55942530	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 18.6;Excitatory neurons: 16.2;Late spermatids: 16.2;Oligodendrocytes: 25.6"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;eosinophil: 2.3;neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoli		"HPA059425: AB_2684013, HPA062887: AB_2684894"	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	0.6	0.9	1.2	0.6	1.2	1.6	1.2	1.6	1.6	0.9	0.3	0.7	1.1	1.7	1.0	0.6	1.9	0.8	0.7	1.1	1.1	1.0	0.6	0.8	0.6	1.7	1.3	1.7	1.2	0.6	1.8	0.7	1.7	1.2	0.5	2.4	0.9	0.8	1.7	1.1	0.7	1.0	0.7	0.9	1.4	3.8	1.5	1.5	1.3	0.7	0.6	0.4	0.4	4.2	1.0	0.4	3.5	3.5	0.3	0.7	1.3	0.4	0.3	0.6	0.6	0.3	1.3	1.5	1.4	0.3	1.1	0.3	0.8	0.3	0.4	0.9	1.5	0.4	1.5	1.1	0.7	2.0	1.1	0.8	0.6	0.3	0.5	0.8	0.8	2.1	1.1	0.8	0.5	0.7	2.3	1.4	2.6	1.2	0.7	1.6	1.0	0.2	1.7	1.8	3.8	5.2	1.8	0.6	0.7	1.7	1.6	1.4	0.7	0.6	1.9	0.4	0.6	0.9	1.2	0.7	0.4	1.1	3.2	2.1	0.4	2.3	0.2	0.4	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.3	3.6	0.4	0.4	0.4	0.1	0.1	1.2	1.2	1.6	1.6	1.1	1.1	1.7	1.3	1.7	0.7	1.5	4.2	1.8	0.0	3.7	11.4	1.2	1.3	3.8	2.6	0.6	3.0	1.6	0.8	1.8	7.2	3.3	0.0	10.4	1.1	0.8	1.3	0.0	1.2	18.6	6.5	2.5	2.2	0.0	3.0	16.2	1.4	1.0	1.6	1.1	2.4	1.3	6.9	1.1	0.3	0.4	8.4	13.3	1.6	4.1	1.3	3.1	16.2	0.6	1.3	0.0	3.7	0.7	6.0	0.0	11.6	25.6	1.6	0.3	2.6	0.1	2.1	0.4	0.5	8.2	2.9	6.6	3.9	2.2	7.0	7.7	0.9	1.8	2.1	1.3	1.2	0.9	2.3
ZNF790	"FLJ20350, MGC62100"	ENSG00000197863	"Zinc finger protein 790"	Q6PG37	19	36817428-36850787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA056134, HPA060288"	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoli		"HPA056134: AB_2683049, HPA060288: AB_2797260"	"unprognostic (1.14e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-2)"	3.6	4.9	4.0	3.8	5.8	2.2	4.3	9.9	5.4	4.2	5.1	3.1	3.9	3.4	3.0	4.5	3.2	5.0	5.5	3.9	6.8	6.0	8.7	3.7	5.4	7.2	5.6	4.5	4.5	5.8	3.0	3.7	6.4	4.0	2.6	8.1	3.1	3.4	5.0	9.7	3.8	3.4	3.6	4.8	4.9	11.3	5.4	4.3	8.0	5.0	3.4	3.6	3.0	7.2	0.0	0.8	6.7	12.2	4.6	4.8	4.3	4.8	6.4	3.8	6.8	0.0	1.5	1.5	9.4	3.5	4.6	1.8	5.4	4.3	3.4	11.4	4.8	8.1	0.7	1.9	3.9	3.6	5.8	6.2	3.6	3.2	0.0	4.4	6.5	6.1	0.3	0.1	8.5	3.8	9.4	2.9	4.6	0.0	0.9	1.6	5.6	6.2	4.1	9.0	8.4	7.6	4.5	0.1	2.6	7.6	5.5	6.7	7.2	5.2	4.0	4.7	6.4	9.5	14.5	5.6	0.0	0.2	4.2	4.5	2.6	5.1	3.9	4.3	4.1	6.8	5.6	5.6	4.8	7.8	5.8	4.9	0.7	4.8	1.6	4.0	4.9	2.3	4.0	5.8	9.9	5.4	3.9	6.8	7.2	5.6	6.4	3.6	5.4	7.2	5.0	3.2	1.1	14.7	7.5	1.8	3.4	8.3	5.2	24.9	3.7	3.0	4.0	7.2	4.3	7.3	31.3	6.9	8.7	4.3	5.9	5.3	109.1	3.8	5.3	7.9	2.4	10.1	12.4	5.1	3.5	4.5	4.1	4.8	4.5	10.6	5.7	5.6	4.3	11.8	14.6	3.5	10.2	4.6	4.0	33.7	8.4	2.3	3.6	16.9	5.0	10.1	24.7	21.1	17.9	4.6	2.4	4.9	1.5	3.5	6.3	10.6	4.3	28.2	0.0	4.9	5.1	6.9	2.9	3.3	4.1	5.9	7.4	8.7	3.1	6.8
ZNF837		ENSG00000152475	"Zinc finger protein 837"	Q96EG3	19	58367618-58381030	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 9.3"									HPA042833	Uncertain		Approved	Nucleoli		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoli		"HPA042833: AB_10806373"	"unprognostic (2.61e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.07e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (2.35e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.07e-2)"	1.2	2.5	0.8	0.4	0.8	0.1	1.7	0.6	0.8	2.3	1.8	1.7	0.9	2.4	0.0	2.4	3.1	0.1	0.6	0.7	0.8	3.2	4.9	1.0	0.4	2.1	2.3	2.8	3.0	0.5	2.9	0.1	1.1	2.8	0.1	0.9	2.4	0.3	0.3	3.1	1.9	0.1	1.5	2.2	2.0	2.1	0.9	0.5	4.1	0.0	0.2	1.5	1.8	1.3	1.5	0.7	0.9	1.0	0.1	0.3	1.6	1.4	0.3	0.0	0.1	0.3	1.5	1.8	1.2	0.0	0.6	0.4	0.1	0.0	0.0	0.9	9.3	0.8	0.2	0.1	0.3	0.6	0.5	0.5	0.3	0.1	0.1	0.3	0.1	2.3	1.1	0.5	0.1	2.0	4.2	1.7	2.4	0.6	2.4	3.6	0.4	1.8	0.2	1.1	2.8	3.6	1.1	0.9	1.7	0.1	1.1	0.8	0.4	2.1	0.1	0.6	0.5	2.2	1.8	1.6	1.3	0.3	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.8	0.6	0.8	0.7	0.8	2.1	2.3	1.1	1.5	0.9	1.3	1.1	3.2	1.8	0.0	3.2	0.9	1.2	2.2	6.2	2.6	2.9	3.2	1.4	1.5	1.7	3.7	0.0	1.7	0.4	2.3	7.9	4.3	4.3	2.3	1.8	1.4	1.2	0.8	1.1	5.2	1.2	1.6	2.6	2.0	0.0	4.8	1.8	4.0	1.0	1.7	1.0	3.2	4.1	0.8	0.3	0.6	1.8	0.8	3.6	0.0	3.0	2.2	4.1	2.5	1.1	2.9	2.4	1.2	0.3	2.5	3.0	6.8	0.6	0.6	0.0	2.1	1.8	2.5	5.8	2.6	1.7	2.2	2.0	4.7	2.8	1.1
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615610-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 13.2;Granulosa cells: 15.1;Muller glia cells: 13.2;Sertoli cells: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.1;SH-SY5Y: 29.5;U-2 OS: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoli		"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	4.1	2.8	24.8	2.3	24.7	0.6	4.5	20.4	24.0	9.6	11.8	12.9	1.1	11.3	4.4	4.3	9.2	4.5	10.5	23.7	23.7	4.9	0.5	3.7	2.9	27.8	27.9	12.0	7.0	5.5	6.6	2.8	25.1	7.8	1.7	5.1	5.4	8.6	27.1	3.1	4.4	6.6	25.6	3.5	4.9	2.6	24.8	3.3	7.9	20.2	2.0	10.1	4.9	21.0	0.0	1.6	4.7	20.1	0.2	0.0	0.2	0.4	0.0	2.1	0.4	3.6	0.8	0.0	7.8	0.0	0.7	0.0	7.2	0.2	2.0	0.0	2.6	0.6	0.0	3.8	2.8	0.0	0.1	0.7	0.6	0.2	0.1	2.0	0.0	1.6	3.2	0.1	1.3	0.1	0.5	2.7	7.5	0.0	0.0	2.3	7.8	0.1	1.5	7.6	6.3	29.5	0.0	0.3	1.2	3.9	1.1	4.3	0.0	1.5	19.5	0.0	1.9	0.4	0.1	0.1	0.0	0.0	7.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	24.8	24.7	20.4	24.0	23.7	23.7	27.8	27.9	25.1	25.6	24.8	21.0	4.3	0.0	0.0	2.0	1.0	0.5	1.5	0.2	1.2	13.2	3.2	4.4	10.4	0.0	0.6	7.3	6.2	0.0	2.0	0.1	0.0	0.6	1.6	7.5	4.3	3.2	1.8	0.4	1.5	0.7	0.0	4.4	0.5	2.3	0.0	15.1	2.5	0.0	0.1	5.0	2.7	0.0	0.0	0.0	0.9	2.4	5.3	0.2	3.6	1.9	0.1	13.2	1.0	2.0	2.8	0.4	0.1	8.6	1.3	3.3	0.0	0.2	2.3	10.4	13.1	6.4	5.4	0.5	0.5	0.4	0.3	0.3	1.8	6.9	0.1	0.7
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034025-58054631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.8;pituitary gland: 15.9;testis: 8.7"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 11.7;Early spermatids: 28.2;Endometrial ciliated cells: 21.8;Late spermatids: 19.6;Spermatocytes: 13.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HMC-1: 2.1;NTERA-2: 2.1;T-47d: 3.1"									HPA007938	Uncertain		Approved	Nucleoli		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoli		"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.1	0.9	3.7	0.0	2.7	0.1	0.9	4.1	4.6	1.2	1.4	0.3	0.0	0.6	6.1	0.1	2.1	0.2	0.5	3.6	7.8	2.6	0.1	0.5	0.0	4.0	5.3	0.6	1.0	2.6	15.9	0.2	3.1	2.4	0.0	2.3	0.4	0.8	0.0	0.2	0.1	0.1	2.1	0.2	0.1	8.7	5.1	0.6	5.9	0.0	0.0	0.5	0.3	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	2.7	4.1	4.6	3.6	7.8	4.0	5.3	3.1	2.1	5.1	1.6	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.2	0.0	3.4	1.8	2.2	1.1	1.5	0.2	1.8	2.1	0.0	0.0	0.0	11.7	1.7	28.2	21.8	3.1	0.5	0.0	0.0	3.8	0.0	0.0	0.8	0.0	1.7	0.0	3.2	0.4	0.0	0.1	3.3	5.4	0.0	0.0	0.0	0.0	19.6	0.9	0.1	1.8	2.8	0.0	8.1	0.0	4.0	1.8	0.3	0.0	0.0	0.0	0.9	0.0	0.2	4.3	2.6	0.0	0.0	0.6	13.7	2.7	0.0	0.0	0.0	0.1	6.7	0.0	0.5
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475891	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Oligodendrocyte precursor cells: 67.8;Oligodendrocytes: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;granulocytes: 1.7;monocytes: 4.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli		Yes	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoli		"HPA049593: AB_2680828"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	6.9	5.2	6.8	6.2	9.4	39.4	6.3	8.7	9.6	8.1	9.2	5.3	5.0	7.8	5.2	7.3	8.8	6.0	5.6	6.6	5.9	6.3	7.6	7.0	7.9	9.6	8.1	10.7	14.9	10.1	3.9	7.5	8.7	7.2	5.4	7.6	8.0	6.6	16.2	9.7	5.9	6.5	6.7	8.8	6.7	6.4	8.3	10.0	8.5	9.8	6.0	6.1	5.6	14.4	15.2	7.6	9.4	8.9	10.1	7.8	16.7	6.7	7.4	9.7	8.6	11.6	6.4	11.2	11.2	6.1	8.9	12.3	12.6	7.9	7.6	6.0	10.8	8.8	9.2	7.7	10.7	13.6	13.7	6.2	15.1	6.0	10.6	9.6	10.0	13.0	9.6	14.6	8.2	8.9	13.1	7.5	13.4	10.0	7.6	14.1	6.4	14.3	6.8	10.9	17.1	9.5	13.0	9.5	18.2	6.2	12.9	11.9	10.2	8.9	11.4	13.4	8.3	12.1	6.1	14.6	9.7	10.5	10.0	1.7	0.4	0.8	0.5	0.2	0.2	0.1	0.3	0.4	0.7	0.4	0.5	0.4	1.2	0.3	4.4	1.1	0.2	0.2	6.8	9.4	8.7	9.6	6.6	5.9	9.6	8.1	8.7	6.7	8.3	14.4	10.1	25.6	15.6	84.5	11.9	6.2	8.3	4.5	10.8	30.1	6.8	6.5	5.5	12.8	7.9	5.5	45.9	7.2	10.0	8.6	7.9	4.8	1.7	8.1	7.9	7.7	3.6	12.0	51.3	6.1	2.6	7.8	9.2	12.2	2.5	16.8	7.9	14.3	5.7	13.5	44.3	6.9	0.0	5.4	4.4	0.8	7.5	9.0	1.8	47.8	7.3	23.0	7.2	67.8	99.2	4.4	5.2	7.5	12.9	6.0	8.4	9.5	7.7	30.4	0.0	13.5	8.9	3.3	9.0	9.0	4.3	6.3	11.1	10.5	6.6	6.3
